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8This study came about as a result of working together with general practiti-
oners (GPs) and because of my interest in multilevel statistical techniques. 
As a methodologist for the Registration Network of Groningen (RNG), I 
contributed to the development of the longitudinal morbidity and medication 
registration programs used by the Department of General Practice Medicine 
in Groningen. The RNG was established and developed by the Department 
of General Practice Medicine at the University Medical Center in Groningen 
(UMCG). Besides for patient care, which is the RNG’s primary purpose, these 
data are meant to be used for research, education, and to help determine 
future directions 1.
The GPs who participate in the RNG have been collecting data since 1989. There 
are 17 GPs participating in the RNG: 3 in a solo practice and 14 in group practices. 
In 2008, the GPs from Groningen, 3 in solo practice and four in group practices, 
joined the University’s ‘General Practice Medicine’ Group Practice. All of the 
participating GPs use the same GP information system MicroHIS. MicroHIS is used 
for all daily practice activities. Every patient contact is registered. The diagnosis, 
referral indications, and medications administered and prescribed are coded 
according to the International Classification for Primary Care (ICPC). For each 
episode, a diagnosis is registered. Medications are automatically coded according 
to the Anatomical Therapeutic Chemical Classification System (ATC). An ’episode 
of disease’ is the period between the moment that a disease is clinically diagnosed 
until the moment that it has been determined the disease came to an end. In the 
GP practice, the term ‘episode of care’1-3 is used, which means: the period that 
starts from the first time the health problem is mentioned by the patient to the GP 
until the last contact with regard to this health problem.The end of the episode of 
care is not necessarily the end of the episode of disease. In this dissertation, the 
term ’episode’, meaning ‘episode of care’, will be used. The amount of medication 
prescribed is recorded in terms of the ‘Defined Daily Dose’ (DDD). DDD is defined 
as the assumed average daily dose of a drug used for its main indication in adults.
The RNG’s data structure is hierarchical; that is to say, the patients are nested 
under their GPs. This allows for a seamless application of multilevel techniques. 
The data collected in the general practices is always hierarchical. Differences 
among GPs and differences among patients are often studied. As a result, though 
much is known in these two areas of study, correlations between the two are not 
often described. Variability in the RNG data may exhibit a hierarchical structure, 
therefore any analysis of that data must take the structure into account 4. 
Some studies 5-9 have tried to explain the variation among practitioners, but 
few conclusions have been drawn. It is not sufficient to identify the variables 
responsible. Multilevel methodology allows us not only to identify the variables, 
but also to quantify their contributions at different levels. Multilevel methodology 
will be described in chapter two as well as the different kinds of multilevel models 
(i.e. multilevel regression models) and the factors affecting the choice of multilevel 
model. The later chapters will be used to describe studies done with multilevel 
methodology using data obtained by the RNG and an insurance company.
9Several research questions that are addressed and analyzed with multilevel 
modelling will be the topics addressed in the subsequent chapters. 
In chapter three, we will look at how general practice and patient characteristics 
relate to appropriate prescribing habits as described in the Groningen Formulary. 
In chapter four we will look at the workload of general practitioners in socio-
economically challenged communities. In 1999, the Netherlands Institute for 
Health Services Research (NIVEL) fine tuned the methods used to identify such 
communities. In Groningen, four of the original eight postal code areas no longer 
met the criteria describing a socio-economically challenged community 10. 
Because of this, we wanted to have a closer look at several aspects of health care 
in those areas. Specifically, we wished to address the research question: Does the 
care required by patients living in socio-economically challenged communities 
cause the GPs to have a heavier workload than GPs in other areas?
In chapter five, we illustrate that a hierarchical model is also well-suited to the 
analysis of a longitudinal data set. We do this by looking at how patient and 
morbidity characteristics are related to the amounts of antibiotics prescribed. 
The research questions in both chapters four and five are addressed using a 
longitudinal dataset.
In chapter six, a treatment control design is used to look at the effect on chronic 
users of benzodiazepines when their GP sends them a letter recommending 
reduction or cessation of benzodiazepine use. The research question here is: does 
a letter from their own family physician recommending decreasing or stopping 
the use of benzodiazepines lead to a decrease in actual use? In answering this 
question, we regard benzodiazepine use as a continuous variable, therefore, 
we will use a random effect regression technique. Vermunt11,12 has shown that 
multilevel models which have a discrete heterogeneity may be used to identify 
discrete patient categories with the help of latent class models. For the research 
question dealing with antibiotic prescriptions, we used the latent class model 
method. Here, we will apply the multilevel latent class model.
In the 7th chapter, our main findings will be summarized along with a critical 
analysis of prior chapters. Conclusions will be drawn and recommendations with 
respect to future directions will be made. The techniques used for this thesis 
appear in the literature under various names, such as: mixed model, random 
coefficient model, covariance components model, and hierarchical linear model. 
With a longitudinal dataset, the terms ‘growth model’ and sometimes ‘individual 
growth model’ have also been used. 
We will consistently use the term ‘multilevel’ throughout this manuscript. 
Although this dissertation is meant for a general audience, avoiding technical 
issues entirely is not possible. Such issues will, however, be discussed in a 
relatively non-technical way; technical details may be found elsewhere 13-21. In the 
Appendix, a few topics are addressed which include some technical issues. This 
may interest some readers. 
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In this chapter we will describe multilevel methodology and introduce 
several different models. The advantages and disadvantages of multilevel 
techniques will be addressed and conclusions will be drawn.
2.1 What is multilevel methodology?
This thesis is concerned with studies of patients and doctors in general practice. 
We will be looking at the relationship between general practitioners (GPs) and 
patients from a health care perspective. The patients who are registered with a 
general practice form a cluster of individuals who add up to an administrative 
group. The health care needs of these patients are served by a single general 
practice and often by a single GP. In this situation, the patients are said to be 
nested under the GP, and in the case of group practices the GPs are nested under 
the practice; a hierarchical data structure results, defined by GPs and practices. 
This results in a complex pattern of variables when undertaking research. 
Multilevel models have been developed for analyzing such data1-4. The hierarchy 
we see here always has the patients nested under the GPs. Snijders and Bosker 
defined multilevel analysis as a methodology for the analysis of data with complex 
patterns of variability with a focus on nested sources of variability4. The term 
‘multilevel model’ is used by many authors1,3-20, but several other terms have also 
been used to describe this technique, such as ‘hierarchical linear models’ 21-23, and 
‘random coefficient models’24,25. 
One may state briefly that multilevel modelling, which includes hierarchical linear 
modelling, random coefficient modelling, variance, and covariance components 
models, is a form of hierarchical regression analysis which has been developing 
since the early 1980s, designed to handle hierarchical and clustered data. 
For these types of studies, descriptive variables for both the GPs and the 
patients are important. Individual level variables characterize individuals and 
refer to individual level constructs. For instance, with respect to the patient, 
gender, age, and socio-economic status are variables that describe individual 
patients. Example variables for GPs include: size of practice, location of practice, 
organization form, etc. Group level variables may be roughly classified into two 
categories:
1 Derived variables, such as mean age or percentage of females. In the literature, 
we find different names for these kinds of data which summarize distributions 
of individuals. Derived variables have been described by Diez Roux11 as a type 
of group level variable which is constructed by mathematically summarizing 
the characteristics of the individuals in the group (i.e. means and proportions 
or measures of dispersion such as percentage of persons, mean income, and 
the standard deviation of the income distribution). Other names for derived 
variables are aggregate variables, compositional variables, and ecological 
variables. Some important derived variables are defined as combinations of 
more basic derived variables; an example is the neighbourhood social class 
measure, which is based on average mean and average education.
2 Purely contextual variables26 that are directly defined. These variables are 
not summaries of the characteristics of individuals in the group. Dogan and 
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Rokkan used the term ‘primary data’27. Examples of these purely contextual 
variables include: degree of urbanization (urban or rural), living in a socio-
economically challenged versus non-challenged community, and type of 
practice (solo or group). Other names for this found in the literature are integral 
variables11 and territorial variables27.
We can describe the nesting of patients under GPs as a situation in which patients 
are seen as individuals and GPs are considered as collectives. The ‘group’ 
mentioned above then is defined, for a given GP, as the set of patients of this 
GP. Lazarsfeld and Menzel have made the distinction between individuals and 
collectives previously28,29 and have identified four characteristics for individuals 
(i.e. patients) and three characteristics for collectives (i.e. GPs).
The four characteristics which apply to individuals are:
1 Absolute: an objective fact about the individual such as age.
2 Contextual: when a patient is described according to a characteristic which 
applies to a group of which the patient is a member (i.e. average age).
3 Comparative: when the patient is characterized according to a comparison with 
another patient (i.e. relative age, deviating from a mean age).
4 Relative: when the patient is characterized on the basis of his or her position in 
a network (i.e. number of contacts with other patients).
The three characteristics that apply to a collective are:
1 Analytical: when a characteristic results from a calculation involving patient 
characteristics (i.e. average age). In this case, average age is registered as a 
collective, and not as an individual characteristic. 
2 Global: these are characteristics that are seen at the GP level. (i.e. location of 
practice and the GP’s medical training).
3 Structural: when a characteristic is calculated based on a relationship pattern 
at the patient level. (i.e. size and number of families in a practice).
In terms of the distinction made above between derived and purely contextual 
variables, the first and third of the three types of characteristics of collectives may 
be regarded as a distinction between two types of derived variables, while the 
second type (‘global’) is the same as what was called above a purely contextual 
group variable. 
In social science research, a number of investigators have been interested in 
the connections between individuals and the contextual settings of their lives12. 
This research method is known as contextual analysis and focuses on the 
effects of the social context on individual behavior4,27. It provides an important 
class of examples of multilevel studies. In health research (particularly in 
environmental health and epidemiology), the connections between individuals 
and their contextual settings are studied, looking, for example, at the relationship 
between a patient’s health status and his or her geographical environment. The 
connections between individuals and their environments have been a notable 
focus in research which seeks to identify the role of factors in the external 
environment which influence individual susceptibility to disease12. The Jarman 
Index resulted from one such study30. The Jarman Index, described in 1984, is 
used to measure the demand for first line health care in specific regions. It can be 
used to identify regions where the demand for primary health care is higher than 
other regions. Reijneveld31 did a study in which patients (at the micro level) were 
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nested in geographical areas (the macro level). He examined the applicability of 
the Jarman Indices at the patient level in an urban GP setting in the Netherlands. 
There are many other studies in which connections between individuals and their 
contextual settings have been investigated6,10,12,16,32-39. Multilevel modelling was the 
statistical technique applied in these studies. Basic ideas of multilevel modelling 
are described and applied in this dissertation. A different but related technique is 
latent class analysis, which was used to study antibiotic prescribing in chapter 5, 
where a multilevel model was adapted to a longitudinal data structure. In this 
model, patients are the second level units who define the ‘clusters’ in the data. 
Whereas in the usual multilevel models individuals are assumed to differ by 
quantitative amounts, which show a normal distribution in the population, in 
latent class models it is assumed that these amounts have only a few possible 
discrete values showing an arbitrary discrete distribution across the values. Latent 
class analysis is much more flexible as it allows discrete classes which take the 
place of any standard distribution. This contrasts with standard multilevel models 
which assume a normal distribution.
2.2 The data structure seen in general practice databases
Before developing a multilevel model, the hierarchy of the data structure must 
be explained. The lowest (i.e., most detailed) level measurements are considered 
to be at the micro level; all higher level measurements are said to be at the macro 
level3. 
For a general practice, we found that the most common data structure consists of 
individual units which fall into a number of clusters or groups39. The individual 
units are the patients, and the clusters may be the GPs or other clusters such as 
the neighbourhoods. For example, if we want to make inferences about patient 
prescriptions, adherence to guidelines, or GP workload in socio-economically 
challenged communities, it is useful to apply a multistage sampling study design 
in which the patients are selected via the GPs4.
Figures 2.1 and 2.2 show examples of two level structures. Hierarchies may consist 
of more than two levels as is shown in figure 2.2. Patients who are registered 
with the same GP are more likely to receive similar care than patients registered 
with different GPs (see figure 2.1). Similarly, the GPs’ treatment decisions may be 
influenced by their specific practice styles (for example, policies with respect to 
generic prescribing) which will again vary from practice to practice19. These are 
examples of the interesting dependency of microlevel unit (patient) observations 
on macrolevel (GPs) characteristics. In abstract terms, this dependency could 
result from:
1 Patients sharing the same physician;
2 Patients within a practice influencing each other by direct communication or 
shared group norms;
3 Patients within a practice living in the same community4;
4 Patients within a group practice sharing the same GPs. This results in a three 
level design where patients are nested under GPs and the GPs in turn are nested 
under general practices.
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Such a hierarchical clustering structure imposes a correlation structure on the 
data which invalidates classical assumptions of independence and, therefore, 
common techniques such as ordinary least squares regression become inefficient 
or even misleading. Furthermore, a single level approach to the analysis of such 
hierarchically clustered data may fail to fully exploit the richness of information 
contained within and between the various levels being considered19.
2.3 Choice of multilevel model
Use of multilevel model
A level in multilevel analysis is a population within which there is meaningful 
variation that is reflected in the phenomenon under investigation. Thus, in a 
multilevel analysis there are always several populations involved. For example, in 
a study of the adherence to guidelines in a population of GPs, or variability among 
GPs with respect to workload or involvement in continuing education, there are a 
population of GPs as well as a population of patients involved. 
There are three kinds of criteria for choosing levels and choosing numbers of 
levels for a given scientific investigation: 
1 The theory under investigation4,17 or the research question
2 The type of sample being used (i.e. multi-stage sampling)4,17
3 The number of units belonging to a particular level (e.g., when there are only 
three units at the highest level there is no point in including that level in the 
final analysis).
Figure 2.1 Patients (Pj) nested under the general practitioner(GPi)
i = 1..k ; j = 1..(n, m, p, q)
. . . .  
. . .. . . . 
GP1
P1 P2 P3 Pn
GP2 GP3 GPk
P1 P1 P1Pm Pp Pq. . .
Figure 2.1 
Patients (Pj) nested under the general practitioner(GPi); i = 1..k ; j = 1..(n, m, p, q)
Figure 2.2
Macro/micro distinction
MACRO – LEVEL (Level 2)
MICRO – LEVEL (Level 1)
. . . . . . 
. . . . .. . . . . 
MACRO – LEVEL (Level 2)
MICRO – LEVEL (Level 1)
Figure 2.2 Macro/micro distinction
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For a given study, it is not always clear at the outset how to define the levels 
and there are times when none of the above mentioned criteria can be used to 
determine the levels, as there is insufficient data to justify applying results to 
the population being studied. With respect to leaving a level out, several studies 
have concluded that the variation which would occur in the excluded level, is 
distributed over the remaining levels40. For example, if we take a three level 
model, in which patients (level 1, micro level) are nested under GPs (level 2), and 
GPs are nested within general practices (level 3, macro level), it would be possible 
to eliminate level 2 entirely. Moerbeek41 showed that in a balanced situation, the 
variation occurring at the level of the GP moves in part to the general practice 
level and in part to the patient level. Both Moerbeek41 and Hutchison42 indicated 
that this shift of variation also occurs with an unbalanced design. Identifying 
one or more levels above the individual level is warranted when more than one 
population influences the dependent variable. If the social context (group level) 
affects the patients, there must be processes that depend on the characteristics 
of the social context (e.g., community). Groups or communities can have a direct 
effect on patients or there may exist cross level interaction effects which are 
defined as interactions between a patient level variable and a context variable. 
This requires the specification of processes within patients that cause those 
patients to be differentially influenced by specific aspects of the context. 
In figure 2.1, the nesting structure of the patients (Pj) nested under GPs (GP1, …, 
GPk) is shown. The number of patients for each GP may differ (shown in the figure 
as n, m, p, q respectively). In figure 2.2, a horizontal line between the two levels 
denotes the levels. Level 2 (macro level) is above the line and level 1 (micro level) 
is below the line. Level 2 represents the GPs and level 1 represents the patients. 
At the patient level, a single level regression equation is specified which may be 
estimated within each higher level (the GPs). In other words, just as with traditional 
regression, the researcher assumes that a common model is appropriate across all 
units at the second level. At this stage, the primary difference between ordinary 
regression and multilevel regression is that the researcher conceptualizes the 
overall data structure differently with multilevel techniques, acknowledging 
the existence of the higher level units under which the lower level units are 
nested4,13,15,43, which will lead to a positive residual correlation between lower-level 
units within the same higher-level units.
There is a logical progressive sequence common to the development of all 
multilevel regression analyses, which we describe here for the case of patients 
nested under GPs.
1 The researcher analyzes variance in an outcome variable, paying special 
attention to the distribution of this variance within and between GPs15.
2 Attention is paid to the development of a random intercept model, which is a 
regression model extended with random differences between GPs in the mean 
of the outcome variable15.
3 The researcher conducts both theoretical and empirical investigations to 
discover for which of the patient variables the effect varies across GPs, the so-
called random slopes15.
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4 Models are developed using higher level variables in an effort to explain 
variation between GPs in parameters discovered in previous stages15.
Multilevel models are useful and necessary only if the extent to which the data is 
being analyzed shows sufficient variation at each level. ‘Sufficiency’ of variation 
is relative and depends as much on theoretical and inferential concerns as on the 
structure and quality of the data15. Step 1 in developing a multilevel regression 
model serves to examine the extent to which variation in patient outcome exists 
within GPs relative to the variation between GPs. This is also known as the ‘empty 
model’. The ‘empty model’ yields a number of important pieces of information. In 
the situation where level 1 units are patients nested under GPs (level 2 units):
1 The empty model yields an estimated mean score of the dependent variable for 
all GPs.
2 This model provides a partitioning of the total variation in scores between level 
1 (patient) and level 2 (GP).
3 The empty model provides a measure of the dependence between the patients 
for a given GP through use of intraclass correlation.
4 A measure of the reliability of each GP’s mean score is provided in case one 
wishes to use this mean as a measurement for a GP characteristic.
5 The model provides the means for a formal test of the hypothesis that there is 
no systematic variation between GPs on the outcome variable.
The above remarks illustrate different ways of considering the relationship 
between the GP and the patient using a multilevel structure. The relationship 
between the GP and his or her organization may be looked at in a similar way, as 
this is also a nested data structure. Whether this is important for a given study 
will have to be addressed on a case by case basis as it is dependent on the research 
question being investigated.
When we expand a two level model to include repeated measurements for 
individual patients, we end up with a three level model. Figure 2.3 shows a 
symbolic representation of a three level model with the measurements (O.) nested 
under the patients (P.), and the patients nested under the GPs (GP.). In this thesis, 









Figure 2.3  A three-level model in which occasions (O.) are nested 
under patients (P.) and patients (P.) are nested under GPs (GP.)
GP=general practitioner; P=Patient; O=Occasion
GP1
Figure 2.3 
A three-level model in which occasions (O.) are nested under patients (P.) and patients (P.) are nested 







Each level in this structure has certain characteristics.
Based on the literature, the following four divisions of characteristics may be 
named:
•	 General	practice	linked	characteristics	(I)44,45.
Some examples of general practice characteristics are: 1) the size of the practice; 
2) the number of patients seen per day; 3) the distance to the nearest hospital; 
4) the degree of urbanization; 5) the age and gender distribution of the practice 
population; 6) the role of the practice assistant; 7) the availability and use of the 
diagnostic and therapeutic aids
•	 GP	characteristics	(II)44,45
Examples include: 1) the age of the GP; 2) the number of years of experience as 
a GP; 3) involvement in continuing education activities; 4) having a pharmacy 
on site or not; 5) number of patients; 6) the GP’s attitude; 7) type and scope of 
diagnostic facilities; 8) the distribution of the practice population according to age 
and gender; 9) length of contact time with patients
•	 Patient-linked	characteristics	(III)44,45
Examples include: 1) type and seriousness of medical condition; 2) patient’s socio-
economic status; 3) patient age; 4) patient gender; 5) patient ethnicity;
•	 Intra	patient	linked	characteristics	(IV)45 
Examples include: 1) nature of complaint; 2) prescribed medication 
2.4 Advantages of multilevel methodology 
The development of multilevel modelling allows new perspectives.
In multilevel research, the data structure in the population is hierarchical 
(e.g. patients nested in a general practice), and the sample data are viewed as 
multistage samples from the hierarchical population. In such samples, the 
individual observations (patient based) are generally not completely independent 
because of selection processes and because of the common context as a result 
of belonging to the same group (see Figure 2.1). Multilevel models take these 
dependencies into account17. 
When a researcher regards the groups as unique entities and tries primarily to 
draw conclusions pertaining to each of these specific groups individually, then it 
is appropriate not to use a multilevel analysis but rather an analysis of covariance. 
This analysis can estimate and test if differences exist between the groups, but 
cannot test the effects of group level variables which is necessary to study the 
antecedents or causes of such differences3. On the other hand, if a researcher 
wants to generalize to a population of groups (in our case: a population of GPs or 
practices), and possibly to investigate the effects of GP characteristics on patient 
outcome variables, a multilevel study is more appropriate.
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Advantages when using multi level modeling techniques are the following.
1 With multilevel modeling, the different sources of variation are taken into 
account, in contrast with the more standard single level statistical methods, 
which have a single source of variation.
 For example, when patients are nested under GPs, there are two sources of 
variation: the patients and the GPs. If the data would be aggregated to GP level 
or distributed to the patient level, we would only see one source of variation. It 
is necessary to take the hierarchical nature of the data structure into account 
and the multiple sources of variation, if we wish to have accurate the standard 
errors of estimates, type-I error rate of statistical tests, and reliabilities of 
measurement. In a multilevel model, the patient groups from each practice are 
seen as a random sample of a population of groups rather than as a random 
sample of individuals. One example may be seen in the study of guideline 
adherence (chapter 3). The hierarchical nature of the data structure here was 
taken into account. The sample took place in two stages. First the GPs were 
selected, and then all of their patients were included.
2 Multilevel analysis distinguishes between regression effects within and 
between the GPs. At the patient level (looking at GPs) we can ask the question 
of whether or not the gender of the patient has an effect on prescribing, and 
then we can do a comparison of different GPs to find out if the gender ratio in 
the practice has an effect on prescribing. The former is the within-GP regression 
of prescribing on gender; the second is the between-GP regression.
3 GPs may also be ranked according to their prescription behavior by making use 
of the so-called posterior means, while controlling for the composition of the 
patient population of each GP.
4 Another advantage is being able to look at differential effects. We can look at 
whether GPs prescribe differently when the patient belongs to a lower socio-
economic class, and even if such differences vary when comparing GPs. The 
latter is reflected by the so-called random slopes in multilevel analysis.
5 Multilevel modeling gives us the chance to look at cross level interactions, 
which means that the interactions between patient characteristics and GP 
characteristics may be studied. For example, we could study if prescribing 
patterns that depend on socio-economic status also are related to the size of the 
practice.
6 Longitudinal data shows a special form of nesting. The dependence of the 
different measurements is important in a longitudinal data set, because the 
measurements are observed each time for the same patient.
7 The original data structures are retained in multilevel modeling; therefore, 
aggregation is not needed. A two level structure, e.g., with repeated 
measurements nested under patients, is the very minimum required.
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8 All patients with missing data values may be included in the analysis, even 
though values are missing for one or more variables for these patients. This 
is due to the permitted format of the data structure. The data structure in use 
with repeated measurements, known under several terms such as univariate 
format46, multiple record file47, long data, and person period46, is permitted 
to be unbalanced, i.e., have different numbers of observations for different 
patients.
9 Multilevel models require fewer assumptions than classical ANOVA-models 
and are less stringent in their application. However, a few key assumptions 
are still necessary for the estimation procedures used in multilevel models. 
The assumptions which are essential to a multilevel model are randomly 
distributed residuals. For classical ANOVA models, the compound symmetry 
characteristic and the assumption of sphericity are important, and these are 
stronger assumptions. Multilevel models require neither compound symmetry, 
nor sphericity, nor homoskedasticity.
10 The empty model (with no explanatory variables) is equivalent to a single level 
one way random effect ANOVA.
Aggregation/disaggregation vs. multilevel analysis. 
The traditional approach to multilevel problems before the invention of 
hierarchical linear modelling was to aggregate the data to a super level (e.g., 
patients’ medications are averaged to the general practice level and general 
practices are used as the unit of analysis) or to disaggregate data to the base level 
and ignore dependencies. An example of disaggregation is the following. For each 
patient, a number of variables are assigned at the practice level, such as type of 
practice (i.e. solo or group), which would cause all patients in a given practice 
to have the same value for this contextual variable. The patient would then be 
used as the unit of analysis. Ordinary regression or another traditional technique 
would then be performed on the chosen unit of analysis. There are three problems 
with the traditional approach: (1) Statistical power is lost as fewer units of analysis 
at the superlevel replace many units at the base level through aggregation; (2) 
disaggregation results in the misinterpretation of information from units at the 
superlevel, when it is erroneously treated as independent data for the many units 
at the base level. This error leads to overly liberal conclusions of significance; and 
(3) with both aggregation and disaggregation, there is the danger of multilevel 
fallacies: there is then no adequate analysis differentiating the individual level 
and group level relationships among the variables. With the ecological fallacy, a 
relationship found at the individual level between two variables is interpreted as 
a relationship at the group level. The atomistic fallacy is the ecological fallacy’s 
counterpart. With the atomistic fallacy, a relationship found at the individual 
level between two variables is interpreted as a relationship at the group level. The 
atomistic fallacy is also known as the individualistic fallacy. Besides these two 
fallacies, there are an additional two fallacies which should be mentioned48:
1 The psychologistic fallacy: This occurs when relevant group variables are not 
taken into account when analyzing data and drawing conclusions at the level 
of the individual.
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2 The sociological fallacy: The converse occurs in this fallacy, as individual 
variables are not taken into account when analyzing data and drawing 
conclusions at the group level.




 GP level Ecological fallacy Sociological fallacy
 Patient level Psychologistic fallacy Atomistic fallacy
2.5 The research questions
In this thesis, we will be concerned with variation in general practice and health 
care interventions. The general research question is: which patient and general 
practitioner characteristics are related to the prescribing of medication. In order 
to answer this general research question, a multilevel design will be used. Related 
to this question the methodological question is: what is the contribution of 
multilevel analysis to answer this question with data from registration databases. 
We will look at four areas having to do with prescribing and for which a case-mix 
adaptation will be applied. Case-mix49 reflects the factors which characterize the 
patient population in terms of diagnosis, age, gender, etc., and using a case-mix 
adaptation aims to control the influence of these factors. The topics addressed in 
these four areas are:
1 The relationship between prescribing and adherence to guidelines.
2 The relationship between the GP’s workload and the patient’s socio-economic 
circumstances.
3 Describing antibiotic prescription behaviors, while at the same time taking into 
account the diagnosis variation.
4 Decreasing benzodiazepine prescriptions in an intervention study.
What the above four areas have in common is the variability in the general 
practice. Davis50 uses the same premise as McPherson, which states that the 
effect of the different sources of variation in medical intervention depends on the 
aggregation level at which the data are analyzed. Davis50 attempts to relate the 
sources of variation to the aggregation levels. The levels of aggregation which he 
identifies are: countries, regions, and GPs. With respect to the sources of variation 
he distinguishes: morbidity, population, health care system, professional, and 
unexplained.
With multilevel analysis we want to discover which contextual and compositional 
characteristics are related to inter and intra practitioner variation. In chapters 
three through six, we elaborate further on the general practice variation relevant 
to the four areas of study.
In the first study (chapter 3), applying concepts developed by Kamps51, we looked 
at the extent to which GPs prescribe medications which are included in a set 
of guidelines. Kamps51 identifies two types of compliance. Global compliance 
is said to exist when the medications listed in the guidelines are prescribed. 
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Specific compliance occurs when the medications are prescribed according to the 
diagnostic indicators listed in the guidelines. In this study, we look at how general 
practice and patient characteristics contribute to the global compliance with 
standard guidelines for prescribing.
In the second study (chapter 4), we look at patient, GP, and community 
characteristics to evaluate GP workload. This data is stratified according to type of 
health insurance coverage.
In the third study (chapter 5), using a longitudinal data set, we examine antibiotic 
prescribing patterns. Here, we try to find out how the variation in prescribing over 
time is structured at the patient level. Moreover, on an individual level, we looked 
at how this is related to demographic characteristics of the prescribing patterns of 
patients. 
In the fourth study (chapter 6) variations in benzodiazepine prescriptions are 
investigated using an intervention study. The intervention is done at the GP level, 
but the dependent variable is at the patient level.
The data for all four of the studies comes from administrative databases, which 
are patient based. In all studies a multilevel study design is applied.
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To identify and assess the effects of physician and patient characteristics on global 
adherence to pharmacotherapeutical guidelines.
Methods: 
In a cross sectional study in the northern Netherlands where a two level multilevel 
model was applied to patients (n = 269,067) in 190 practices with a total of 251 
general practitioners, where the main outcome measures was the identification of 
significant indicators for good prescribing on patient and practice level.
Results: 
The mean global adherence was 82%. Two general practice variables, organisation 
form and degree of urbanization influenced the global adherence, while 
all patients variables (age and gender) and the patient related prescription 
characteristics (costs, volume, different ATC-codes) were significant predictors for 
the global adherence. The total explained variance was 28%. 
Conclusions:
Patient characteristics have a greater influence on prescribing behavior than 
physician characteristics. 
Keywords:
Practice guidelines, Multilevel model, The Netherlands
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3.1 Introduction
In 1987, the World Health Organisation (WHO) published a statement about good 
prescribing: “rational use of drugs requires that patients receive medications 
appropriate to their clinical needs, in doses that meet their own individual 
requirements, for an adequate period of time and at the lowest costs to the 
community”.1 To amplify this statement, Barber described good prescribing as 
based on four criteria: maximize effectiveness, minimize risks, minimize costs, 
and respect for the patient’s choices.2
It is not easy for general practitioners (GPs) to comply with the above criteria, as 
the prescribing of drugs is a process affected by many factors.
Kamps et al. chose adherence to a set of regional pharmacotherapeutical 
guidelines as a criterion for good prescribing.3 They evaluated the adherence of 16 
GPs to the third edition of the Groningen formulary (GFIII)4, taking into account 
two forms of adherence: global adherence, defined as the prescribing of a drug 
mentioned in the formulary; and specific adherence, defined as the prescribing 
of a drug mentioned in the formulary for an indication which is also mentioned 
in the formulary. The global adherence varied from 76-89% and the specific 
adherence from 55-71%. GPs with a high percentage of adherence were considered 
to be appropriate prescribers.
Factors which can act as predictors for good prescribing are divided into 
patient related and physician related. Straand et al. estimated the incidence of 
inappropriate prescribing for the elderly at 13.5%.5 Using a multilevel analysis, 
Houghton concluded that patients aged over 65 years used more prescriptions, 
and therefore indirectly contributed to higher prescribing costs. Independent of 
age, women were given more prescriptions by their GPs than men.6 Elderly people 
living in a nursing home received more prescriptions than those living at home. 
This was accompanied by an increase in prescription associated health care costs.7 
With respect to the identified GP related factors, funded and training practices 
are associated with prescribing fewer and less expensive drugs.6 The level of 
knowledge of Canadian physicians and the financial demographics of the practice 
(government funded versus fee –for service physicians) are GP related factors 
which contribute to the inappropriateness of prescribing behavior.8 Variation in 
GP prescribing and the associated costs can partially be explained by the number 
of partners in the practice, the level of poverty in the practice population, and the 
preceptorship status of practice.9 
A review of 62 studies by Buetow et al. revealed circumstantial evidence for 
inappropriate prescribing by GPs in the UK.10 However, qualification and 
quantification of the apparent indicators was not possible, because of limitations 
of these studies.
The effect which feedback has on prescribing habits is variable 11-13also when 
computers are used to provide information about drug prescribing and the 
associated costs.11,14 Consensus or guidelines may enhance the quality of 
prescribing. GPs adhered to 61 % of prescribing advices in the national guidelines 
of the Dutch College of General Practitioners.15
In the present research, we studied the contribution of practice and patient 
characteristics on global adherence to pharmacotherapeutic guidelines as a 




In the Netherlands, community pharmacists deliver medications as they are 
prescribed by the GP. The prescriptions for patients with obligatory public health 
insurance, approximately 60% of all patients, were registered. The data were 
collected over the period January to December 1997 in the province of Groningen 
in the North of The Netherlands. At that time the population of Groningen was 
558,000 (3.6% of the Dutch population). The database included 269,000 patients 
with approximately 3.2 million prescriptions.
3.2.1 General practices
The following variables were recorded: the number of male and female patients; 
the gender and the mean age of the GP; the localization of the practice (rural 
if the population density is less than 1,500 addresses per square kilometer or 
urban if the population density of the environment is 1,500 addresses per square 
kilometer). The number of GPs per practice was also recorded, as well as the type 
of practice (solo practice and group practice). For each patient, age and gender 
were recorded. For each prescription, the Anatomical Therapeutic Classification-
code (ATC), the Defined Daily Dose (DDD), and the costs were registered (in 
Euro). The number of different ATC’s was considered as a proxy for multiple 
morbidity and severity of morbidity.An ATC was missing in 6% of the 3.2 million 
prescriptions. 
Global adherence was defined as a prescribing of a drug which is mentioned in the 
Groningen Formulary (GFIII). The GFIII appeared for the first time in 1991, and was 
formulated based on a consensus reached by three GPs, two specialists and seven 
pharmacists.4 The third edition of the Groningen Formulary, published in 1995, 
was used for the present study. It contained 186 health classifications and 251 
medications. Two of the GPs participating in the present study also participated in 
the development of the GFIII. As the database was blinded, it was not possible to 
identify these two GPs.
The GFIII was distributed to all GPs in the region, free of charge, by the public 
health insurance organization. 
3.3 Analysis
The total database included 251 GPs from 190 general practices. Since the database 
of 3.2 million prescriptions was too large to analyse, a stratified random sample 
of 12.5% of patients per general practice was used. The data were analysed on a 
per practice basis, because public health insurance registration is not always GP 
based. All the prescriptions for each patient in the sample were included, and 
aggregated to patient-level.
The influence of the different factors and the interpractice variation were 
analysed with multilevel models. The dependent variable was the percentage 
global adherence per patient. The multilevel modelling technique from the SAS 
statistical package (Proc Mixed) and Mlwin program from Goldstein was used to 
analyse the data.16,17
Three blocks of variables were used in succession: practice related, patient related 
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and to patient level aggregated prescription related variables. We used a two level 
model: level one the patient level, and level two the practice level. To obtain a 
meaningful interpretation of the estimated parameters, the data were centered 
on their grand mean.. The practice characteristics, type and localisation, and the 
patient characteristic gender are dummy variables (with values 0 or 1). The value 1 
is for urban, solo practice and male patient respectively.
The following statistics were used:
1 Intraclass correlation coefficient (ICC). It measures the proportion of the 
variance which exists in the global adherence between different practices. 18,19
2 Explained variance 
3 -Log-likelihood, which is useful for comparing the goodness of fit of different 
models. If the ratio between parameter estimate and standard error is larger 
then 1.96, then the parameter estimate under consideration is significant.
Several models were used in succession. First, the baseline (or null) model 
concerning the influence of the variation on global adherence was fitted. With the 
addition of other variables (three blocks), the influence of practice characteristics 
(Model A), patient characteristics (Model B) and patient related prescription 
characteristics (Model C) was assessed. In Model D, only the significant variables 
were indicated.
To investigate if interdependent relations existed between different variables, 
interactions between two variables were studied. In model D a cross level 
interaction between two variables of different levels was studied: age of the 
patient and morbidity. 
In the models described above, the so-called fixed effects were described. The 
objective of fixed effects is to compare means of treatment groups or populations, 
while random effects are computed when the objective is to determine sources 
of variability. The latter were studied to assess which patient characteristics 
are responsible for the interpractice variation (model E). In order to determine 
which variables are the most important, the coefficients of the final model will be 
standardised.
3.4 Results
The mean age of practitioners per practice was 48.2 years (SD 6.0). Of the general 
practitioners 91% were men (SD 24.2). The number of solo practices was 149 
(78.4%), while 30 (15.8%) were duo-practices and the remaining 11 (5.8%) were 
group practices with three to six GPs. 60% of the practices were situated in an 
urban area. 
The mean number of male patients per practice was 681.8 (SD 209.3); and the 
mean for female patients was 749.2 (SD 208.1).
Table 3.1 shows that the sample was found to be a good representation of the 
total database with regard to the patient characteristics age and gender, the 
prescription characteristics costs, DDD and number of different prescriptions per 
patient and the global adherence.
Table 3.2 shows the different models that were assessed. 
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Table 3.1 
Patient characteristics in database and sample

























Percentage global adherence * 0.79 (0.41) 0.79 (0.41)
Mean and between brackets standard deviation; *(computed on prescription level)
In Model 0 the maximum likelihood estimate for the global adherence is 
82% (standard error 0.33). The maximum likelihood estimate of the variance 
component at patient level was 682.9 (standard error 5.3) and the estimated 
variability of means for the different practices was 15.4 (standard error 2.1). These 
variance components indicate that most of the variation of the global adherence 
was not at practice level, but at patient level. The intraclass correlation (ICC) 
of 0.02, indicated that 2% of the variance in global adherence existed between 
practices.
In Model A, in which the practice characteristics were added, the mean 
global adherence (82%) did not change. The variables organisation form and 
urbanisation degree were the only significant practice characteristics revealed 
with model A. The interaction term (organisation form by urbanisation degree) 
was not significant. In table 3.2 Model 0 yields a deviance of 308,373.6, while 
Model A has a deviance of 308,345.7. The difference 27.9 is significant as calculated 
with a chi-squared distribution test with seven degrees of freedom (d.f.).
In Model B, patient characteristics were added, and the level of adherence stayed 
the same (82%). The age and gender of the patient were both significant factors, 
and their interaction term, age by gender, was also significant. The deviance 
difference between Model 0 and Model B was 536.2. This difference is significant 
when calculated with a chi-squared distribution test having three degrees of 
freedom. 
In Model C, the patient related prescription characteristics (as aggregated 
prescription to patient level) were added. All of these characteristics (costs, 
volume and different ATC-codes) were significant. In this model, the cross-level 
interaction term between age of the patient and different ATC-codes was also 
significant. The deviance difference between Model 0 and Model C is 1,175.2 (is 
significant in a chi-squared distribution with four d.f.).
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Table 3.2 
Parameter estimates for five multilevel models (and standard errors) 
Model 0 Model A Model B Model C Model D






Type of practice (ref: solo)
Localisation of the practice 
(ref: urban)
Interaction-term
Type of practice * 
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Relation between global adherence (percentage) and age of the patient, including the
contraceptive pill-ATC-codes
Figure 3.2 
Relation between global adherence (percentage) and age of the patient, excluding the contraceptive 
pill-ATC-codes
In figure 3.1 the relation between global adherence and age for men and women 
is illustrated. An important difference between the genders became apparent, 
particularly in the age group 15-35 years. We assumed that the effect was mainly 
due to the contraceptive pill, since the prescription of nearly all the contraceptive 
pills is adherent to the formulary.
Figure 3.2 shows that the difference in gender for all ATCs without inclusion of 
the contraceptive pill codes (G03AA, G03AB, G03FA, G03FB and G03HB) virtually 
disappeared in the age group 15-35 years. This clearly illustrates the effect of the 
contraceptive pill. 






















































Parameter estimates of the random-coefficient model of the significant variables (and standard errors) 
Model E












































The total explained variance for all significant factors that influence global 
adherence was 28%. These are as well practice as patient related, and constitute 
the fixed effects in model E. 
Model E
The interpractice variation is studied using the random effects seen in Model E 
(Table 3.3). The effects which differ between practices were the age and gender 
of patients and mean prescription costs. The most important variable is the age 
of the patient, followed by the cost, the mean volume (DDD), different ATCs, 
the interaction between age and different ATCs, organisation form and finally 
urbanization degree , gender and age by gender.
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3.5 Discussion
The present research shows that two of the general practice characteristics and all 
the patients’ characteristics influenced the degree of adherence to guidelines.
The study does have limitations, however. Firstly, the population included 
only patients (ca. 60%) having obligatory health insurance. Secondly, only the 
adherence to advised medications could be studied, as the database used did not 
contain indications for prescriptions. We assume that studies adding prescription 
indications might result in superior models.3,10,20 In all the models studied, a global 
adherence of 82% was found, which is comparable to the results of others (Kamps, 
Barber and Grant).2,3,21 28% explained variance was due to the characteristics of 
the general practices and patients. The differences between patients are much 
greater. Other variables which may account for the remaining unexplained 
variance are hospital initiated prescribing, the prescription history of the patient 
and patient insistence. 20 Therefore the development of models which take the 
patient’s perspective into account is necessary. 
Compaired to the study of Davies and Gribben, in which the practice variable 
small practice was one of the significant predictors we found a significant 
contribution of our organization form. 22
All the patient characteristics affect global adherence, including the interaction 
age by gender and the cross-level interaction age by different ATC. Since there was 
a negative relation between the age of the patient and the global adherence, The 
GP appeared generally less compliant with guidelines as the age of the patient 
increased. Multiple morbidity in the elderly likely is a contributing factor for this 
trend. In a patient with multiple morbidity, GPs more often prescribe medications 
of second choice. This explanation also applies to the negative relation which 
exists between global adherence and the number of different ATCs. Usually, 
a patient who is more seriously ill or who suffers from multiple diseases is 
prescribed more medications, including an increasing number of second choice 
medications, which are not mentioned in the formulary. 
The total number of prescriptions in a practice correlates positively with 
global adherence. This could be caused by the increased number of repeat 
prescriptions.23 As the cost increased, adherence decreased. This is in agreement 
with one of Barber’s criteria, as increasing adherence would therefore tend to 
minimise costs.2 The negative relation between global adherence and cost for the 
fixed effects implies that, in general, when global adherence increases, mean cost 
decreases. The random effect of mean cost indicates that the general practices 
show different relations between global adherence and mean cost. All these 
significant characteristics of patient and practice merit further investigation to 
improve the quality of prescribing in general practice.
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Abstract
In 1996, a fund was set up by the Ministry of Health and health insurance 
companies in order to give financial support to general practitioners (GPs) who 
have patients living in disadvantaged communities. The relationship between 
patients and their GP may be modelled in a hierarchical, nested structure, as well 
as the relationship between patients and where they live (postal code region). 
The model which is used here is a cross-classified multilevel model. With this 
model, the workload will be evaluated with data from the morbidity Registration 
Network Groningen (seven GPs) and data from the biggest regional health 
insurance company (70 GPs). The data are stratified according to the way patients 
are insured. The workload of GPs is higher in disadvantaged communities. The 
most important determinants of the workload are patient characteristics such as 
age and gender. The characteristics of the GP are of minor importance. According 
to this study, the number of foreigners in a particular community appears to have 
no clear influence on the workload. The method of calculating workload may 
be improved by assigning greater importance to the patient factors. Replication 
research is necessary to determine if the results are also applicable to other cities 
with disadvantaged communities.
Key words: 




Since the beginning of the 1990s there were increasing reports from general 
practitioners (GPs) concerning their large workload in disadvantaged communities 
in large urban centers1. This is still a relevant issue2-10. According to the 
Netherland’s Institute for Health Services Research (NIVEL), a disadvantaged 
community is characterized by inhabitants with a low socio-economic status and 
complicated health issues. To address this problem, in 1996 the Ministry of Health 
Wellness and Sports (VWS) and the health insurance companies set up a fund 
(Achterstands Ondersteunings Fonds AOF) to support GPs with patients living 
in such communities. Similar measures have been taken in the United Kingdom 
(UK) where funds were earmarked to compensate physicians for the higher 
workload resulting from caring for patients in disadvantaged communities11,12. 
In The Netherlands, communities were classified as disadvantaged according 
to the postal codes. Three criteria were used: (i) population density: the number 
of addresses in a specific postal code region quantified per square meter; (ii) the 
average income per working adult; and (iii) the percentage of people between 
the ages of 15 and 64 within the community who were receiving disability 
compensation. According to this method, a set of eight postal code areas were 
identified in 1996 in Groningen as disadvantaged. In the present article we address 
the following question: does the care for patients in disadvantaged communities 
require extra effort from the GP as compared with other communities? In 
answering this question, we will take into account the patients’ demographic 
characteristics, their place of residence, as well as the way the GP’s practice is 
organized.
4.2 Materials and Methods
Seven GPs from Groningen participated in this study, all of whom were registered 
with the morbidity and medication Registration Network in Groningen (RNG) 
and affiliated with the Department of General Practice medicine at the University 
of Groningen (RUG). Four of these GPs work part-time as members of a group 
practice, and the other three are full-time solo practitioners. The data which were 
used for this article were prospectively collected during 199713.
The GP’s workload is calculated taking into account the following variables:
1 The number of contacts with the patient.
2 The number of care episodes per patient, coded according to the International 
Classification of Primary Care (ICPC)14.
3 The number of prescriptions per patient. The medications are automatically 
coded according to the Anatomical Therapeutical Classification system (ATC)15.
In addition to the data obtained from the RNG, we also obtained the prescribing 
data of the 70 GPs in Groningen for patients registered with the largest health 
insurance company in Groningen (Geové-RZG) for 1997.
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The disadvantaged areas were identified according to the criteria mentioned in the 
introduction which resulted in the identification of eight postal code regions (9711, 
9713, 9715, 9716, 9724, 9729, 9741, and 9742)16,17. The percentage of foreigners living 
in each of these regions was calculated using information from the Statistics 
Netherlands (CBS) for 1997. A person is classified as an foreigner if s/he or at least 
one of the parents was born outside of The Netherlands18.
4.3 Analysis
To discover to what extent community, GP, and patient characteristics contribute 
to the GP’s workload, the information of all the patients registered with the RNG in 
1997 was linked with information on the communities as compiled by the CBS. The 
patients were registered with a GP and lived in regions designated by postal code. 
GP and postal code region factors were used during the analysis of the data. Using 
multilevel analysis techniques, variables from different hierarchical levels can be 
considered within a single model which takes into account the hierarchical nature 
of the information which is being analyzed19-21. Age and gender were used as 
characteristics at the patient level, whereas socio-economic status (disadvantaged 
or non-disadvantaged) and foreigner versus indigenous was considered at the 
level of the postal code region. At the GP level, we considered the type of practice 
(solo or group). The advantage of such a model is that the effects of community 
and practice organization are corrected for the demographic differences. This is 
achieved by using a cross-classified multilevel model19-21.
Figure 4.1 shows how the three levels of the model relate to the specific variables 
belonging to each level. The patients on the first level are clustered both under 
the GP and under their postal code region on the second level. The dependent 
variables can be found at the patient level. The arrows in figure one show the 
influence of the independent variables on the dependent variables. The binary 
variables practice organization (solo/group), gender (male/female), and socio-
economic group (disadvantaged/non-disadvantaged) had, as their reference 
group: group practice, male, and non-disadvantaged respectively.
With the multilevel analysis, for the work load variable, a log transformation 
was applied, as these variables were skewly distributed. Figure 4.2 shows that 
the relationship between age and the natural log (ln) of the average number of 
prescriptions, divided according to gender, is non-linear. For all of the workload 
variables, a model was used which incorporated both age and age squared 
(second degree polynomial). We also looked at whether patients aged older than 
65 added even more to the GPs workload.
With the analysis, the data were stratified according to type of insurance. The 
coefficients presented may also be interpreted from a regression model, for which 
the log transformation of the dependent variable has to be taken into account. By 
taking the antilog of the coefficient, the relative effect of the variable concerned is 
calculated. Regression coefficients between the strata were tested with a t-test22. A 
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confidence level of 0.05 was used. The significance of the variables was calculated 
using the standard deviation (s.d.). The variables age and percentage of foreigners 
were centered. This means that the average result is subtracted from each score. 
Variance components which are represented at the patient, GP, and postal code 
level show the amount of unexplained variance which is present at each level. As 
a log transformation was used, the variance maybe approximated as the square 
of the variation coefficient of the original variable. In the model presented here, 
patient, postal code region, and one GP variable were considered.
Because the RNG only contains the data for seven GPs, the model would be tested 
with the addition of the prescription data obtained from the Geové-RZG. The data 
from the Geové-RZG include prescription information for 66,028 patients with 
public health insurance registered with 70 GPs who practice in Groningen.
4.4 Results
14,984 patients were registered with the seven RNG GPs in 1997 in the city of 
Groningen (Table 4.1). 5,906 of these (39.4%) lived in disadvantaged communities. 
Table 4.2 shows the demographics of disadvantaged communities versus other 
communities. There was no relevant difference in the male/female ratio with the 
disadvantaged communities being 53.3% female versus 52.7% female in other 
communities. The average age of residents living in disadvantaged communities 
was 37.8 years, whereas the average age of people living in non-disadvantaged 




Niveau 2:  General Practitioner level Zipcode- (= residential) level
  Independent variable: Independent variables:
	 	 •	 Practice	organisation	 •	 %	foreigners
	 	 	 (soloist/grouppractice)	 •	 Deprived	area	(yes/no)
Niveau 1:  Patient-level
  Independent variables: Dependent variables:
	 	 •	 Age	 •	 Number	of	face	to	face	contacts
	 	 •	 Gender	(male	/female)	 •	 Number	of	episodes
	 	 •	 Insurance	(sickfund/non-sickfund)	 •	 Number	of	prescriptions
   
44
Table 4.1 
Characteristics of patients, GPs and zip code area, their means (standard deviation) or percentages
RNG
Patients N = 14984
Mean age 36.1 (20.7)
Gender (% women) 53.0
Insurance type (% sick fund) 54.2
Mean of face to face contacts 1.9 (2.9)
Mean of episodes 2.0 (2.6)
Mean prescriptions 10.2 (23.1)
GPs N = 7
Organisation of the practice (% soloist) 42.9
Mean of enrolled patients 2142.6 (1053.4)
Geové-RZG
Patients N = 66028
Mean age 43.3 (22.3)
Gender (% female) 61.1
Mean number of prescriptions 11.4 (17.5)
Insurance type (% sick fund) 100.0
GPs N = 70
Organisation of the practice (% soloist) 48.6
Mean number of sick fund patients 943.3 (337.5)
RNG and Geové-RZG
Zip code areas N = 29
Social economic status (% deprived areas) 27.6
Mean percentage of foreigners 13.2 (5.5)
 
The average number of patients per RNG GP was 2,143 (sd=1053) (Table 4.1). 21.7% 
of registered patients did not have any contact with their GP in a single year (not 
included in Table 4.1). 54.2% of patients in the RNG had public health insurance 
(Table 4.1). Table 4.2 shows that the variables affecting GP workload were different 
for men and women from disadvantaged communities versus non-disadvantaged 
communities. This held true for the number of GP-patient contacts, the number 
of registered care episodes, and for the number of prescriptions. The number of 
GP-patient contacts was 23.9% higher in disadvantaged communities, the number 
of registered care episodes was 22% higher, and the number of prescriptions was 
48% higher than in non-disadvantaged communities. These differences in workload 
could, in part, be caused by age differences among the communities.
According to the Geové-RZG database 36.4% of registered patients live in 
disadvantaged communities. On average, 943 publicly insured patients were 
registered per GP (sd=337.5) (Table 4.1). Prescriptions were 16.4% higher in 
disadvantaged communities (Table 4.2). The average patient age with public 
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health insurance in disadvantaged communities was 45 years, whereas in other 
communities the average age was 42.4 years. This is a significant difference. 
(p<0.05)
The results of the multilevel analysis are presented in tables 4.3 and 4.4. To use 
the coefficients listed in tables 4.3 and 4.4, they first have to be divided by 1000.
When we look at the relationship between the number of patient-GP contacts 
(Table 4.3) and patient characteristics, gender and age are contributing factors for 
patients covered by public health insurance as well as for patients with private 
insurance. For patients with private health insurance, the effect of age is different 
for men and women. Patients with public health insurance in disadvantaged 
communities visited their GPs more often than those living in non-disadvantaged 
communities, after correction for all other variables. This difference was not seen 
for patients with private health insurance. The way the GP practice was organized 
did not influence the number of patient contacts. The number of care episodes, 
as is seen in table 4.3, was related to the way the practice was organized and to 
patients with public health insurance’s residency in a disadvantaged community. 
Patients with public health insurance had 23% fewer episodes of care when they 
Table 4.2 
Comparison between deprived areas (Deprived) en non-deprived areas (non-deprived) of the workload 




RNG: Deprived Non-deprived Deprived Non-deprived Deprived Non-deprived
Face to face contact 2.18 (3.3) 1.76 (2.6) 1.75 (3.1) 1.41 (2.3) 2.56 (3.4) 2.06 (2.8)
Number of registered 
episodes (ICPC)* 2.27 (2.9) 1.86 (2.4) 1.68 (2.3) 1.39 (2.0) 2.79 (3.3) 2.28 (2.6)
Number of prescriptions 12.67 (27.8) 8.56 (19.2) 8.43 (20.5) 6.25 (16.8) 16.38 (32.5) 10.64 (20.8)
Age 37.75 (21.4) 35.08 (20.2) 35.89 (19.8) 34.10 (19.3) 39.39 (22.6) 35.95 (20.9)
Number of persons 5906 9078 2756 4293 3150 4785
Geové-RZG:
Number of prescriptions 12.47 (19.6) 10.71 (16.1) 10.85 (20.9) 9.48 (15.1) 13.52 (18.7) 11.49 (16.6)
Age
44.99 (22.7) 42.38 (22.0) 43.13 (22.0) 41.19 (21.9) 46.05 (23.2) 43.36 (22.0)
Number of persons 24042 41986 9510 16203 14532 25783
* ICPC = International Classification of Primary Care
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were registered with a GP working in a solo-practice (because exp(-0.255) = 0.77). 
The number of care episodes in disadvantaged communities was 9% higher for 
patients with public health insurance. The number of patient-GP contacts in 
disadvantaged communities was also 9% higher for patients with public health 
insurance. 
The number of prescriptions written for women with private health insurance 
was 52% higher than for men, whereas for women with public health insurance 
the number of prescriptions was 73% higher than for men. Patients with public 
health insurance who lived in disadvantaged communities contributed more to 
the GP workload than those who lived in non-disadvantaged communities. In 
terms of prescriptions, the workload is 11% higher, after correction for all other 
variables. All the patient characteristics (age and gender) and the characteristics 
of the community (residency in a disadvantaged community and the percentage 
of foreigners) of the patients with public health insurance from the Geové-RZG 
database (Table 4.4) shows a relationship with the number of prescriptions, 
whereas no relationship was identified with the GP practice organization. Patients 
with public health insurance who lived in a disadvantaged community cause 7% 
more workload than publicly insured patients who live in non-disadvantaged 
communities. In the comparison of the three variation components, most of the 
variance, interestingly, is seen at the patient level. The variation coefficient for 
the number of prescriptions from the Geové-RZG data for the GP is 11% (=100% x 
√0.013). For patients, this calculation yields only a rough estimate.
The results in the previous sections were presented according to outcome variable. 
If we look at the results per determinant (tables 4.3 and 4.4), after correcting for 
other variables, the following becomes clear:
Gender and age are related to all aspects of work load for both patients with public 
health insurance as well as patients who are privately insured. The difference 
between men and women is greater for those who have public health insurance 
which is represented by the higher coefficients in table 4.3. For the three workload 
variables (patient contacts, number of registered care episodes, number of 
prescriptions) the workload (men less than women) for privately insured versus 
publicly insured patients is 18% versus 24%, 22% versus 30%, and 52% versus 
73% respectively. The effect of age is different for women than for men when 
privately insured with respect to patient-GP contacts and the number of care 
episodes. The older the privately insured female patient, the greater the difference 
in the number of contacts and care episodes between men and women. The 
number of prescriptions, on the other hand, becomes less different from the men 
as age increases.
With respect to the effect of environment, we found that publicly insured patients 
who live in disadvantaged communities cause 7-11% more workload than publicly 
insured patients who live in non-disadvantaged communities. This difference 
is not seen for patients with private health insurance. When there is a higher 
percentage of foreigners in a particular community, we found that privately 
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Table 4.3
Regression coefficients en standard error (s.e.) of num
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Table 4.4 
Regression coefficients en standard error (s.e.) of the num

























































































































insured patients had fewer GP contacts and fewer care episodes than when the 
percentage of foreigners was lower. In the Geové-RZG database for publicly 
insured patients the number of prescriptions in a community was higher when 
there was a higher percentage of foreigners.
GPs who work in a solo practice write fewer prescriptions than those in a group 
practice. This is true for publicly insured patients (38% lower) and for privately 
insured patients (21% lower). Solo GPs registered 23% fewer care episodes than 
GPs in the RNG group practices.
In disadvantaged communities, all of the workload indicator coefficients differed 
depending on whether the patient was publicly or privately insured (tables 4.3 
and 4.4). Namely, for: a) the number of GP contacts (t=2.25, p=0.02), b) the number 
of care episodes (t=2.26, p = 0.02), and c) the number of prescriptions (t=2.04, 
p=0.02)22.
In tables 4.5 and 4.6 the effects of the patient’s residence and GP characteristics 
are compared. The standardized coefficients allow us to compare the different 
variables according to the degree of impact each has. It turns out that age and 
gender contribute the most with respect to all of the workload variables.
4.5 Discussion
In this study, the workload faced by GPs in disadvantaged communities was 
examined using three separate, dependent variables (patient-GP contacts, care 
episodes, and prescriptions). These three variables all had higher values in these 
neighborhoods. The differences seen between disadvantaged communities and 
other communities, for patients with public health insurance, remained, despite 
being corrected for age, gender, percentage of foreigners, and the type of general 
practice organization. Once community characteristics have been taken into 
account, it appears that demographic variables such as age and gender have the 
largest impact on the GP workload. Earlier studies have demonstrated that there 
is a difference between patients who receive public health insurance as opposed 
Figuur 4.2 
The relation between the natural logaritm of the mean prescriptions and age 
for women and men of the RNG-data






































Standardised coefficients of number of face to face contacts en episodes of RNG-data 
(multilevel regression) stratified by private insurance patients (ZF0) and public insurance patients (ZF1)
Number of face to face contacts Number of episodes
Model ZF0 Model ZF1 Model ZF0 Model ZF1
coefficient coefficient coefficient coefficient
Levels Variables
GP
Organisation: soloist 0.00 -0.06 -0.08 -0.16 *
Neighbourhood
Deprived area -0.001 0.06 * -0.001 0.06 *
% foreigners -0.04 * 0.01 -0.04 * 0.00 
Patient
Age (yr) 0.21 * 0.19 * 0.20 * 0.19 *
Age-square 0.16 * 0.06 * 0.11 * 0.00 
Over 65 years -0.05 -0.01 -0.01 0.09 *
Gender: women 0.12 * 0.14 * 0.14 * 0.18 *
Interaction :
Age and gender 0.03 * 0.01 0.04 * 0.02
* p < 0.05
Table 4.6 
Standardised coefficients of the number of prescriptions of RNG-data and Geové-RZG-data (multilevel 
regression) stratified by private insurance patients (ZF0) and public insurance patients (ZF1)
RNG-data: Number of prescriptions Geové-RZG-data: Number of 
prescriptions




Organisation: soloist -0.10 * -0.17 * -0.02
Neighbourhood
Deprived area -0.020 0.04 * 0.027 *
% Foreigners -0.01 0.01 0.03 *
Patiënt
Age (yr) 0.36 * 0.42 * 0.50 *
Age-square 0.46 * 0.07 * 0.09 *
Over 65 years 0.12 * 0.04 -0.02 *
Gender: women 0.18 * 0.20 * 0.10 *
Interaction :
age and gender 0.00 -0.04 * -0.01
* p < 0.05
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to those who are privately insured12,23-27. This supports discussions about socio-
economic health differences in which it was concluded that one’s neighborhood 
(or community) might be a determinant for the health of the inhabitants28. This 
has been termed the composition effect: the average health status for a community 
remains lower than that seen in other communities because of the composition 
of a particular neighborhood. Besides this composition effect, also a contextual 
effect has been observed. This means for example that a person’s health may be 
influenced  by living in a disadvantaged community9,29. More insight into these 
effects may be gained by looking at projects which have been developed and 
funded to help disadvantaged communities30. Our study shows that, even when 
age and gender are taken into account, treating patients who live in disadvantaged 
communities adds to the GP’s workload. This is a contextual effect. This supports 
the idea that patients with public health insurance who live in disadvantaged 
communities contribute more to increase the GP’s workload than patients with 
publicly funded health care who do not live in such communities31.
The methods for defining disadvantaged communities were implemented in 1996 
and revisited and revised in 199816. The percentage of foreigners was added as 
a defining characteristic, whereas the number of inhabitants per square meter 
was no longer weighted as heavily, signifying that the degree of urbanization 
is no longer the unique and absolute criterion. Our analysis of the RNG data 
does not show a clear relationship between the percentage of foreigners and the 
GP workload. This may be due to the particular diversification and integration 
policies which are in effect in Groningen. Therefore, any concentration of 
foreigners in disadvantaged communities is not as evident as in the larger cities 
of the Randstad (this is the area in The Netherlands surrounding the cities of 
Amsterdam, Utrecht, Rotterdam, Den Haag, Amersfoort, Dordrecht, Hilversum, 
and Haarlem). 
In the Geové-RZG data, a positive correlation was seen between the percentage 
of foreigners and the number of prescriptions. This finding indicates that an 
foreigner who visits his or her GP is more likely to receive a prescription than an 
indigenous resident32-34.
In this study, the GP workload was only assessed with respect to activities directly 
involving the patient. It can therefore only approximate the actual workload of 
GPs. Other patient related factors such as continued education, ICT, teaching, and 
administrative duties which must be considered when determining the actual 
workload of the GP were not considered in this study6,35,36. The effect of the size of 
the practice was likewise not investigated. The data used for this study originated 
in a single geographical area from only seven GPs. The average number of patient-
GP contacts found in this study is low compared to other studies27,33,37. We did not 
have access to the specific socio-economic status of each patient. Much research 
has shown that this is a prerequisite to identifying ‘vulnerable groups’ within GP 
practices. These are groups who, because of their social position, have limited 
access to intervention opportunities of both a preventive and a curative nature. 
We are dealing here with people whose financial problems, mental deficiencies, 
chronic unemployment, problems relating to addiction, and specific groups such 
as foreigners and illegal aliens.
The ‘inverse care law’ applies to the above identified special groups: the 
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availability of good medical care tends to vary inversely with the need for it in the 
population served38,39.
With the help of contributions from the AOF, an attempt is being made to make 
working in disadvantaged communities more attractive40. This study shows that 
the age and the gender of the patient have a larger effect on increasing the GP’s 
workload than their residency in a disadvantaged community. This could be an 
argument for placing greater emphasis on the age criterion when determining 
financial compensation for an increased workload.
4.6 Conclusion
GPs face a larger workload in disadvantaged communities than they do in non-
disadvantaged communities. The differences for patients with public health 
insurance living in disadvantaged communities remain even when the data are 
corrected for patient and community variables. Higher age in particular has an 
effect on the GP workload. The procedure of using aggregated data to identify 
disadvantaged communities is open for discussion, because both at the level 
of the GP and at a regional (postal code) level there is less variance than at the 
patient level. The opportunities for improving the algorithm are primarily found 
at the level of the patient. Our findings are based on a single city, which has 
already been addressing health issues caused by low socio-economic status, using 
the RNG database with data from a limited number of GPs. Both of these factors 
limit the external validity of the present results. This study could be replicated 
elsewhere in The Netherlands (i.e. by using the data from the second national 
NIVEL study) to check the validity of the results found in Groningen37,41. If these 
results were replicated, societal bodies would have to consider goal oriented 
improvements to the support systems required for physicians facing a higher 
workload.
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Although there are many antibiotic studies, a classification of the antibiotic 
prescribing over time in family practices with regard to all body systems is 
lacking.
Objectives: 
(1) To identify prescribing patterns for patients receiving antibiotics in family 
practice. (2) To assess whether these patterns are stable across time, and to 
determine correlates of patient characteristics with these patterns.
Methods: 
Data came from a morbidity and medication registration network of adult patients 
over the period 1998 – 2002. Latent class analysis was used to identify clusters of 
patients with similar antibiotic prescribing patterns.
Subjects: 
A total of 125,707 observations were nested in 30,167 patients.
Results: 
Interpretable three class models emerged for diagnostic indications involving 
the respiratory and urinary tract and the skin. A two-class model could be used 
for patients with indications involving the auditory system. Class 1 is a group 
of patients for whom no antibiotics were prescribed (non prescription group). 
Class 2 included patients who received less than one prescription per year with 
a total prescription number less than five for the duration of the study period 
(intermediate prescription group). Patients in class 3 received, on average, one to 
three prescriptions per year (high prescription group).
Conclusions: 
This useful three-class structure shows relationships to sex, age, and socio-
economic status of the patients. Women and the elderly received more antibiotic 
prescriptions, as did patients with a lower socio-economic status.
Key words: 




Antibiotic use is lower in The Netherlands than anywhere else in Europe (ESAC-
data 1997-2002)1 and is estimated at 9.8 defined daily doses per 1,000 inhabitants 
per day. The number of antibiotics prescribed during the year 2000 was 0.4 per 
person. 80-86% of all antibiotics were prescribed by the family physicians.2,3 
Several studies during the past decade have evaluated family physician antibiotic 
prescribing patterns. Antibiotics are prescribed for a variety of indications, and 
most of these studies focused on a specific infection, disease, or complaint.4-7 
Cough, phlegm, rhonchi, cervical lymphadenopathy, and post-nasal drip are 
some of the symptoms associated with upper respiratory tract infections. Studies 
found these symptoms to account for many of the antibiotics prescribed by family 
physicians.8-15 Also most studies are concerned with a specific indication (such as 
a urinary tract infection) or with a specific patient population (such as children). 
There are no studies in which a meaningful classification of antibiotic prescribing 
over time is evaluated with regard to all body systems. Most antibiotics are 
prescribed for complaints relating to the respiratory, urinary, auditory systems, 
and the skin, therefore these systems will be the focus of this study. 
The aim of this study is to assess patterns of antibiotic prescribing by family 
physicians over time specified for morbidity specific factors. Three research 
questions will be answered:
1 Which pattern, if any, can be identified for patients receiving antibiotics in 
family practice setting?
2 Are these patterns stable across time, and do they have specific characteristics?
3 What are the pattern frequencies depending on patient characteristics?
An understanding of the long-term use of antibiotics may contribute to the 
fundamental and increasing bacterial resistance to antibiotics.
5.2 Methods
 
5.2.1 Study population 
Starting in 1992, sixteen family physicians participated in the Morbidity and 
Medication Registration Network Groningen (RNG) of the Department of General 
Practice of the University of Groningen (UMCG). They registered all encounters 
with enrolled patients, specifically recording the diagnosis and any prescribed 
medication. The diagnoses were classified according to the International 
Classification of Primary Care (ICPC). The ICPC is based on body systems in a bi-
axial classification structure, with the body systems on one axis (chapters having 
a letter code) and seven components of the other (having a two-digit numeric 
code).16 In this study we use two components: component 1 provides terms for 
symptoms and complaints (code 01-29) and component 7 provides terms for well-
defined diseases (code 70-99). Prescriptions were automatically coded according 
to the Anatomical Therapeutical Classification (ATC). ATC codes are alphanumeric 
and use seven positions. All antibiotic prescriptions for subjects 18 years and 
older registered with the RNG family practices from 1998 to December 2002 were 
included in this study. The sub-groups provided additional information on J01, 
the ATC code for antibiotics, specifying specific types of antibiotics. To determine 
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whether results found for the study population could be applied to the general 
Dutch population, a comparison was made with results of previous studies.
5.2.2 Study Design 
The longitudinal data set (1998 – 2002) was used to assess intra- and interpatient 
variability. The dependent variable is the total number of antibiotic prescriptions 
per year per patient. The explanatory variables are those relating to the individual 
patient and those relating to the morbidity (specific disease groups) (Table 5.1).
In table 5.1, the following distinctions were made:
1 Variables at the patient level such as age, sex, type of insurance, and the 
duration of registration with the practice were recorded. Age was categorized 
into 10 year intervals, where the first category consisted of patients younger 
than 20 years, and the final category included those patients aged older than 
90. Sex was expressed as a dummy variable (female = 1, male = 0). Type of 
insurance was also expressed as a dummy variable, with the value of one 
for public insurance (state funded) and zero for private insurance. This last 
variable is a proxy variable for socio-economic status of the patient (SES) 
(public = low, private = high). The variable ‘duration’ (as percentage) expressed 
the length of time a patient was registered with the practice. A value of 100 
indicates that the patient was registered with the practice for the total duration 
of the study.
2 Variables at the prescription level included the following: specific ICPC chapter 
according to the primary diagnosis as recorded by the family physician. Most 
of the diagnoses fell into the four ICPC chapters for the respiratory, urinary, 
auditory systems, and the skin. The remaining diagnoses were grouped 
together as a miscellaneous group. We were therefore able to distinguish five 
separate groups: the four body systems and the miscellaneous group.
5.2.3 Statistical analysis
In order to deal with unobserved heterogeneity in antibiotic prescribing, we 
applied mixture modeling with a latent class model (LCM).17 From Deb18 we 
adopted the hypothesis that the underlying unobserved heterogeneity which splits 
the patients into latent classes is based on an individual’s latent long-term health 
status. ‘Latent’ refers to a characteristic that is not observed directly. Latent class 
analysis is based on the assumption that the observed dependent variable, which 
here is defined as antibiotic prescribing, can be represented by a model in which 
patients are divided into a number of groups, such that the dependent variable 
differs in average across groups, and is randomly distributed within groups. 
The groups are called latent classes because group membership is not directly 
observed but can be inferred, with a margin of error from the observations of the 
dependent variable. 
In this study, we will apply the first three of the four capabilities distinguished by 
Nagin19 with relation to latent class modeling:
1 Identify distinct groups of patterns. 
2 Estimate the proportion of the population according to each trajectory group.
3 Relate group membership probability to individual characteristics and 
circumstances.
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4 Use the group membership probabilities for various other purposes such as 
creating profiles of group members.
LCM provides a good framework with which we can distinguish between groups 
with high and low average antibiotic prescriptions.20 As this methodology has not 
yet been widely applied, we also wanted to determine its feasibility in the study of 
antibiotic prescribing.
We used a Poisson distribution with overdispersion for this analysis because the 
dependent variable was a count. For the counts per patient per year we assumed 
a negative binomial distribution, which can be regarded as an overdispersed 
Poisson distribution.21 In this case the count has a basic Poisson distribution 
with a Poisson rate that has a gamma distribution with variance σ2. The expected 
value of the count distribution depended on the latent class. The overdispersion 
parameter σ2 was assumed to be constant across the latent classes. Models were 
tested both with latent classes that had constant rates across the years, and with 
classes where rates fluctuated over the years.
To determine the number of classes, we used the Bayesian information criterion 
(BIC).17 To answer the research questions, latent class modeling was done with the 
use of the computer program LatentGOLD.22 A separate model was used for each of 
the five ICPC chapters. Mixture Poisson models with five year predictor periods as 
dummies were applied, with the following specifications: overdispersion, equal 
dispersion across the classes, and class dependency for the time-predictor. Models 
with fluctuating rates within classes did not have better BIC values than models 
with constant rates, and therefore the constant rate models are presented here. For 
the patients who were in the registration an offset was used in the logarithm of 
the expected value. For a more extended discussion of the method of latent class 
analysis the reader is referred to Vermunt and Magidson.23
Table 5.1
Description of the data set
Explanatory variables : 
Patient characteristics
All patients in 5 years Patients who received one 
or more prescription(s) 
for antibiotics during the 
5 years
Number 30167 12415
Mean age(std) (in years) 44.2 (18.1) 48.7 (19.5)
Women (percentage) 52.7 % 61.2 %
Insured (percentage) 53.5 % 61.7 %
Mean duration in study (percentage) (std)a 78.96 % (31.2) 87.51 % (23.7)
Diagnosis groups
Respiratory system 26.1 % 63.4 %
Urinary tract 14.2 % 34.5 %
Dermatological system  6.7 % 16.4 %
Auditory system  1.9 % 4.7 %
Miscellaneous group  8.0 % 19.5 %




30,167 patients, aged 18 to 102 years, were included in this study. To 41.2% of these 
patients antibiotics were prescribed at some point during the five-year period of 
the study. The mean age was 44 years, and 53% of patients were women (Table 
5.1). The mean registration time for all patients was 79%, with 59% of patients 
registered for the full five years. More than 50% of patients had public health 
insurance. To estimate the degree to which the sample of this study accurately 
reflects the overall demographic in the Netherlands, three patient characteristics 
(age, sex and insurance status) are compared between this study and Statistics 
Netherlands in 2001. Statistics Netherlands is a Dutch governmental institution 
that gathers statistical information about the Netherlands. Based on the total 
number of patients of this study, the number of patients over 65 years is 11.0%, 
the number of female in terms of percentage is 51.5%, and number of patients who 
are public insured is 54.4%. Derived from Statistics Netherlands the numbers for 
age, sex and insurance state in terms of percentage are 13.6%, 50.5% and 64.1% 
respectively. Our study population has lower numbers of people who are publicly 
insured and of elderly. Women are over-represented in the study group.
Table 5.1 shows that about two-thirds of patients for whom antibiotics were 
prescribed received these for respiratory system indications, while about one-
third of patients received them for urinary system indications. The biggest overlap 
was seen between the respiratory and urinary tract body systems. Four percent 
of patients had both diagnoses relating to the urinary and respiratory tract (not 
presented).
5.3.2 Latent class analysis
We initially determined the number of latent classes using the Bayesian 
Information Criterion.17 The smallest BIC values were obtained for the following 
numbers of classes: five for the respiratory ICPC chapter, six for the urinary 
chapter, three for the skin chapter, two for the auditory ICPC chapter, and three 
for the remaining miscellaneous category. For the respiratory and urinary 
tract systems, the results led to models that seemed to overfit the data; this is 
understandable in view of the large number of cases. We therefore decided to 
determine numbers of classes giving a good fit while at the same time leading 
to a clear clinical interpretation. When increasing the number of classes from 
two to higher values, the main decreases in BIC were obtained for an increase to 
Table 5.2 
Estimated latent class rates and class proportions for the classes determined by latent class analysis
Rates Proportions
Class 1 Class 2 Class 3 Class 1 Class 2 Class 3
ICPC- chapters :
Respiratory 0.029 0.380 1.752 74.8 22.4 2.9
Urinary 0.010 0.424 2.525 84.9 13.3 1.9
Dermatology 0.007 0.149 1.154 88.4 11.1 0.5
Auditory 0.002 0.093 94.9 5.1
Miscellaneous group 0.002 0.113 0.804 76.8 22.6 0.7
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three classes for the respiratory and urinary ICPC chapters. In all of these cases, 
any further increase in the number of classes led to differentiation within the 
classes of patients who received prescriptions at least once during the observation 
period, but with an average number of prescriptions of hardly more than one 
per year. This seemed to be a differentiation, which is not meaningful clinically, 
and was therefore not pursued by us. The results presented here are for the 
2-class (for auditory) and 3-class solutions (for respiratory, urinary, skin, and the 
miscellaneous group), which were best interpretable. The estimated prescribing 
rates and frequencies of the latent classes were calculated and are presented in 
table 5.2. The estimated Poisson rates in the three-class model of the respiratory 
body system were 0.03, 0.38, and 1.75, and the frequencies were 0.75, 0.22, and 
0.03. This means that class 1 consisted of 75% of the patients and they received 
an average of 0.03 antibiotic prescriptions per year. The average number of 
prescribed antibiotics in class 2 (22% of the patients) was 0.38, and in class 3 (3% 
of the patients) it was 1.75.
Table 5.2 shows that the rates in class 1 are very low for all ICPC chapters (0.002-
0.029). This class can be described as the class of patients for whom no antibiotics 
were prescribed (non prescription) or only very rarely. Class 3 is the group 
containing patients who received more than one antibiotic prescription per year. 
This group can be described as the high prescription group. The rates in class 2 are 
intermediate between classes 1 and 3. These patients did not receive a prescription 
each year, but received some amount greater than zero and less than five for the 
complete five-year period. We called this group the varied prescription group. 
The sequence of the three classes (class 1 = non prescription, class 2 = varied 
prescription, and class 3 = high prescription) shows an ascending progression of 
prescribing.
Figure 5.1 










  1 2 3
Respiratory  1.0 1.3 1.6
Urinary  1.0 2.8 6.1
Skin  1.1 1.1 1.0
Auditory  1.1 1.1
Miscellaneous  1.1 1.1 1.0
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Table 5.3 
Proportion of the patient characteristics (gender, age and socio-econom




































































































































































































































5.3.3 Group membership related patient characteristics
In table 5.3, the patients’ demographic characteristics are related to their 
positioning within the three classes. Women make up more than 50% of all the 
classes of the five ICPC chapters. Women receive more prescriptions than men. In 
figure 5.1, the odds ratios (with men as reference category) of the three classes are 
represented from table 5.3. The elderly show the greatest representation in class 3 
(high prescription group). More than 50% of each class is made up of patients from 
the lower SES as determined by health insurance coverage. They make up about 
50% of class 1 and more than 60% of class 3.
In figure 5.1 we see that the respiratory and urinary tract ICPC chapters are distinct 
from the other ICPC chapters because of an increasing odds-trend. The urinary 
tract ICPC chapter’s odds ratio increases more than the one for the respiratory 
system. The other ICPC chapters all have odds ratios around 1. Odds ratios greater 
than 1 signify that more prescriptions are written for women than for men.
With respect to SES (in which the high SES group is the reference category), it 
can also be seen that the odds ratios increase with an ascending progression of 
the latent classes. Therefore, in cases of low SES, the prescribing rate is higher 
than for the higher SES group. Whether or not complaints occur with relation to 
diseases in the three latent classes is explored in figure 5.2. Odds ratios for the 
respiratory, urinary and dermatology chapters shows this relationship.
5.4 Discussion 
A pattern of three classes of antibiotic prescribing was identified in this study 
population, which takes into account the respiratory, urinary, auditory, and 
dermatological systems as well as a miscellaneous group. The three classes 
Figure 5.2 
Odds ratios of having well-defined diseases versus complaints (as reference category) indication in the 












include class 1, the non prescription group; class 2, the varied prescription group; 
and class 3, the high prescription group. No class 3 group was identified for the 
auditory ICPC chapter. This was due to the low prevalence of ear related infections 
in age groups older than 18 years. This agrees with the prescription pattern of 
antibiotics in The Netherlands which shows that prescriptions relating to the 
auditory system are very low in populations of patients aged 18 years and older.1,24
A comparison of the two largest ICPC chapters for which antibiotics are 
prescribed, namely the respiratory and urinary tracts, revealed that 75% of 
respiratory patients and 85% of the urinary tract patients were in class 1. The 
number of antibiotic prescriptions for class 2 was 0.4 for both the respiratory 
and the urinary tract ICPC chapters. An average of one prescription per year was 
prescribed for patients in class 2. There were differences between the respiratory 
and urinary groups for class 3. More prescriptions were written for indications 
involving diseases of the urinary tract, but for fewer patients. This could be the 
result of prescribing a number of courses of antibiotics for urinary tract infections 
for these patients. The fact that we did not find any fluctuation over time was 
likely caused by the relatively stable rates of antibiotic prescribing seen between 
1992 and 2001. Kuyvenhoven reported that the number of antibiotic prescriptions 
has been rather stable since the early 1990s in The Netherlands, whereas these 
rates have decreased in the United Kingdom and in the United States. 25 This stable 
prescription rate likely accounts for there being no clearly identifiable fluctuations 
during our study period from 1998-2002. To distinguish clear fluctuations, a longer 
study period would be required. 
Gender was the focus of 11 studies. In five of these, it was found that more 
antibiotics were prescribed for women.7,13,26-28 Straand et al 28 reported that 61% of 
women received prescriptions for antibiotics which is supported by our findings. 
Sorenson 29 mentioned a relationship between gender and antibiotic prescriptions, 
but did not explain any further. Five of the studies concluded that gender did not 
affect prescription rates for antibiotics. 5,30-33 In our study, for 63% of the patients 
who received antibiotics prescriptions, the indication involved the respiratory 
tract. Other studies have reported between 60% and 70%.34,35 
We confine ourselves to the results seen in class 3, as this is the most relevant 
class of patients for the family physician. From table 5.2 it is apparent that the 
highest percentages of patients in class 3 have well defined diseases from the 
respiratory and urinary tract ICPC chapters; 2.9% and 1.9% respectively. 42 
patients fell into both categories. These patients represent a small group of mainly 
women who are public insured (low SES), and elderly who have well defined 
diseases.
5.4.1 Limitations and strengths
McManus reported a seasonal fluctuation in the rates of prescribing antibiotics.10 
We have not addressed this point, as our data were aggregated into numbers per 
year.
One of the strengths of this study is that the diagnostic indication was actually 
linked to the antibiotic prescription. This clearly produces more meaningful 
results than those that would be obtained by using data from a pharmacy 
database. One of the limitations of this study is that patients who received 
antibiotic prescription from the specialist are not represented. 
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5.4.2 Conclusions
In conclusion, this study models antibiotic prescribing patterns along with the 
diagnostic indications for a population of adult patients registered with family 
physicians during a five-year period. A three-class structure was apparent for the 
respiratory, urinary, and dermatological body systems. Only two classes were 
identified for the auditory system, which has a lower prevalence. The remaining 
diagnoses were grouped together as a miscellaneous-group, and also showed the 
three-class structure.
This class structure consists of a group of patients for whom few or no antibiotics 
were prescribed (class 1), a group of patients for whom antibiotics were prescribed 
from time to time on average less than 1 per year (class 2), and for the respiratory, 
urinary, and dermatological body systems a group of patients for whom antibiotics 
were regularly prescribed (class 3). Class 1 consists of the largest group of patients 
varying between 75% and 95%. Class 2 varies from 5 to 25%, and class 3 varies 
between 0.5% and 3%. There is a relationship between gender, age, and SES and 
class of antibiotic prescribing. More antibiotics are prescribed for women, the 
elderly, and patients with a low SES. This pattern of a three-class structure should 
be reinvestigated in a future study with an extension of the covariates before any 
results can be applied in health care and policy.
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This study investigated the effects of general practitioner, patient, and 
prescription characteristics on the reduction of long-term benzodiazepine 
prescribing by sending a letter to chronic users. The data were analyzed with a 
method respecting the hierarchical data structure.
Study Design and Setting: 
Data were obtained from 8,170 chronic users nested in 147 general practices. One 
thousand two hundred fifty-six chronic users in 19 general practices received 
a letter with the advice to reduce or stop the use of benzodiazepines after the 
general practitioners had attended a course on benzodiazepine use. In a three-
level random intercept multilevel regression model, long-term prescribing of 
benzodiazepines was the dependent variable.
Results: 
The reduction in benzodiazepine prescribing was significantly larger in the 
intervention than in the control group: 16% after 6 months and 14% after 12 
months, respectively. The age of the patient, gender, and the interaction between 
age and gender were significant. The combination of the duration (long acting 
or short acting) with the type of benzodiazepine (anxiolytic or hypnotic) was an 
important pharmacological baseline covariate.
Conclusions: 
The reduction of benzodiazepine prescribing was mainly explained by the letter 
intervention and individual patient characteristics. Multilevel analysis was a 
worthwhile method for application in this study with its unbalanced design. 
Keywords: 
Benzodiazepine use; Intervention study; Multilevel modelling; General 
practitioner; Chronic user; Long-term prescription
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6.1 Introduction
Benzodiazepines are the most widely prescribed drugs for a variety of conditions, 
particularly insomnia, anxiety disorders and disorders associated with 
psychiatric conditions1-4. The prevalence rate of benzodiazepine-use varies from 
2.2 – 17.6%5,6. Long-term benzodiazepine use has negative health effects7,8. In 
some studies an attempt is made to reduce the high prevalence or to stop the 
benzodiazepine-use in general practices by sending a letter to patients9-11.
Egan et al.12 demonstrates that patient factors should be taken into account to 
estimate the association between general practitioner factors and the use of long-
acting benzodiazepines. A lot of studies report that patient age, in particular older 
age has a relation to the use of benzodiazepines3,13-16.
Holden et al find that younger patients are significantly more likely than those 
over the age of 65 to stop benzodiazepines 14. Cormack indicates that a simple 
intervention such as a letter from the general practitioner can have considerable 
effect on the use of hypnotic and anxiolytic drugs, also when the sample 
consists of elderly users17. He also concludes that the use of benzodiazepine is 
reduced up to 30%, compared with the use in a control group. Morgan11 based on 
Cormack9 describes the economic advantages. Apart from the reduction of the 
use of benzodiazepine, Bashir18 shows that there is an increase of antidepressiva 
accompanying the reduction of benzodiazepine use.
Isacson15 shows that the following factors predicting long-term benzodiazepine-
use are: age, a combined use of tranquilizers and hypnotics, and prescriptions 
from more than one doctor. According to Morrison19 an intervention is worthwhile 
and the increase in workload is very small. The intervention implies that the 
patient is asked to discontinue the use of benzodiazepines with the help of 
the general practitioner. Other studies 7,13,20-22underline the role of the general 
practitioner. 
6.1.1 Present investigation
With regard to all these studies concerning the use of benzodiazepine three 
groups of characteristics are distinguished:
1 patient characteristics as age and gender
2 prescription characteristics, e.g. duration
3 general practitioner characteristics as workload.
Since prescription, patient, and general practitioner are hierarchically related 
– patients are nested under general practitioners and prescriptions under 
patients – a multilevel approach is an appropriate technique of analysis23-28. 
Because we are interested in reducing the chronic use of benzodiazepines we 
initiated a study with following research question: what is the influence of sending 
an educational letter to patients on the reduction of long-term benzodiazepine 





All general practitioners in the northern and eastern part of the province 
of Groningen in the Netherlands with chronic users of benzodiazepine 
are candidates for inclusion in the study. In this rural region the use of 
benzodiazepines is very high, according to local reports29. The chronic 
benzodiazepine users, who are included in the study, are patients who obtain 
at least 180 defined daily doses (DDD) of benzodiazepine in the course of one 
year (November 1997 – November 1998). The patients are extracted from the 
administrative database of the largest health insurance company. Patients who 
transferred from the insurance company or from one general practitioner to 
another general practitioner (not included in the study) and patients who died are 
excluded from the analysis. 
6.2.2 Intervention and control group
In this study, two groups of chronic benzodiazepine-users are compared. 
The allocation of patients to one of the two groups takes place at the general 
practitioner level. The intervention group receives a letter of the general 
practitioner with the request to stop or to reduce their benzodiazepine use. 
The control group does not receive a letter. All general practitioners from 
the intervention group and a selection of the control group were offered a 
postgraduate course, including information about the pharmacokinetics of 
benzodiazepines and a schedule for slow reduction of benzodiazepine-use to 
prevent withdrawal symptoms. The trial is described on detail elsewhere30.
The research period includes one and half year (from November 1998 – May 
2000) during which an intervention in May 1999 was accomplished (Figure 6.1). 
The intervention implies that a letter was sent by the general practitioner to the 
chronic users with information about the risks of continuous use and the advice to 
reduce or to stop the use of benzodiazepine. In November 1999 a random selection 
of the general practitioner practices sent a reminder to those patients who did not 
react on the first letter. 
6.2.3 Outcome 
The study period from November 1998 to May 2000 consists of three periods: 
1) baseline period from November 1998 to May 1999, 2) post-intervention period 1 
from May 1999 to November 1999 and 3) post-intervention period 2 from November 
Figure 6.1 
Design of the study
 Baseline    Post intervention
 Nov Period 0 May Period 1 Nov Period 2 May
 1998   1999  1999  2000
   Intervention  Reminder
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1999 to May 2000 (Figure 6.1). The outcome in this study is the sum of the 
defined daily doses of benzodiazepine prescriptions per period prescribed by the 
general practitioner per patient. The defined daily dose is the assumed average 
maintenance dose per day for a drug used for its main indication in adults31. 
According to the Anatomical Therapeutic Chemical classification system (ATC) all 
drugs are classified and benzodiazepines are defined by the codes N05BA, N05CD, 
and N05CF32.
6.2.4 Statistical analysis
The primary outcome is the sum of prescribed number of DDD’s per patient 
per half year, controlled for general practitioner, patient and prescription 
characteristics. The influence of these characteristics will be analysed by means 
of multilevel modelling. 
The general practitioners characteristics are: belonging to the course or the non-
course group, belonging to the intervention or control group, and the sending of a 
reminder or not.
The patient characteristics are age and gender. Age is centred around the grand 
mean.
Prescribing characteristics are the duration of effectiveness (long acting versus 
short acting benzodiazepine) and the type of benzodiazepine (hypnotic or 
anxiolytic) as indicated by the total of prescribed benzodiazepines in the baseline 
period. Long-acting benzodiazepines include chlordiazepoxide, diazepam, 
flurazepam and nitrazepam. Shorter-acting benzodiazepines are alprazolam, 
bromazepam, lorazepam, temazepam en triazolam. The dummy variables of the 
prescription characteristics are the combination of the duration of effectiveness 
(long acting or short acting) and the type of benzodiazepine (hypnotics or 
anxiolytics). Per period the prescription characteristics are aggregated to patient 
level (pharmacological variables). In Table 6.1 a summary of these dummy 
variables is given with the number of patients. The reference category is the group 
patients which use long acting anxiolytics and short acting hypnotics.
6.2.5 Multilevel model
A three-level random intercept multilevel regression model will be used with 
periods nested within patients nested within general practitioners. This 
multilevel model is used to assess the effects of general practitioner, patient, and 
prescription characteristics on the defined daily dosage of benzodiazepines. The 
first step is a null model which serves as a baseline for other models. This null 
model (Model 0) reflects the situation of figure 6.1 but without the intervention 
and the two groups. The next model (Model 1) adds the effects of the intervention. 
Baseline and the post-intervention periods are estimated in Model 1 and also 
the differences between baseline and post-intervention periods as a result of 
the letter in the intervention and control group. Next, Model 2 is fitted with 
all remaining general practitioner, patient characteristics, and theoretically 
relevant interactions. The patient characteristics include variables which are 
directly related to the patient and variables which are indirectly related. Age and 
gender are directly related variables. Examples of the indirectly related variables 
are prescription characteristics, aggregated to patient level as anxiolytics and 
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Table 6.1
 Description of general practice characteristics at general practice level, and patient characteristics at 
patient level. (Total, percentage, mean, and standard deviation)
General Practice characteristics N = 147
Allocation:
 Intervention 19  (12.9%)
  Control (ref.) 128  (87.1%)
Education group:
  Course group 56  (38.1%)
  Non-course group (ref.) 91  (61.9%)
Reminder letter:
  Yes 9  (6.1%)
  No (ref.) 138  (93.9%)
Patient characteristics N = 8170
Gender:
  Female 5978  (73.2%)
  Male (ref.) 2192  (26.8%)
Age (years) mean = 64.63  (std. = 14.97)
Prescription characteristics (Number of patients (percentage)) aggregated at patient level  
(pharmacological variables)
 Hypnotic Short-acting (HS) only 2396  (29.33%)
 Hypnotic Long-acting (HL) only 965  (11.81%)
 Anxiolytic Short-acting (AS) only 1455  (17.81%)
 Anxiolytic Long-acting (AL) only 1025  (12.55%)
 Hypnotic Short-acting + Hypnotic Long-acting (HS + HL) 63  (0.77%)
 Anxiolytic Short-acting + Anxiolytic Longacting (AS + AL) 194  (2.37%)
 Hypnotic Short-acting + Anxiolytic Short-acting (HS + AS) 989  (12.11%)
 Hypnotic Long-acting + Anxiolytic Long-acting (HL + AL) 140  (1.71%)
 Hypnotic Long-acting + Anxiolytic Short-acting (HL + AS) 279  (3.41%)
 Hypnotic Short-acting + Anxiolytic Long-acting (HS + AL) (ref.) 441  (5.40%)
 Hypnotic Short-acting + Hypnotic Long-acting + Anxiolytic Short-acting  
 (HS + HL + AS)
56  (0.69%)
 Hypnotic Short-acting + Hypnotic Long-acting + Anxiolytic Long-acting  
 (HS + HL + AL)
13  (0.16%)
 Hypnotic Short-acting + Anxiolytic Short-acting + Anxiolytic Long-acting  
 (HS + AS + AL)
106  (1.30%)
 Hypnotic Long-acting + Anxiolytic Short-acting + Anxiolytic Long-acting  
 (HL + AS + AL)
34  (0.42%)
 Hypnotic Short-acting + Hypnotic Long-acting + Anxiolytic Short-acting +  
 Anxiolytic Long-acting (HS + HL + AS + AL)
14  (0.17%)
8170  (100%)
 Abbreviations: std. = standard deviation; ref. = reference category
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hypnotics, which can be short acting as well as long acting. The prescription 
characteristics aggregated to patient level are intended to control for the effect of 
baseline prescribing. Differences between subsequently fitted models are tested 
by deviance (i.e. likelihood ratio) chi-squared tests. Also the explained variance 
and t-ratio of the estimates will be calculated. The significance level used is 0.05. 
The fixed and random parts are modelled using dummy variables for baseline, 
post-intervention period 1, and post-intervention period 2, defined mutually 
exclusively so that for each data point exactly one of the three dummy variables 
is 1. These dummy variables have random effects at level two (patient level) and 
level three (general practitioner level). There is no random part at level one28. The 
SAS statistical package (Proc Mixed)33 and the multilevel program MLwiN34 are 
used in order to analyse the data.
6.3 Results
6.3.1 Characteristics of the population 
Of the 147 general practitioners, 19 general practitioners (13%) are allocated 
to the intervention group and, 128 to the control group. About one third of the 
general practitioners (38.1%) followed the course on reducing benzodiazepine 
use, namely all general practitioners of the intervention group and 37 (29%) of the 
control group. (Table 6.1) The total number of patients is 8170 (about 65 patients 
per general practitioner, range 7-251). The mean age of the 8170 patients is 65 year. 
In the baseline period the percentage of only long-acting benzodiazepine users 
is 26%, the percentage of only short-acting benzodiazepine users is 59% and the 
percentage of both long and short acting users is 15%. The prescribing of the two 
type of benzodiazepines, hypnotics or anxiolytics only are respectively 42% and 
33%, while both hypnotics and anxiolytics are prescribed to 25% of the patients. 
In Table 6.1 the 15 different kind of users are specified, which will be used in the 
analysis. The combination short-acting hypnotic and long-acting anxiolytic will 
be the reference category. The percentage patients using psychofarmaca is seven 
percent in the baseline period. The mean defined daily dosage of benzodiazepines 
in the intervention-group at the baseline period is 207.4, decreasing to 197.2 in 
post-intervention period 1 and increasing to 200.49 in post-intervention period 2; 
in the control group these values are 203.5, 208.4 and 205.3 respectively (Table 6.1). 
Since the distribution of defined daily dosage is skewed, a log transformation was 
applied. After the log transformation no relapse is found in the intervention group 
with regard to post intervention period 2.
6.3.2 Multilevel analysis 
Table 6.2 (Model 0 to Model 2) shows the results obtain from multilevel analysis. 
Model 0 is the null model. The estimate ‘Baseline’ in Model 0 is the maximum 
likelihood estimate for mean defined daily dosage in the baseline period. This 
estimate is transformed and becomes 163.36 (an antilog transformation of the 
estimate baseline is e5.096). This mean of 163.36 DDD can be interpreted as the 
expected total of the defined daily dosage in the baseline period of a random 
patient prescribed by a random general practitioner. Six month and a year 
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later the mean becomes respectively, 157.43 DDD and 153.70 DDD. The random 
parameters in Model 0 express the between-patient variability at patient level and 
the between-general practitioner variability at general practitioner level. They 
indicate that most of the variation of the defined daily dosage is at patient level. 
In Model 1 (Table 6.2) the effect of the letter (intervention) is estimated in post 
intervention period 1 and 2 by the interaction parameters ‘intervention by post 
period 1 and post period 2’ respectively. The reduction obtained by the letter is 
significant in period 1 (t = -12.30, p<0.05) and also in period 2 (t = -10.34, p<0.05). 
Comparing the intervention group to the control group, a reduction of ((1-
e-0.175)*100) = 16% appears after a half year and 15.6% after one year. The finding 
that the intervention parameter (estimate = 0.03, t= 1.01, p>0.05) is not significant 
in this model, indicates that there is no difference between the intervention group 
and the control group in the baseline period. In Model 1, the explained variance 
at general practitioner level in the post intervention period 1 and 2 is 27% and 25% 
respectively. 
In Model 2 the general practitioner and patient characteristics, the prescription 
characteristics aggregated to patient level and interactions terms are included. 
All patient characteristics are significant as well as the interaction term ‘age by 
gender’. The informed general practitioners (education group) differ from the non-
informed general practitioners (t=-3.05, p<0.05). The significant pharmacological 
variables include: the four main kinds of benzodiazepines (the prescribing of 
only: 1. short-acting hypnotic (HS), 2. long-acting hypnotic (HL), 3. short-acting 
anxiolytic (AS), and 4. long-acting anxiolytic (AL)), three combinations of two 
benzodiazepines (1. HS + HL, 2. AS + AL, and 3. HS + AS), a combination of three 
benzodiazepines (HL + AS + AL), and the combination of four benzodiazepines 
(HS + HL + AS + AL). Psychiatric medication is not significantly related with the 
sum of defined daily dose of the baseline period. After adjusting for all variables, 
the reduction of defined daily doses is 16% after a half year and 14% after one 
year. The explained variances of Model 2 on general practitioner level for the three 
periods baseline, post intervention period 1 and post intervention period 2 are 
respectively 22%, 44% and 37%, and at patient level respectively 8%, 5% and 5%. 
As a result of the letter intervention, a change can be seen between baseline and 
post intervention period 1. The correlation between this change and the baseline 
is -0.12 as calculated from the variance/covariance at patient level. In figure 6.2 is 
Table 6.2
Statistics (mean(std.) and median (IQR)) of defined daily dosages (DDDs) of benzodiazepines at baseline, 






Mean (std.) 207.33 (155.64) 196.44 (172.42) 199.84 (174.81)
median (IQR) 180.27 (130.99) 163.02 (133.90) 168.02 (145.36)
Control group
Mean (std.) 203.50 (160.95) 207.49 (168.00) 204.28 (163.84)
median (IQR) 180.27 (119.30) 180.27 (130.90) 180.27 (130.99)
std. = standard deviation; IQR = inter-quartile range
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Table 6.3
Parameter estimates (standard errors and t-values) of general practice, patient and period 
characteristics of three multilevel models
Model 0 Model 1 Model 2
Fixed estimate s.e. estimate s.e. estimate s.e.
General Practice level
Intervention (vs control) -0.002 0.033 -0.022 0.039
Education group (vs non education) 0.049 0.023 * 0.045 0.022 *
Reminder-letter yes (vs no) 0.004 0.051
Patient Level
Female (vs Male) -0.047 0.015 **
Age (years) -0.005 0.0009 ***
Period level
Baseline 5.096 0.011 *** 5.075 0.014 *** 5.433 0.033 ***
Post-intervention period 1 5.059 0.012 *** 5.064 0.014 *** 5.421 0.033 ***
Post-intervention period 2 5.035 0.013 *** 5.039 0.015 *** 5.396 0.034 ***
Anti-depressant yes (vs no) -0.042 0.027
Interactions:
Gender * Age 0.004 0.001 ***
Intervention * post period 1 -0.175 0.014 *** -0.176 0.014 ***
Intervention * post period 2 -0.170 0.016 *** -0.155 0.02 ***
Post period 2 * Reminder-letter -0.032 0.025
Hypnotic short-acting [HS] only -0.417 0.031 ***
Hypnotic long-acting [HL] only -0.385 0.035 ***
Anxiolytic short-acting [AS] only -0.378 0.033 ***
Anxiolytic long-acting [AL] only -0.479 0.034 ***
HS + HL -0.26 0.079 ***
AS + AL -0.307 0.052 ***
HS + AS -0.086 0.034 **
HL + AL -0.014 0.058
HL + AS -0.064 0.046
HS + AL 0
HS + HL + AS 0.027 0.085
HS + HL + AL 0.299 0.169 *
HS + AS + AL 0.046 0.065
HL + AS + AL 0.278 0.107 *
HS + HL + AS + AL -0.338 0.163 *
Random
Level: General Practice:
Variance / covariance Baseline PIP-1 PIP-2 Baseline PIP-1 PIP-2 Baseline PIP-1 PIP-2
Baseline 0.008 0.007 0.006
Post-intervention period 1 (PIP-1) 0.007 0.011 0.007 0.007 0.006 0.006
Post-intervention period 2 (PIP-2) 0.008 0.011 0.012 0.008 0.008 0.009 0.007 0.007 0.008
Level: Patient:
Variance / covariance Baseline PIP-1 PIP-2 Baseline PIP-1 PIP-2 Baseline PIP-1 PIP-2
Baseline 0.400 0.400 0.368
Post-intervention period 1 (PIP-1) 0.367 0.508 0.367 0.509 0.338 0.482
Post-intervention period 2 (PIP-2) 0.351 0.433 0.519 0.351 0.434 0.52 0.322 0.407 0.493
-2Loglikelihood 31370.1 31261.1 30605.6
* = 0.01 < p < 0.05; ** = 0.001< p < 0.01; *** = p < 0.001; s.e. = standard error
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shown that the intervention group decreases after the intervention. The estimates 
in figure 6.2 are based on contrast coding, referring to a female patient who is 65 
years old and who does not use psychiatric medication. However, she uses both 
short-acting hypnotic and short-acting anxiolytic benzodiazepine and belongs to 
a general practice where the general practitioner did not receive a post graduate 
course and no reminder letter was sent. Residual diagnostics are checked in all 
models showing approximate normality. 
6.4 Discussion
This study demonstrates the reduction of benzodiazepines by means of a 
multilevel model in a natural field experiment. The reduction is caused by a 
letter from the general practitioner to his patients. The general practitioners with 
their patients are allocated either to an intervention group or to a control group. 
Benzodiazepine use has been the subject of continuing discussion for many years, 
as well in the primary care setting as in public health policy1,8,19. An advantage 
of the multilevel model is that prescription, patient and general practitioner 
effects can be analysed simultaneously in a hierarchical structure (Table 6.1) 
following the plea of Leyland and Goldstein23. After adjusting for patient, general 
practitioner and prescription characteristics the reduction of benzodiazepine 
prescribing as a result of a letter can be found in the models. 
Previous studies have reported this reduction of benzodiazepines by the use of 
a letter but without using a multilevel model11,17,18,35. Oude Voshaar36 shows that 
49% of long-term users remain completely abstinent during two-year follow-
up after quitting benzodiazepine use (a discontinuation letter was preceded), 
while 51% patients relapse after a median period of abstinence of 243 days. By 
means of multilevel analysis, this study shows that the variability of the general 
practitioner is small compared to the variability of the patients. This means that 
the inter-general practitioner variability of the prescription and reduction of 
benzodiazepines is smaller than the inter-patient variability. Simon37 found in 
his study that the variability of the prescription of long term benzodiazepines 
by general practitioners was significantly greater than expected by chance. An 
omission in the study of Simon is that patients are not nested within general 
practitioners in the study design. The result of the current study shows that for 
reducing benzodiazepine use, we mainly have to concentrate on patient level38. 
Previous studies9,11,18,35,39 support the reduction of benzodiazepine use by an 
intervention letter. However Hartlaub40 argues that the setting of the study could 
be the reason why he had not found a reduction. To analyse this kind of problems 
a multilevel setting is prefered. 
With the multilevel approach we find that patient age is an significant determinant 
of benzodiazepine use as confirmed in previous studies6,11,14,15,20,37,41-46. Gender is 
also significant as reported in other studies13,15,41,47-51. Many studies41,48,50,51 mention 
that women use more benzodiazepines than men. In our study the interaction 
between gender and age indicates that when people get older, benzodiazepine use 
is different between men and women.
In this study, short-acting hypnotica is prescribed to 30% of the chronic users. 
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A decreasing effect can be seen in the use of benzodiazepines for patients who 
use one drug of two drugs, after adjusting for the other variables. The studies 
who refer to the effect of short- versus long-acting benzodiazepines52,53, report 
that general practitioners tend to prescribe short-acting benzodiazepines. The 
tendency of prescribing short-acting benzodiazepines is also found in this 
study. In accordance with the study of Pimlott the proportion of long-acting 
benzodiazepines decreases more than the combination of short-acting and 
hypnotics. Adding benzodiazepines to antidepressants is commonly used to treat 
people with depression. This relation between benzodiazepines and psychiatric 
medication is not shown in this study, but is reported in other studies19,37,54,55. As 
mentioned before a change can be seen between baseline and pot intervention 
period 1. The negative correlation (-0.12) between baseline and this change 
corresponds with the statement of Cormack that after a letter intervention, a high 
reduction is related with a low baseline drug consumption9.
 
6.4.1 Limitations and strengths
In this study the information whether the patient actually used the drug is not 
known, and the indication of the prescription is not taking into account in this 
study. The patients included this study are only obligatory insured, as about 60% 
of the Dutch population is obligatory insured with public health insurance funds. 
Only users of more than 180 DDD are included in the study. Since patients with 
lower mean baseline drug consumption are more successful at reducing their 
medication. The strength of this study is the relatively large population size and 
its realistic practice based design. The benefits of being able to evaluate a large 
number of patients and doing population-based data-analysis have its definite 
advantages.
Figure 6.2 
Adjusted benzodiazepine means of model 2, at baseline, post intervention period 1 (Post 1), and post 













Improvement in the rational prescribing of benzodiazepines is not achieved by 
the medical board making new rules but rather by offering general practitioners 
education in communication and negotiating skills as well as more time with the 
individual patient who is requesting benzodiazepines7. Other possibilities for 
reducing benzodiazepine prescribing are a leaflet56, online drug telepharmacy45 
and feedback to general practitioners57,58.
Another clinical implication is that general practitioners have a tool at their 
disposal, e.g. sending a letter, to discontinue the use of benzodiazepines. Such a 
letter is advisable in cases of abuse or heavy use and particularly in the case of 
elderly.
The findings of the current study are not consistent with those of Pimlot57 who 
find that educational material for general practitioners has no impact on general 
practitioners benzodiazepines prescribing. This paper has outlined a multilevel 
approach which analyses an intervention study. The study demonstrates 
that a simple letter from the general practitioner reduces the prescribing of 
benzodiazepines. Moreover, it will benefit public health.
Acknowledgment
We thank Eddie Bruin from the Health Care Insurance Organisation for his 
assistance with data collection.
81
References
1 Hollister LE, Müller-Oerlinghausen B, Rickels K, et al. Clinical uses of benzodiazepines. 
Journal of Clinical Psychopharmacology 1993; 13:1S-169S.
2 Longo LP, Johnson B. Addiction: Part 1. Benzodiazepines - Side Effects, Abuse risk and 
alternatives. American Family Physician 2000; 61:2121-8.
3 Nolan L, O’Malley K. Patients, prescribing, and benzodiazepines. European Journal of Clinical 
Pharmacology 1988; 35:225-9.
4 Petrovic M, Mariman A, Warie H, et al. Is there a rationale for prescription of benzodiazepines 
in the elderly? Review of the literature. Acta-Clinica-Belgica 2003; 58:1-36.
5 Magrini N, Vaccheri A, Parma E, et al. Use of benzodiazepines in the Italian general 
population: prevalence, pattern of use and risk factors for use. Pharmacoepidemiology and 
Prescription 1996; 50:19-25.
6 Zandstra SM, Furer JW, van de Lisdonk EH, et al. Different study criteria affect the prevalence 
of benzodiazepine use. Social Psychiatry and Psychiatric Epidemiology 2002; 37:139-44.
7 Bendtsen P, Hensing G, McKenzie L, et al. Prescribing benzodiazepines--a critical incident 
study of a physician dilemma. Soc Sci Med 1999; 49:459-67.
8 van Hulten R, Teeuw KB, Bakker AB, et al. Characteristics of current benzodiazepine users as 
indicators of differences in physical and mental health. Pharm World Sci 2000; 22:96-101.
9 Cormack MA, Owens RG, Dewey ME. The effect of minimal interventions by general 
practitioners on long-term benzodiazepine use. The Journal of the Royal College of General 
Practitioners 1989; 39:408-11.
10 Gorgels W, Oude Voshaar R, Mol A, et al. Discontinuation of long-term benzodiazepine use by 
sending a letter to users in family practice: a prospective controlled intervention study. Drug 
and Alcohol Dependence 2005; 78:49-56.
11 Morgan JD, Wright DJ, Chrystyn H. Pharmacoeconomic evaluation of a patient education letter 
aimed at reducing long-term prescribing of benzodiazepines. Pharm World Sci 2002; 24:231-
5.
12 Egan M, Wolfson C, Moride Y, et al. Do patient factors alter the relationship between 
physician characteristics and use of long-acting benzodiazepines? Journal of Clinical 
Epidemiology 2000; 53:1181-7.
13 Brownlee K, Devins GM, Flanigan M, et al. Are there gender differences in the prescribing of 
hypnotic medications for insomnia? Human-Psychopharmacology 2003; 18:1-73.
14 Holden JD, Hughes IM, Tree A. Benzodiazepine prescribing and withdrawal for 3234 patients 
in 15 general practices. Fam Pract 1994; 11:358-62.
15 Isacson D. Long-term benzodiazepine use: Factors of importance and the development of 
individual use patterns over time--A 13-year follow-up in a Swedish community. Soc Sci Med 
1997; 44:1871-80.
16 van der Waals FW, Foets M. Sex differences among recipients of benzodiazepines in Dutch 
general practice. British Medical Journal 1993; 307:363-6.
17 Cormack MA, Sweeney KG, Hughes-Jones H, et al. Evaluation of an easy, cost-effective 
strategy for cutting benzodiazepine use in general practice. British Journal of General 
Practice 1994; 44:5-8.
18 Bashir K, King M, Ashworth M. Controlled evaluation of brief intervention by general 
practitioners to reduce chronic use of benzodiazepines. British Journal of General Practice 
1994; 44:408-12.
19 Morrison JM. Audit and follow-up of chronic benzodiazepine tranquillizer use in one general 
practice. Fam Pract 1990; 7:253-7.
82
20 Dybwad TB, Kjolsrod L, Eskerud J, et al. Why are some doctors high-prescribers of 
benzodiazepines and minor opiates? A qualitative study of GPs in Norway. Fam Pract 1997; 
14:361-8.
21 Cormack MA, Howells E. Factors linked to the prescribing of benzodiazepines by general 
practice principals and trainees. Fam Pract 1992; 9:466-71.
22 Bjorner T, Laerum E. Factors associated with high prescribing of benzodiazepines and minor 
opiates: A survey among general practitioners in Norway. Scandinavian-Journal-of-Primary-
Health-Care 2003; 21:2-120.
23 Multilevel modeling of health statistics. Chichester: John Wiley & Sons, Ltd, 2001.
24 Carey K. A multilevel modelling approach to analysis of patient costs under managed care. 
Health Economics 2000; 9:435-46.
25 Diez-Roux AV, Nieto FJ, Muntaner C, et al. Neighborhood environments and coronary heart 
disease: a multilevel analysis. Am J Epidemiol 1997; 146:48-63.
26 Duncan C, Jones K, Moon G. Context, composition and heterogeneity: using multilevel models 
in health research. Soc Sci Med 1998; 46:97-117.
27 Goldstein H, Browne WJ, Rasbash J. Multilevel modelling of medical data. Statistics in 
Medicine 2002; 21:3291-315.
28 Snijders TAB, Bosker RJ. Multilevel analysis; An introduction to basic and advanced multilevel 
modelling. London: SAGE Publications Ltd, 1999.
29 Niessen WJM. Ingeslapen? Een onderzoek naar het gebruik van benzodiazepines in Oost-
Groningen. Veendam: GGD Oost-Groningen; 1996. 
30 Niessen WJM, Stewart RE, Broer J, et al. Vermindering van gebruik van benzodiazepinen door 
een brief van de eigen huisarts aan chronische gebruikers [Reduction in the consumption of 
benzodiazepines due to a letter to chronic users from their own general practitioner]. Ned 
Tijdschr Geneeskd 2005; 149:356-61.
31 Defined Daily Dose (DDD). www whocc no 2005Available from: URL: www.whocc.no/atcddd/
atcsystem.html
32 ATC Index with DDDs. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 1999. 
33 Littell RC, Milliken GA, Stroup WW et al. SAS System for Mixed Models. First ed. North 
Carolina: SAS Institute Inc., 1996.
34 A user’s guide to MLwiN [computer program]. Version 1.0. London: Multilevel Models Project; 
1998.
35 Gorgels WJMJ, Oude Voshaar RC, Mol AJJ et al. Discontinuation of long-term benzodiazepine 
use by sending a letter to users in general practice. In: Oude Voshaar RC, ed. Consecutive 
treatment strategies to discontinue long-term benzodiazepine use: a systematic evaluation in 
general practice.Nijmegen: University of Nijmegen, 2003.
36 Oude-Voshaar RC, Gorgels W, Mol A, et al. Predictors of relapse after discontinuation of long-
term benzodiazepine use by minimal intervention: a 2-year follow-up study. Fam Pract 2003; 
20:370-2.
37 Simon GE, Vonkorff M, Barlow W, et al. Predictors of chronic benzodiazepine use in a health 
maintenance organization sample. Journal of Clinical Epidemiology 1996; 49:1067-73.
38 Barter G, Cormack M. The long-term use of benzodiazepines: patients’ views, accounts and 
experiences. Fam Pract 1996; 13:491-7.
39 Rascati KL, Okano GJ, Burch C. Evaluation of physician intervention letters. Medical Care 
1996; 34:760-6.
40 Hartlaub PP, Barrett PH, Marine WM, et al. Evaluation of an intervention to change 
benzodiazepine-prescribing behavior in a prepaid group practice setting. American Journal of 
Preventive medicine 1993; 9:346-52.
83
41 De las Cuevas C, Sanz E, De las Fuente JA, et al. Prescribed daily doses and risk factors 
associated with the use of benzodiazepines in primary care. Pharmacoepidemiology and 
Drug Safety 1999; 8:207-16.
42 Howes JB, Ryan.J, Fairbrother G, et al. Benzodiazepine prescribing in a Sydney teaching 
hospital. Medical Journal of Australia 1996; 165:305-8.
43 Mant A, Mattick RP, de Burgh S, et al. Benzodiazepine prescribing in general practice: 
dispelling some myths. Fam Pract 1995; 12:37-43.
44 McNutt L, Coles FB, McAuliffe T, et al. Impact of regulation on benzodiazepine prescribing 
to a low income elderly population, New York state. Journal of Clinical Epidemiology 1994; 
47:613-25.
45 Monane M, Matthias D, Nagle B, et al. Improving Prescribing Patterns for the Elderly Through 
an Online Drug Utilization Review Intervention: A System Linking the Physician, Pharmacist, 
and Computer. JAMA 1998; 280:1249-52.
46 Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive 
decline in the elderly: the epidemiology of vascular aging study. Journal of Clinical 
Psychopharmacology 2002; 22:285-93.
47 Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly 
in the United States. Journal-of-the-American-Geriatrics-Society 2003; 51:5-677.
48 Groenewegen PP, Leufkens HG, Spreeuwenberg P, et al. Neighbourhood characteristics and 
use of benzodiazepines in The Netherlands. Soc Sci Med 1999; 48:1701-11.
49 Lagnaoui R, Begaud B, Moore N, et al. Benzodiazepine use and risk of dementia: a nested 
case-control study. Journal of Clinical Epidemiology 2002; 55:314-8.
50 Myers B, Siegfried N, Parry CDH. Over-the-counter and prescription medicine misuse in Cape 
Town - Findings from specialist treatment centres. South-African-Medical-Journal 2003; 93:5-
370.
51 Tu K, Mamdani MM, Hux JE, et al. Progressive trends in the prevalence of benzodiazepine 
prescribing in older people in Ontario, Canada. Journal-of-the-American-Geriatrics-Society 
2001; 49:1341-5.
52 Miyamoto M, Hirata K, Miyamoto T, et al. Hypnotic prescriptions in a university hospital: 
Analysis of data from the computer-ordering system. Psychiatry Clin Neurosci 2002; 56:305-
6.
53 Tu K, Mamdani MM, Hux JE, et al. Progressive trends in the prevalence of benzodiazepine 
prescribing in older people in Ontario, Canada. Journal of the American Geriatrics Society 
2001; 49:1341-5.
54 van Broekhoven F, Kan C, Zitman F. Dependence potential of antidepressants compared to 
benzodiazepines. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2002; 
26:939-43.
55 Zandstra SM, van Rijswijk E, Rijnders CAT, et al. Long-term benzodiazepine users in 
family practice: differences from short-term users in mental health, coping behaviour and 
psychological characteristics. Fam Pract 2004; 21:266-9.
56 Chung KF, Cheung RCH, Tam JWY. Long-term benzodiazepine users - characteristics, views 
and effectiveness of benzodiazepine reduction information leaflet. Singapore Medical Journal 
1999; 40:1-8.
57 Pimlott N, Hux J, Wilson L, et al. Educating physicians to reduce benzodiazepine use by 
elderly patients: a randomized controlled trial. CMAJ 2003; 168:835-9.
58 Elliott RA, Woodward MC, Oborne CA. Improving benzodiazepine prescribing for elderly 




The model represents the repeated measures as a multilevel model for three levels. 
The measurement occasions constitute the first level, the patients the second level, 
and the general practices the third level. Consequently the data are represented 
in a format where each record is identified by its measurement occasion t (‘level 1 
unit’), its patient j (‘level 2 unit’), and its general practice k (‘level 3 unit’).
The fixed and random parts are modelled using dummy variables for the three 
measurement occasions: baseline (B), post-intervention period 1 (PIP-1), and 
post-intervention period 2 (PIP-2), defined mutually exclusively so that for each 
data point exactly one of the three dummy variables is 1. A model with correlated 
random slopes at level-2 for these dummy variables specifies a fully multivariate 
model and replaces the level-1 random part[28](p. 174). Omitting the explanatory 
variables except for the measurement occasions, the expected value for 
measurement occasion t can be denoted by μt and this model can be expressed by:
 
Ytjk = μt + Ptjk + Gtk ,
where the fixed part can be written as μt = μ1(B)tjk + μ2(PIP-1)tjk + μ3(PIP-2)tjk and 
does not contain a constant term, but represents the three measurement occasions 
by three dummy variables.
Ptjk and Gtk are normally distributed random variables with expectations 0 and 
variances σ21 for Ptjk and τ
2
1 for Gtk, and with covariance matrices
 σ21
Level 2: cov(Ptjk ) = σ12 σ
2
2   ;




Level 3: cov(Gtk ) =  τ12 τ
2
2   .
 τ13 τ23 τ
2
3
σ21 = variance of baseline (B) in level 2.
σ12 = covariance between level 2 baseline (B) and post-intervention period 1(PIP-1).
 
The level-2 component of the covariance between B and the difference between  
B – (PIP-1) is equal to σ12 – σ
2
1 ,
and the correlation between baseline (B) and the change between B and PIP-1 is 
estimated by: σ12 – σ
2
1
 √ σ2dif σ21
where σ2dif= σ
2
1 – 2σ12 + σ22
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Appendix B 
Letter from general practitioner received by intervention group
Dear Ma’am / Sir,
This letter is directed at you because during the past year, you have regularly 
received prescriptions for sleep and/or anxiety. Although these medications are 
generally prescribed to help you through a difficult period, they will not solve your 
problems in the long-term. You yourself know whether you have benefited from 
these medications.
It is currently not recommended to take these medications for periods longer than 
two to six weeks due to adverse side effects. I would like to call your attention to 
that fact with this letter. If you are willing, I would like to work together with you 
to decrease or stop your use of these medications.




The side effects increase with age. Because of the drowsiness caused by these 
medications, your chances of falling and possibly breaking bones is increased.
In my opinion, these reasons are sufficient cause to decrease or stop these 
medications.
A number of people develop symptoms as a result of decreasing or stopping these 
medications. These symptoms may be similar to those you had before you started 
the medication. In general, these symptoms will not last long, usually less than 
two weeks, at which time even people with these symptoms feel a great deal 
better.
I invite you to make an appointment to come and see me. We can then discuss how 
best to help you stop these medications. If necessary, we can agree to a gradual 
decrease in dose.









This dissertation presents four studies using multilevel methodology in the 
domain of general practice, with a focus on the different methods used. The two 
common and most important topics addressed by the four studies are the variation 
between patients and the variation between general practitioners (GPs) – and 
their interrelation. The combined presence of these two sources of variation is the 
reason why a nested structure has always been used for the statistical analysis. In 
the first study (S1) (chapter 2), the global adherence to guidelines was studied for 
patients who are nested within general practices. In the second study (S2) (chapter 
3), the GP workload caused by providing care for patients in socio-economically 
challenged communities was compared to the GP workload in other communities. 
In this second study, the patients are nested under their GPs, and they are also 
nested according to the neighbourhood they live in. In the third study (S3) (chapter 
4), we use several measures to investigate which antibiotic prescribing patterns 
can be distinguished. In this study, antibiotic prescriptions over a period of 
several years, with repeated measurements for each patient, are nested under 
the patients. In our last study (S4) (chapter 5), the effect of a letter from the GP 
to chronic users of benzodiazepines was investigated in an intervention study. 
In this study, benzodiazepine prescriptions over a period of several years, again 
with repeated measurements for each patient, are nested under patients, and the 
patients were nested under their GPs. Multilevel analysis techniques are effective 
when looking at the influence caused by different sources of variation such as the 
patients, the GPs, the neighbourhoods, and repeated measurements. 
In the present chapter, we present the main findings of the studies. We will 
discuss the theoretical and methodological consequences of these results and for 
future research.
7.2 Summary of the four studies
7.2.1 Main findings
The overall conclusion that gives an answer to the general research question 
is that both patient and general practitioner characteristics were related to the 
prescribing of medication. Moreover the multilevel design was applicable to this 
research question. 
The first study demonstrated that the degree of adherence to guidelines was 
influenced by two practice characteristics (solo or group practice, and rural 
or urban location) and by all patient characteristics under consideration (age, 
gender, mean costs, mean volume, and different ‘Anatomical Therapeutic 
Classification’-codes (ATC)). Mean costs, mean volume and different drugs are 
contact-level costs, volume and drugs, aggregated to the patient over a given time 
interval. With respect to the characteristics of the general practice, adherence to 
guidelines proved to be 2% lower in the solo practices than in the other practices. 
In urban areas it was 2% lower than in rural areas. With regard to patient 
characteristics, age and gender showed the largest effects. Age showed a negative 



















































































































 In the second study we found that the GP’s workload in socio-economically 
challenged communities was indeed higher than in other communities. These 
differences remained when we controlled for demographic characteristics such 
as age and gender, neighbourhood characteristics, and organizational aspects 
of the practice. For patients with government funded health insurance, the 
workload was 7 to 11 percent higher in socio-economically deprived communities. 
For patients without government funded health care, no difference was found 
between socio-economically challenged and non-challenged communities. Just as 
in study 1, the patient variables turned out to be the most important variables in 
explaining the variance in workload.
In the third study, the variation between patients could be well described by 
dividing the patients into three groups based on antibiotic prescriptions. The 
data for the study covered a period of five years. The three groups were: group 
1: the non-prescription group, group 2: the varied prescription group, and group 
3: the high prescription group. The diagnostic indications for this distinction 
were derived for each of five diagnostic clusters: 1) respiratory, 2) urinary, 3) 
dermatological, 4) auditory, and 5) miscellaneous. In these clusters the proportion 
of patients in prescription group 1 varied from 75% to 95%, in group 2 from 5% to 
22%, and in group 3 from 0.5% to 3%. For auditory, there was no high prescription 
group. Age was positively correlated to the amount of antibiotics prescribed. 
 In study 4 we found that the informative letter from the GP to chronic 
benzodiazepine users advising them to reduce or cease using benzodiazepines 
was effective. We concluded this as there were fewer benzodiazepine prescriptions 
written following the intervention. The reduction of prescribing was 16% after a 
half year, and 14% after one year. Not taking the covariances into account, the 
explained variance on general practitioner level, was 22 % before intervention, 
44% a half year after the intervention , and 37% one year after the intervention. 
At patient level the explained variances were respectively 8%, 5% and 5%. Taking 
the covariances into account, the explained variances on general practitioner level 
for the three periods: baseline, post intervention period 1 and post intervention 
period 2 were respectively 25%, 27% and 28%. At patient level the explained 
variances were respectively 8%, 7% and 7%.
7.2.2 Characteristics of the studies
In table 7.1 a summary of the four studies is given classified according to research 
methods, nesting structure, total units by level, total number of records, time 
period of the research, demographic characteristics of the patients, and dependent 
variables. The recruitment will also be discussed.
With regard to research methods, the studies were classified according to 
two principles: a) exploratory versus testing and b) longitudinal versus cross-
sectional. Three of the studies are exploratory (S1, S2, and S3) while the fourth 
study (S4) focuses on hypothesis testing; two studies are longitudinal (S3 and S4) 
and two are cross-sectional (S1 and S2).
Table 7.1 also shows the organization of the four studies with respect to the nesting 
structure or multilevel structure. The following levels are distinguished: general 
practices, GPs, neighbourhoods, patients, and repeated measurements (for the 
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patients). As patient variation is the most important focus for all of the studies, it 
is represented in all of the studies.
Studies S3 and S4 are longitudinal and present repeated measurements nested 
under patients. In study 2 (S2), the patients are nested under the GPs as well as 
in neighbourhoods, which leads to a cross-classified model. The model is cross-
classified because GPs and neighbourhoods are present in different combinations, 
which makes case nesting impossible. Combining all this, we can distinguish a 
total of five levels: repeated measurements (level 1), nested under patients (level 2), 
nested under GPs (level 3), who are nested within general practices (level 4), while 
the general practices are cross-classified with the neighbourhoods (level 5). In two 
studies (S1 and S2) the GP data concerning the nesting structure was not available, 
therefore the data were aggregated to the general practice level.
Table 7.1 shows the total units per level, including the number of patients, the 
number of GPs and/or the number of general practices. The number of patients in 
these four studies ranges from 8,170 to 66,028. The number of GPs ranges from 7 to 
70, and the numbers of general practices ranges from 147 to 190. 
The total number of records varied from 14,984 to 125,707.
The period wherein the data were collected is from 1997 to 2002. 
The demographic characteristics, age and gender are presented in table 7.1 to 
present an overview of the demographic distribution between the studies. In 
three studies (S1, S3, S4), patients under age 18 were excluded. The mean patient 
characteristics (age and gender) in study 4 are different from the other studies, 
because the average age of chronic benzodiazepine users is higher than the norm. 
Study 4 showed a mean age of 65 (SD 15) with 73% women. In the three other 
studies (S1, S2, and S3), the mean age is from 36 to 44 years. The percentage of 
women is more than 50% in all four studies.
The dependent variables are all related to prescribing. The global adherence was 
defined as prescribing of a drug which is mentioned in the Groningen Formulary1. 
The workload of the GP was calculated by taking into account: 1) the number 
of contacts with the patient; 2) the number of care episodes per patient; 3) the 
number of prescriptions per patient. The total number of antibiotic prescriptions 
per year per patient was used as the dependent variable in study 3, and in study 
4 the sum of the defined daily doses of benzodiazepine prescriptions in per six-
month-period per patient was used as the dependent variable.
The data for the four studies were recruited from the insurance company MENZIS 
(S1 and S4) and from the Morbidity and Medication Registration Network 
Groningen (RNG) of the Department of General Practice at the University Medical 
Center in Groningen (UMCG). In study 2, data from the RNG as well as data from 
MENZIS are used. A common characteristic of all studies is that the data originate 
from databases designed for administrative purposes. The data from the RNG 
are also used for patient care. The RNG data are reliable, because the GPs were 
intensively trained and they received feedback about the data they provided 
between four and six times per year2. All of the assistants and researchers who 
were involved in this data processing meet regularly. The GPs who are involved 
in the RNG are not a random sample selected from the Dutch GP population. 
However, the GPs of the RNG are comparable with their regional colleagues 
based on information from the regional health care organizations. With respect 
to incidence and prevalence, the morbidity pattern seen in the RNG data does 
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not deviate significantly from other GP registration groups. Administrative 
databases have been criticized for underestimating the prevalence of certain 
diseases (co-morbidities). However, Maselli et al. concluded that administrative 
databases are accurate sources for measuring profiling3. In her study, Lamers 
presents a comparison between a pharmacy database and a database from 
a general practice. She ascertains that the only objection to use a pharmacy 
database is the absence of diagnoses4. Treweek mentions that we have to make 
careful interpretations when using data generated by GPs. She concludes that 
data from GP generated databases may support quality improvement work, 
however this requires an awareness of how the electronic medical record system 
is actually used by general practice staff5. As previously mentioned, the data 
are primarily registered for administrative purposes. But if attention is paid to 
consistent registration in a standardized way, and if this is supported by regular 
meetings and feedback, the general practitioner registration system can be used 
for the evaluation of the GPs’ activities and professional competencies, as is also 
demonstrated in this dissertation. The general practice registration system can be 
used for other purposes such as education. Additionally, policy decisions may be 
based on the collected data, such as is seen when looking at the workload of GPs 
in socio-economically challenged communities.
7.2.3 Limitations
We used pre-existing data for these studies, and therefore we had to make use 
of existing patient, GP, and general practice variables. This implies that we 
could not develop operationally well founded variables in an optimal way. The 
patient variables appeared to be related to medical variation, but the higher-level 
variables, such as the GP and practice variables, showed a weak relationship 
to medical variation. This may be due, in part, to the fact that we were limited 
to the existing variables, and that no other variables could be used other than 
those previously collected in the databases. It would be interesting to collect 
additional relevant variables at both the GP and practice level, this allowing to 
explain more of the variance in the outcome measures under study. Additional 
GP-level variables are for example: collaboration with (Farmaco Therapie Overleg) 
FTO-group and connected with family practice research networks. An example 
of an additional variable at practice level is the availability of other paramedical 
specialisms.
 7.3 Methodological issues / reflections
7.3.1 Methodological issues
In multilevel research, the data structure in the population is hierarchically 
nested (in this case, patients nested in a general practice), and the data are 
regarded as a multistage sample from a hierarchically structured population. In 
such samples, the patients in the same practice, or with the same GP, are generally 
not independent because they are treated in the same organization or by the 
same person, because of selection processes, and due to the common context and 
history they share as a result of belonging to the same general practice.
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Table 7.2
Overview of independent, dependent and stratification variables of the different studies grouped by 
level
Level:
Level 4: General Practice Stratification variables:
Characteristics: 1. Mean age of the GPs
2. % men of the GPs
3. Mean male patients
4. Mean female patients
5. Practice-type





Level 3: General practitioner Neighbourhood Insurance:
Characteristics: 1. Organisation 1. Deprived area
2. Percentage of foreigners
1. Public
2. Private




4. Duration in practice
5. Aggregated mean Costs
6. Aggregated mean Volume
















Prescription: 1. DDD’s of benzodiazepine
2. Antibiotic prescriptions
1  There are two main general arguments for applying a multilevel design.
 The nature of the research question, in which various units of analysis play 
different roles, such as patients and GPs. Because the dependent variable is 
always a micro-level variable, usually one or more variables defined at a higher 
level (so-called macro-level variables) will be included among the independent 
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2 The mutual dependence of observations, inherent to a nested data structure, 
renders invalid more common research methods, which require independence 
of cases.
Each of the four studies satisfies both arguments, as may be concluded from the 
substantive importance of the levels as mentioned in tables 7.1 and 7.2. 
7.3.2 Number of units needed per level for a multilevel analysis
Multilevel design is being applied increasingly to nested data structures. There are 
different opinions regarding the minimum number of units needed, on the macro 
as well as on the micro level6-9. A number of authors standardly use a minimum 
of 100 to 150 subjects8, or a rate of 5 to 10 subjects per variable when applying 
a single-level statistical model10. The efficiency and power of multilevel tests is 
based on pooled data of units at two or more levels, which requires large datasets. 
Kreft’s simulation study6 showed that adequate statistical power is achieved 
with at least 30 groups of 30 observations each, 60 groups of 25 observations 
per group, or 150 groups of 5 observations per group. The number of groups has 
a stronger effect on the power than the total number of observations, although 
both are important. The numbers that are used in our four studies are sufficient 
with the partial exception of study 2, for which only seven GPs were present at the 
macro level for the RNG section of the study. These results are therefore purely 
exploratory with respect to the GP level. 
Theoretically, a total of five levels may be distinguished in the four studies. If we 
put all the variables from the four studies together in one design and require strict 
nesting, we can reduce the number of levels to four. In table 7.2 a summary of the 
dependent and independent variables is presented, indicating the stratification 
variables. The interaction terms are not included in this summary. 
A basic operation when using a model with several levels is to decompose the total 
variance across the levels. This allows us to compute several kinds of intraclass 
correlations, indicating the relative variance contribution of individual levels. For 
example, we can find out the proportion of total variance accounted for by the GP. 
In two studies (S1 and S4) it was not possible to nest the individual GPs within 
general practices, therefore the data were aggregated to the general practice level. 
As a result, it was impossible to make a distinction between ‘general practice 
variation’ and ‘general practitioner variation’. The intraclass correlations are 
summarized and discussed in Section 7.3.3.
7.3.3 Reflections with regard to the methodology
In addition to the reasons previously mentioned, the size of the intraclass 
correlation (ICC) may be important when deciding whether or not to apply a 
multilevel design. This coefficient indicates the contribution of the higher level 
to the variation in the outcomes of the dependent variable(s). In table 7.3 the ICCs 
found in some multilevel studies reported in the literature11-14 are presented, to 
give an impression of the amount of ICC in different studies of general practice. In 
this literature the ICCs for two level cross-sectional designs in which patients are 
nested under GPs, vary between 1.3 – 19%. 
The ICCs (i,e., proportions of variance at the practice or GP level) in all four studies 
are very low when compared to the other studies in table 7.4, with the exception of 
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study 4 and the cluster respiratory-body system of study 3. In study 2, if we would 
ignore the neighbourhood level, the associated variance would be added to the 
variance at the general practice level, yielding intraclass correlations from 0.013 to 
0.07. In chapters 2 (S1) and 3 (S2), a multilevel design is used in which the patient 
level is the lowest level. Based on both studies, we conclude that the patient level 
has a larger variance partition coefficient than is found at the GP level. In chapter 2 
(S1), it appears that 98% of the total variance of the global adherence is accounted 
for at the patient level.
Concerning the GP level, studies 1 and 4 did not include the GP level in the study 
design (table 7.1). In order to assure anonymity in these studies, the data were not 
released at GP level, but aggregated to the level of the general practice. Moreover, 
in certain duo-practices it was not possible to make a distinction between the 
GPs of the patients. This means that the GP level was skipped, and two levels 
remained. According to the study of de Jong15, the loss of information resulting 
from this aggregation is minimal. De Jong15 found more similarities between 
GPs who share a work environment than between GPs who do not share a work 
environment. These similarities15 consist primarily of self reported behaviour, and 
Table 7.4









Study 1 0.02 0.98
Study 2
RNG Vis-a-vis
ZF0 0.01 0.004 0.99
ZF1 0.03 0.005 0.96
Episodes
ZF0 0.02 0.02 0.96
ZF1 0.03 0.03 0.93
Prescriptions ZF0 0.03 0.008 0.96
ZF1 0.04 0.03 0.93
RZG ZF1 0.02 0.01 0.96
Study 3







DDD’s of Benzodiazepine 0.02 0.78 0.20
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behaviour reported by the GP during GP-patient contact. De Jong15 concluded that 
variation seen at the practice level does not only indicate individual differences 
in the GPs, but also patterns that are formed by social processes caused by the 
interaction between the GP and local circumstances. This suggests that there is 
not a large loss of information in studies 1 and 4 due to aggregation to the practice 
level.
Table 7.4 shows the variance partition coefficients for the four studies. The largest 
proportion of variance is found at the patient level (range: 0.78 – 0.99). The cross-
sectional studies (S1 and S2) show higher coefficients at the patient level than the 
longitudinal studies. In the longitudinal studies, 3 to 20 percent of the variance is 
found at the intra-patient level. Study 2 includes a comparison between patients 
on government funded health care (ZF1) and privately insured patients (ZF0). This 
shows that there is less patient level variance in the ZF1 group, which is why the 
contextual variance is proportionately larger in this group. 
Two studies in this thesis presented multilevel models of a special nature. In 
chapter 5 (S4) a repeated measurement design was used with the defined daily 
dose (DDD) of prescribed benzodiazepines as the dependent variable. The 
three sources of variation were the repeated measurements, the patients, and 
the general practice. This design can be modelled as a multilevel structure. 
These repeated measurements, in this case three in number, are the first level 
in multilevel terminology. The three measurements include one at baseline, 
one at post intervention period 1, and one at post intervention period 2. The 
measurements are nested under the patients (the second level), and the patients 
are nested under the general practices (the third level). The basic version of the 
multilevel model that could be used, in this case a three level random intercept 
model, implies equal variances for all three measurements and equal correlations 
between all pairs of measurements, which means a severe restriction for the 
statistical model. If no independent variables are included in the three-level 
random intercept model, four parameters can be distinguished: one parameter 
that represents the mean DDD of the prescribed benzodiazepines and variance 
parameters for each of the three levels. This model will further be referred to 
as model RM0. In this model the repeated measurements are not included in 
the fixed part of the model. If these measurements are included as a linear 
variable (time), the model is extended with five extra parameters, one parameter 
for the fixed part of the model representing average differences between the 
measurements and two random slopes of the variable time, indicating differential 
variability in trends over time between, respectively, practices and patients; with 
two associated slope-intercept covariance parameters. These two random slopes 
are parameters for the general practice level and the patient level, respectively. We 
call this model RM1. The time variable here is assumed to have a linear effect, in 
which the change per unit of time is constant for each patient but allowed to differ 
between patients and between GPs. This assumption can also be stated by saying 
that the difference between post intervention period 1 and baseline is the same as 
the difference between post intervention period 2 and post intervention period 1. 
In a further extension of this model, the assumption that time has a linear effect 
is dropped. This leads to model RM2. For each of these models the restriction 
of equal variances within patients for all three measurements, and equal 
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correlations between all pairs of measurements, still remains. The assumption of 
the validity of such restrictions can lead to incorrect conclusions if they are not 
valid in practice, especially in large datasets such as the ones in our four studies. 
Therefore, we chose in this study (S4) for a so-called fully multivariate model 
(FM0). In the fully multivariate model, the expected values and the covariance 
matrix are estimated without any restrictions, so that restrictions of equal 
variances and equal correlations are not made. According to Snijders9, one of the 
characteristics of the fully multivariate model is that in the case of a balanced 
dataset, the fully multivariate model corresponds to the usual multivariate 
analysis of variance (MANOVA) model, and the estimates of means, regression 
coefficients, variances and covariances will be the same. Each of the other 
multilevel models mentioned is a submodel of the fully multivariate model. To 
compare the previous models (RM0, RM1, RM2, FM0) we calculated the deviances 
and two associated goodness of fit indices (GOF): Akaike’s Information criterion 
(AIC) and the Bayesian Information criterion (BIC). In table 7.5, the GOFs of the 
models are presented and the differences in deviances are calculated (omitting 
meaningless comparisons). Table 7.5 also includes the two final models, RM-fin 
and FM-fin. These are models in which independent variables have been added, 
and which are similar to the RM and FM models with respect to the restriction 
of variances and correlations. Model FM-fin is the final model as it is included 
in study 4 (chapter 5). Model RM-fin is an extension of RM0 with variables that 
appear in this final model. Comparing the models RM0, RM1, RM2, and FM0 with 
each other, it appears that the null model (FM0) of the fully multivariate model 
is the best with regard to the two GOFs. Based on this result we can expect that 
the final model of the fully multivariate model will be the best (AIC = 30684; BIC 
= 30999). Comparing the two final models RM-fin and FM-fin confirms this same 
result.
Table 7.5
Comparison between models by deviance (-2LL), Akaike Information criterion (AIC), Bayesian 
Information criterion (BIC), and their differences express in Chi-square and degree of freedom difference 
(df_delta)
Models
RM0 RM1 RM2 FM0 RM-fin FM-fin
-2LL 32266 31571 32142 31370 30856 30606
K 4 9 7 15 31 39
AIC 32274 31589 32156 31400 30918 30684
BIC 32307 31662 32213 31521 31169 30999
df_delta
RM0 - 5 3 11
RM1 695* - 2 6
Chi-square RM2 124* 571* - 8
FM0 896* 201* 772* -
RM-fin - 8
FM-fin 250* -
* = p<0.001; K = number of parameters; fin = final; -2LL = minus twice the natural logarithm of the likelihood;  
RMx (where x =0, 1, 2, fin) = repeated measurement model x; FMx (where x = 0, fin) = fully multivariate model x
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7.3.4 Latent class 
A variant of the multilevel model, namely a multilevel latent class model, is 
applied in chapter 4 (Study S3). This model is used to investigate antibiotic 
prescribing patterns in general practices over a period of five years. The 
longitudinal character of the data was taken into account by the specification 
of the latent class model. The usual assumption for multilevel models with 
longitudinal data is that the differences between the individuals are normally 
distributed. A different possibility is to make the assumption that the individuals 
differ in the sense that they belong to different discrete groups. These groups 
are called latent classes, because they are not directly observed but have to 
be estimated from the data. Such models have been proposed by Vermunt16,17, 
generalizing previous models developed by Lazarsfeld and Goodman. In 
chapter 4, the patients are clustered in groups (forming latent classes) that are 
homogeneous with respect to the amount of antibiotics prescribed. For these 
kinds of medication variables, which develop over a period of several years, a 
model with latent classes is more suitable than a model with normal distributions. 
The reason is that discrete latent classes, because of their flexibility, are better 
for representing the discrete and skewed distributions typical of prescription 
data. An additional level of detail is possible because for each prescription in 
this data set, the prescribed antibiotic is known. The latent class structure can 
thus differ according to the indication cluster, or system. A two-class solution 
was found as the best interpretable solution for the auditory system, while for 
the other indication clusters, a three class solution worked best. These three 
classes may be described as group 1: the non-prescription group, group 2: the 
varied prescription group, and group 3: the high prescription group. These names 
reflect the ordering of the classes with regard to the number of prescriptions. 
To a good approximation, the average number of prescriptions in these groups 
was constant over the five years of this study. The fact that such a latent class 
solution provided a good representation of the data points towards a high degree 
of continuity over time in the extent of antibiotic prescribing per patient. In order 
to assess the validity18 of these solutions, the relationship was calculated using 
known variables, in this case: age, gender, and the insurance status of the patient. 
Relationships found by other investigators19-21 with regard to antibiotic prescribing 
were confirmed in our study. If more variables had been measured, it would be 
possible to relate these classes to other patient variables, allowing further use of 
this type of analysis. Classes 2 and 3 are the most important ones relating to the 
GP in view of the risk of developing antibiotic resistance.
7.4 Contextual and compositional effects
 The use of multilevel modelling is the only statistically viable way to distinguish 
compositional from contextual effects22. In chapter 4 (study 2), a distinction was 
made between contextual and compositional effects. Goldstein and Leyland23 
discussed these effects as follows: The questions facing researchers concern the 
degree to which observed differences at the macrolevel – typically GPs or general 
practices – reflect genuine contextual differences between those general practices, 
or whether they do little more than reflect the composition of those general 
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practices in terms of microlevel (here: patient-level) factors. In accordance with 
Duncan24 the two types of effects can be described as follows: The composition 
of the general practice in chapter 4 refers to the make-up of the general practice 
in terms of the net characteristics of the patients who attend the general 
practice (for example foreigners); the contextual differences are the additional 
differences between general practices, that cannot be attributed to differences 
in the composition23. In addition to these two effects, Duncan distinguishes a 
third aspect, namely the interaction between composition and context. Similar to 
Goldstein and Leyland, we consider compositional variables at the micro as well 
as at the macro level. 
In order to demonstrate the distinction between compositional and contextual 
effects, we can use the results presented in table 4.4 of chapter 4, limited to the 
number of prescriptions for patients who have government funded health care as 
the dependent variable. 
We consider the coefficients of the two following variables: percentage of 
foreigners as a compositional effect, and whether or not patients live in a socio-
economically challenged neighbourhood as a contextual effect. Figures 7.1a 
and 7.1b show the relationship between the mean number of prescriptions 
for government funded patients (y-axis) and the percentage of foreigners in a 
neighbourhood (x-axis). The relationship is represented by a dashed line for 
patients living in a socio-economically challenged neighbourhood and by a 
solid line for patients in other neighbourhoods, controlled for the remaining 
variables. The percentage of foreigners represents the compositional effect of the 
neighbourhood. With respect to the contextual effect, which is expressed as the 
difference between socio-economically challenged and non socio-economically 
challenged communities, the number of prescriptions was 7% higher in socio-
economically challenged communities.
Figure 7.1b shows that, when the percentage of foreigners is low, there is only 
a small difference in the number of prescriptions between socio-economically 
challenged and non-challenged neighbourhoods. The difference becomes larger 
when the percentage of foreigners increases in such a way that the effect of 
the percentage of foreigners in a socio-economically challenged neigbourhood 
increases steeper than in other neigbourhoods. Duncan24. noted that the 
distinction between contextual and compositional effects is generally relevant, 
and that these concepts are applicable not only in cases where the attention is 
focused on the context, i.e. neighbourhoods, but also if the context can be seen in 
terms of administrative units (i.e. group practices), time periods, or institutional 
settings. Van Weel25 argues that besides the neighbourhood in which the patient 
lives, the patient’s family and work situation should also be considered as 
context. The patient’s family, work situation, and neighbourhood all belong to the 
background setting in which the patient’s health problems take place. It is this 
context in particular which determines the complexity of the GP’s role.
7.5 General conclusions
The theoretical and methodological aspects involved in modelling the variation 
found in a medical practice are continually developing26, and the application of 
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Figuur 7.1a 
The relation between number of prescriptions and percentage of foreigners (no interaction)
Figuur 7.1b 
The relation between number of prescriptions and percentage of foreigners (interaction)
multilevel models represents a major step forward. The studies in this thesis show 
that patient characteristics are more important than the characteristics of either 
the GP or the general practice, when modelling the medical variation in general 
practice using a minimal multilevel design (a design with the patients nested 
under GPs). This agrees with other sociological research in which multilevel 
analysis was applied. Because of the importance of not only patients but also GPs 
and practices on processes and outcomes in primary care, multilevel analysis 
is the only reliable way to estimate and test the effects of GP characteristics and 
case-mix characteristics on patient level outcome variables. For an explanation 
of the variance in patient-level-variables in a general practice, the variables at 
the patient level are usually the most important. In this thesis, the patient’s age 
turned out to be the most important of the case-mix variables. Age is negatively 
correlated to adherence to guidelines and the prescribing of benzodiazepines, 
while there is a positive association with antibiotic prescribing and GP workload 
(the number of face to face contacts, disease episodes, and prescriptions). 
With respect to the variables at the level of the GP and the medical practice, 
the practice type (single or group practice) shows an important relationship 
with the medical variation, while the designation of a community being socio-
economically challenged does not show a clear association with medical variation 
in these studies. 
Moreover, multilevel research methodology can be used in the context of quality 
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of care research, and in particular in relation to indicators of quality of care, 
also called performance indicators. Performance indicators are used as a tool in 
quality improvement as well as in performance-based reimbursement programs 
that reward health care providers for meeting preset targets27,28. Reliable and valid 
measurement of quality is essential. One of the problems in measuring quality 
of care provided by a particular health care provider is the issue of differences 
in case mix of the patient population underlying the performance. Multilevel 
research methodology can provide here an important progress29,30 by assessing the 
relative contributions of different levels or types of providers (e.g. GPs, GP-groups) 
and patients to the performance measured, such as prescribing. 
Also in the domain of care in deprived areas (described in study 2), the Ministry of 
Health Wellness and Sports (VWS) and the health insurance companies set up a 
fund (Achterstands Ondersteunings Fonds). This led to an administrative inter-
vention for improving the quality of care that patients living in disadvantaged 
communities in large urban centres, receive. From this fund, financial incentives 
were offered to achieve assigned-quality-related performance targets. The 
underlying assumption is that the incentives will motivate providers to achieve 
the performance targets. Multilevel research helps to clarify the causes and 
associated interventions for poor performance. For example, GP-level variation 
of global adherence may be indicative of differences in clinical training among 
GPs, pointing to a need for the implementation of evidence-based guidelines. 
However the greatest proportion of observed variation was actually at the 
patient level, which raises a question about what might be gained by directing 
incentives to patients to modify their own behaviour31. Research that determines 
the contribution of each provider level to observed variation in care, can inform 
policy decisions regarding incentives. If policymakers and insurers can better 
understand the sources of variations in performance, they will be more able to 
develop payment systems that reward providers based on the quality of care32 .
Choosing to look at compositional or contextual variables depends largely on 
the research question33. This implies that in the case of medical variation, it is 
impossible to indicate unambiguously in a general way whether medical variation 
is primarily related to the composition or the context. 
For the specific studies the most important conclusions may be summarized as 
follows:
 With respect to the medical variation represented as adherence to guidelines, 
it appeared that adherence is lower for older patients and for men, and also it is 
lower in solo practices compared to group practices, and in urban compared to 
rural regions; among these, the patient characteristics are more important than 
the practice characteristics (S1).
With respect to the medical variation represented by the GP workload, in the 
case of patients with government funded health care, we found that there was 
a difference depending on whether or not they lived in a socio-economically 
challenged neighbourhood. This difference was not found for patients with private 
medical insurance. In this study again, the patient characteristics were the most 
important predictors.
With respect to the medical variation seen in antibiotic prescribing, a distinction 
of patients in three groups appeared to be empirically meaningful: 1) the largest 
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group, in which no antibiotics were prescribed, 2) a smaller group, in which 
a varied pattern of prescribing was seen, and 3) the smallest group, in which 
antibiotics were prescribed on a regular basis. In this study it made more sense to 
divide the patients into three categories than considering them as a single group 
distinguished by continuously varying differences. The patient characteristics 
(age and gender) are related to these three groups (S3).
 With respect to the medical variation represented by benzodiazepine prescribing, 
it appeared that a written recommendation by GPs to chronic benzodiazepine 
users, advising them to decrease benzodiazepine use, leads to a reduction in 
benzodiazepine prescriptions for these patients (S4). 
The development of multilevel analysis started in the 1980s and became widely 
accepted among methodologists in the 1990s, but there are still many researchers 
who are somewhat reluctant to apply it. The studies in this thesis illustrate that 
multilevel analysis has many advantages compared to analysis at a single level. 
Single level analyses at either the GP or patient level carry the risk of leading to 
incorrect or incomplete conclusions. The complexity of multilevel techniques 
does not need to prevent their use, as we have demonstrated in this dissertation. 
In fact, the flexibility of the model should be a stimulus for researchers to apply 
multilevel analysis more frequently. In addition, graphic representation of the 
multilevel models can be helpful for their development and testing.
In this study the intraclass correlations seen in the structure with patients nested 
under GPs, general practices, or neighbourhoods, were very low. This could be 
regarded as an argument for using a single level model instead of a multilevel 
model. One would, in that case, choose the patient level because most of the 
variance is present at that level. Whether this is warranted depends in the 
first place on the effect this would have on the significance level of hypothesis 
tests. The consequence of ignoring the multilevel structure can be summarized 
by saying that treating a two-level design as a single-level design will inflate 
t-statistics erroneously by a factor which is approximately the square root of the 
design effect. The design effect is a measure combining the size of the clusters 
or groups and the intraclass correlation9. For a design effect less than 1.2 the 
inflation of the t-statistic, and the associated unjustified lowering of the p-value, 
are so small that they are not very serious. For higher values of the design effect, 
however, ignoring the multilevel structure has undesirable consequences. 
Because of the large number of patients in each general practice the design effect 
is larger than the threshold value of 1.2. Notwithstanding the relatively low values 
we found for the intraclass correlations or variance partition coefficients at the GP 
level, multilevel analysis remains the model of choice because the importance of 
the GP level variance is multiplied by each GP’s number of patients.
7.5.1 Implications
The implications for directions of future medical research will be discussed 
separately for each study.
In study 1, we investigated the global adherence to medical guidelines. Apart 
from the global adherence, Kamps also distinguished the specific adherence. 
As multilevel methodology has been applied in this dissertation, with regard 
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to global adherence, it could be useful to investigate the specific adherence in a 
multilevel design.
In study 2, we demonstrated that the GP workload shows a weak relationship with 
the way the general practice is organized. Solo practices are expected to merge 
increasingly with larger professional organization forms such as group practices 
and health centres. This will necessitate further studies into the workload and 
the quality of care in these newly developing professional organizations. The 
nature of these organizations, consisting of groups of GPs, implies that here 
again, multilevel techniques – distinguishing between patients, doctors and other 
professionals, and practices – will be the most suitable method to analyze clinical 
activities26. 
In study 3, we suggested that with regard to the three antibiotic prescription 
groups (no prescriptions, various prescriptions, and many prescriptions), the 
second, intermediate group, turns out to be the most important group when 
considering the development of antibiotic resistance. With respect to this group, 
the GP would be able to coordinate medical policies to limit antibiotic use, thereby 
preventing patients from becoming chronic users. It turns out that the closeness 
between patient and GP can be investigated by evaluating an intervention, such 
as preventing patients to become chronic users of antibiotics.
In study 4, we found that a letter from the GP recommending the reduction 
or cessation of benzodiazepine use resulted in decreased use. Based on this 
empirical result, it would be interesting to carry out further research to investigate 
patients’ reactions to letters about other specific medications and medical issues 
and to explore additional forms of non-conventional communication methods 
between GPs and their patients.
As this dissertation is primarily methodologically oriented, it will hopefully 
stimulate an increased use of multilevel analysis techniques in the research of 
general practice issues. The development of latent class models (an extension of 
multilevel analysis) presents perspectives well adapted for research involving 
variables with discrete or skewed distributions. However, besides methods, 
theories are also important for scientific advancement. For a theoretical 
argumentation of research involving medical variation, the supplier-induced 
demand theory34,35, the income incentives model32, or the demand control 
model36 (with regard to workload) are good starting points. But these theories 
are not sufficiently specific, and there is an urgent need for these and other 
general theories and models to be further elaborated for this particular research 
domain, and to take into account the specific nested position of patients, GPs, 
and practices. Such theories would be a major help in starting to explain which 
variables, GP dependent or practice dependent, are responsible for the variation 
seen between GPs and between practices. 
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This dissertation applies multilevel analysis to large databases originating 
from general practices. The multilevel aspect concerns the way the data of 
patients and general practitioners (GPs) are taken together in one analysis, 
viz. patients nested within GPs. The reason for this dissertation, and the 
layout are described in chapter 1.
Chapter 2 includes a description of multilevel methodology, in which case the 
research question and the data structure, as used in research with regard to 
the general practice, is important. As well the research question as the data 
structure refer to two populations, patients and GPs. In a statistical sense, the 
concept ‘dependency’ is crucial: because the observations of patients are nested 
within GPs, there is a dependency between the data of patients of the same GP. 
Because of this, the traditional analysis methods, as linear regression-analysis, 
that are based on the assumption of independent observations, are not directly 
applicable. This is explained in chapter 2, in which case the arguments for the 
choice of multilevel modelling are given, such as the decomposition of different 
variance components, the calculation of random slopes, or the fact that multilevel 
models need less assumptions in comparison with the classical ANOVA-models. 
Finally, in this chapter, the advantages of the use of multilevel modelling will be 
discussed. The chapter ends with the main research question.  In the multilevel-
analysis results of GPs or general practices are adjusted with factors that 
characterise the patient population of the GP or the general practice (case-mix) as 
diagnosis, age and gender.
This research question concerns four choice-topics with regard to prescribing.
The issue of the four choice-topics concerns:
1 The relation between prescribed and adherence to guidelines
2 The relation between workload of the GP and the patient and his neighborhood
3 To map out the prescribing of antibiotics, taking into consideration the 
diagnostic variation
4 The reduction of benzodiazepine prescribing in an intervention study
In chapter 3 the term ‘global compliance’ is used to describe the variance of 
patients nested within GP-practices in a two level model. Global compliance is 
defined as the prescribing of a medicine that is mentioned in a formulary. This 
chapter investigates the extent to which global compliance can be explained by 
patient and GP-characteristics. For 269067 patients of 190 general practices in 
the North of the Netherlands, the global compliance was defined as the outcome 
measure in a two-level model. The mean global compliance was 82%. Two general 
practices variables viz. organisation of the practice and the degree of urbanisation 
were related to the global compliance. The patient characteristics that are related 
to the global compliance are the case-mix variables age and gender, and variables 
that are aggregated from prescription to patient level, viz. costs, volume and 
different Anatomical Therapeutic Chemical-codes (ATC). The total explained 
variance of the final model in which GP-practice variables, patient characteristics 
and variables that are aggregated to patient level, turned out to be 28%.
In chapter 4 the workload of the GP is investigated using a model in which 
the patients are nested within GPs and the patients are also nested within a 
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neighborhood (postcode-area). This model is called a cross-classified model. By 
means of this model the question on whether the workload of GPs working in 
deprived areas in Groningen is higher than in non-deprived areas. The workload 
was operationalized by means of the total number of prescriptions, the total 
number of face-to-face contacts and the total number of episodes. The data 
derive from the Registration Network Groningen (RNG) and the biggest regional 
health insurance company. The data from this insurance company include 
the prescription data of 66028 sickfund-patients enrolled in the practices of 70 
GPs. Concerning the RNG, 14984 patients (54.2% being sickfund patients) were 
enrolled in the practices of 7 GPs. They are stratified by insurance type. The 
conclusion was that the workload turned out to be higher in the deprived areas. 
The most important determinants of the workload were patient-characteristics. 
Among the patient-characteristics, the most important were age (especially the 
age group above 65 years old), gender and insurance-type. The organisation of the 
general practice does not have a significant influence. The number of foreigners in 
a zipcode area did not have any significant influence on the workload. The patient 
characteristics are therefore the most important predictors for the workload. The 
method of calculating the workload can be improved by granting a higher weight 
to the patient factors. Replication research is necessary to determine if the results 
are also applicable to other cities with deprived areas.
In chapter 5 a two level model is presented to identify patterns from prescription 
data of patients older than 18 years, derived from the RNG for whom antibiotics 
was prescribed. It concerns a longitudinal design in which 125705 prescriptions 
are nested within 30167 patients in a period of five years (1998-2002). Three 
research questions will be answered, viz. 1) which pattern, if any can be identified 
for patients receiving antibiotics; 2) are these patterns stable across time, and 
do they have specific characteristics? 3) what are the relations with patient 
characteristics? In order to answer the research questions, a latent class model 
was applied stratificating the five chapters of the International Classification for 
Primary Care-system (ICPC), viz. tractus respiratorius, urinary tracts, ear, skin and 
the rest group. In this patient population of 18 years and older, two to three classes 
were identified. The three classes can be defined as class 1: ‘no prescriptions’-
group, class 2: ‘varied prescriptions’-group and class 3: ‘high prescriptions’-group. 
With regard to the chapter concerning the ear a two-class model was identified. 
This is related to the low prevalence of prescribing of antibiotics to patients older 
than 17 years. Comparing the two most important ICPC-chapters in which most 
antibiotics were prescribed, viz. tractus respiratorius and urinary tracts, it turns 
out that 75% of all patients did not receive antibiotics with regard to the tractus 
respiratorius and that 85% of all patients did not receive antibiotics with regard 
to the urinary tract. This means that patients with tractus respiratorius problem 
receive more antibiotic prescriptions than patients with urinary tract problems. 
The mean number of antibiotic prescriptions in class 2 (‘varied prescriptions’-
group) is in both cases (tractus respiratorius and urinary tract) 0.4 per year. So, 
patients belonging to class 2 get an antibiotic prescription once in two years. In 
class 3 differences can be seen between the tractus respiratorius and the urinary 
tract, viz. the number of antibiotic prescribing for urinary tract is higher but the 
number of patients to whom the antibiotics are prescribed, is lower. We found that 
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between 1998 and 2002 the rates were rather stable over time and that there was 
also a relation between the rates and patient characteristics (age and gender).
In chapter 6 the efficiency of the reduction of prescribing benzodiazepines using a 
minimal intervention in the North of the Netherlands (the Province of Groningen) 
is investigated. The method in order to reduce the use of benzodiazepines 
concerned a letter of the GP to chronic users. The letter included information about 
the disadvantages of regular use and the advice to reduce or to stop antibiotic 
use. The study was carried out in the region East- and North-West Groningen from 
November 1998 to May 2000. The outcome measure was the sum of the number of 
Defined Daily Dose (DDD) benzodiazepines in six months. DDD is an international 
volume-measure for the use of drugs. Among the 56 general practices in East-
Groningen, 19 general practices made up the intervention group, while the control 
group consisted of 37 general practices from East-Groningen and 91 general 
practices from North-West-Groningen. A three level model was used to answer the 
research question. This model consists of half-year periods nested within patients 
and the patients were nested within general practices. The half-year periods 
were defined as dummies in a fully multivariate model. A reduction of 16% was 
demonstrated after six months and 14% after one year, controlling for patient 
characteristics (age and gender) and aggregated prescription characteristics 
(duration and benzodiazepine-type). In this study it is demonstrated that a 
substantial decrease of prescribing antibiotics can be realized by a simple 
intervention using a letter of the GP.
Chapter 7 is a general discussion of the four studies comparing the characteristics 
of the research in which case the multilevel aspect was the main issue. 
Comparisons between presented models are discussed. Moreover methodological 
issues, as the advantages of multilevel models are discussed and the arguments 
in order to apply multilevel in the four studies, were mentioned. Because patients 
are nested within the GP and/or general practices, multilevel models are the most 




Deze dissertatie beschrijft de toepassing van multilevel analyse op grote 
databestanden uit de huisartspraktijk. De multilevel methode of methodo-
logie heeft betrekking op de manier waarop de gegevens van de patiënt en 
huisarts samen in één analyse worden genomen, namelijk patiënten zijn 
genest onder de huisartsen. 
In hoofdstuk 1 wordt de ontwikkeling tot deze dissertatie beschreven.
Hoofdstuk 2 bestaat uit een bespreking van wat multilevel methodologie inhoudt, 
waarbij de vraagstelling en de datastructuctuur, gebruikelijk bij onderzoek 
naar de huisartspraktijk, belangrijk is. Vraagstelling zowel als datastructuur 
hebben betrekking op twee populaties, patiënten en huisartsen. In statistische 
zin is het begrip ‘afhankelijkheid’ cruciaal: doordat bij de observaties patiënten 
genest zijn onder huisartsen ontstaat er een afhankelijkheid tussen de 
gegevens van patiënten van dezelfde huisarts. Hierdoor zijn meer traditionele 
analysemethoden, zoals lineaire regressie-analyse, die gebaseerd zijn op de 
assumptie van onafhankelijke waarnemingen, niet direct toepasbaar. Dit wordt 
nader toegelicht, waarbij argumenten voor de keuze voor multilevel modellering 
worden gegeven. Tenslotte worden in dit hoofdstuk de voordelen van het gebruik 
van multilevelmodellen besproken, zoals het ontleden van de verschillende 
variantie-bronnen, het uitrekenen van random slopes of dat er voor multilevel 
modellen minder assumpties nodig zijn in vergelijking met de klassieke ANOVA-
modellen. Het hoofdstuk eindigt met de probleemstelling van de hoofdstukken in 
dit proefschrift, die betrekking heeft op vier gebieden m.b.t. het voorschrijven van 
geneesmiddelen. In de multiniveau-analyse worden resultaten van huisartsen, of 
praktijken, aangepast volgens factoren die de patiëntenpopulatie van de huisarts-
kenmerken of praktijkkenmerken (‘case-mix’) zoals diagnose, leeftijd en geslacht.
De problematiek van de vier onderzoekingen betreft:
1 De relatie tussen het voorschrijven en de adherentie aan de richtlijnen.
2 De relatie tussen de werkbelasting van de huisarts, en de patiënt en zijn 
leefomgeving.
3 Het in kaart brengen van het antibiotica-voorschrijven, waarbij rekening wordt 
gehouden met de diagnostische variatie.
4 Het verminderen van benzodiazepine-voorschrijven in een interventie 
onderzoek.
In hoofdstuk 3 wordt het begrip globale compliantie gebruikt om in een twee 
niveau model de variatie tussen patiënten, en tussen  huisarts-praktijken, te 
beschrijven. Globale compliantie wordt omschreven als het voorschrijven van een 
middel dat in een formularium wordt genoemd. Onderzocht wordt in hoeverre 
globale compliantie verklaard kan worden met patiënt- en huisartskenmerken. 
Bij 269067 patiënten van 190 huisartspraktijken in Noord-Nederland werd de 
globale compliantie bepaald als uitkomstmaat in een twee niveau model. De 
gemiddelde globale compliantie was 82%. De twee huisartspraktijk-variabelen 
organisatievorm van de praktijk en urbanisatiegraad zijn gerelateerd aan de 
globale compliantie. De patiëntkenmerken die gerelateerd zijn aan de globale 
compliantie zijn de case-mix variabelen leeftijd en geslacht en de naar patiënt-
niveau-geaggregeerde-voorschrift variabelen, kosten, volume, verschillende 
ATC-codes. De totale verklaarde variantie van het model waarin huisarts-
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praktijk variabelen, patiëntkenmerken en variabelen die naar patiënt-niveau zijn 
geaggregeerd, is 28%.
In hoofdstuk 4 wordt de werkbelasting van de huisarts onderzocht in een 
model waarin de patiënten genest zijn onder huisartsen en de patiënten ook 
genest zijn onder bepaalde door postcode geïdentificeerde woongebieden 
(postcode-gebieden). Dit model wordt een gekruist multiniveau model (cross-
classified model) genoemd. Met dit model werd de vraag beantwoord of de 
zorg voor patiënten in achterstandswijken in Groningen arbeidsintensiever 
is voor huisartsen dan in niet-achterstandswijken. De werkbelasting werd 
geoperationaliseerd aan de hand van het aantal voorschriften, het aantal 
face-to-face contacten en het aantal episoden. De gegevens zijn afkomstig van 
het Registratie Netwerk Groningen (RNG) en van de grootste zorgverzekeraar 
in de stad Groningen. De gegevens van de zorgverzekeraar bevatten de 
prescriptiegevens van 66028 ziekenfondspatiënten ingeschreven bij 70 huisartsen. 
Wat het RNG betreft zijn 14984 patiënten ( waarvan 54.2% ziekenfondspatiënten 
zijn) ingeschreven bij 7 huisartsen. Ze zijn gestratificeerd naar verzekeringsvorm. 
De conclusie luidt dat de werkbelasting hoger is in achterstandswijken. De 
belangrijkste determinanten van de werkbelasting zijn de patiëntkenmerken 
leeftijd (speciaal de leeftijdsgroep 65+), geslacht en verzekeringsvorm. De 
organisatie van de huisartspraktijk speelt een geringe rol. Het aantal allochtonen 
in een postcodegebied blijkt in deze studie geen eenduidige invloed te hebben 
op de werkbelasting. De patiëntkenmerken zijn dus de belangrijkste voorspellers 
van de werkbelasting. Het sterker laten meewegen van patiëntgebonden 
factoren kan de systematiek van berekenen van de zorgbelasting  verbeteren. 
Replicatieonderzoek is nodig om te bepalen of deze bevindingen ook in andere 
achterstandsgebieden van (grote) steden van toepassing zijn.
In hoofdstuk 5 wordt met een twee niveau model beoogd patronen te identificeren 
uit de prescriptiegegevens van antibiotica aan patiënten die ouder dan 18 
jaar zijn, afkomstig uit het RNG. Het betreft een longitudinale design waarin 
125707 voorschriften zijn genest bij 30167 patiënten over een periode van vijf 
jaar (1998-2002). Drie onderzoeksvragen zijn beantwoord, te weten: 1) zijn 
voorschrijfpatronen wat betreft antibiotica te identificeren bij patiënten? ; 2) 
hebben zulke voorschrijfpatronen, als ze bestaan, bepaalde kenmerken die 
stabiel zijn in de tijd?; 3) zijn er relaties van deze patronen met patiëntkenmerken?  
Om deze onderzoeksvragen te beantwoorden is een latente klasse modellering 
toegepast, waarbij gestratificeerd is naar vijf hoofdstukken van het International 
Classification for Primary Care (ICPC)-systeem, namelijk: luchtwegen (Tractus 
respiratorius), urinewegen, oor, huid en de rest-groep.  In deze patiënten-populatie 
van 18 jaar en ouder werden 2 tot 3 klassen geïdentificeerd. De drie klassen zijn te 
omschrijven als klasse 1: ‘geen voorschriften’ , klasse 2: ‘matig veel voorschriften’ 
en klasse 3: ‘zeer veel voorschriften’. Voor het ICPC-hoofdstuk ‘oor’ was klasse 
3 niet van toepassing. Dit komt door de lage prevalentie in een populatie van 18 
jaar en ouder. Vergelijken we de twee belangrijkste ICPC-hoofdstukken, waarvoor 
de meeste antibiotica worden voorgeschreven, met elkaar, te weten: de Tractus 
respiratorius en de urinewegen, dan blijkt dat aan drie kwart van alle patiënten 
geen antibiotica met betrekking tot de luchtwegen werden voorgeschreven 
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en bij 85% van alle patiënten geen antibiotica met betrekking tot urinewegen 
werden voorgeschreven. Dus er worden minder antibiotica voorgeschreven aan 
patiënten met een aandoening van de urinewegen dan aan patiënten met een 
aandoening van de Tractus respiratorius. Het gemiddeld aantal voorgeschreven 
antibiotica bij de klasse 2 (‘matig veel voorschriften’-groep) is bij de Tractus 
respiratorius evenals bij de urinewegen 0.4 per jaar. Dus dit betekent dat voor 
de patiëntengroep uit klasse 2 geldt dat gemiddeld in twee jaar een voorschrift 
antibiotica wordt voorgeschreven. In de klasse 3 zijn verschillen te zien tussen 
de Tractus respiratorius en de urinewegen, namelijk het aantal voorgeschreven 
antibiotica bij de urinewegen is hoger, maar de recepten worden aan minder 
patiënten voorgeschreven. De gevonden schattingen bleken stabiel te zijn tussen 
tussen 1998 en 2002 en er bleek een relatie te zijn tussen de schattingen en de 
patiëntkenmerken, leeftijd en geslacht.
In hoofdstuk 6 wordt de doelmatigheid bepaald van een minimale interventie om 
het voorschrijven van benzodiazepinen te verminderen in de provincie Groningen. 
Deze interventie bestond uit het versturen van een brief van de eigen huisarts 
aan chronische gebruikers van benzodiazepinen. De brief bevatte informatie 
over nadelen van regelmatig gebruik en een advies het gebruik te verminderen 
of te stoppen. Het onderzoek werd uitgevoerd in de regio Oost- en Noord-West 
Groningen in de periode november 1998 tot mei 2000. De uitkomstmaat was de 
som van het aantal ‘Defined Daily Dose’ (DDD) benzodiazepinen per zes maanden. 
DDD is een internationaal gehanteerde volumemaat voor medicijngebruik. Van de 
56 huisartspraktijken in de regio Oost-Groningen vormden 19 huisartspraktijken 
de interventiegroep, terwijl de controle-groep bestond uit 37 huisartspraktijken 
uit Oost-Groningen en 91 huisartspraktijken uit Noord-West Groningen. Een drie 
niveau model werd gebruikt om de onderzoeksvragen te beantwoorden. Het model 
bestond uit halfjaarlijkse perioden genest binnen patiënten, en de patiënten 
waren genest binnen huisartspraktijken. De halfjaarlijkse perioden werden als 
dummies gedefinieerd in een volledig multivariaat model. Er werd een reductie in 
voorschrijven aangetoond van 16% na zes maanden en 14% na een jaar, waarbij 
gecontroleerd werd voor patiëntkenmerken (leeftijd en geslacht) en geaggregeerde 
voorschriftkenmerken (werkingsduur en benzodizepine-type). Aangetoond 
wordt in dit onderzoek dat een substantiële afname van het voorschrijven van 
benzodiazepinen gerealiseerd kan worden met een eenvoudige interventie in de 
vorm van een brief van de eigen huisarts.
In hoofdstuk 7 worden de vier studies besproken en vergeleken op verschillende 
aspecten zoals hun onderzoeksvorm. Hierbij staat het multiniveau aspect centraal. 
Tevens worden de gepresenteerde modellen vergeleken en methodologische 
discussiepunten zoals de voordelen van multiniveau modellen besproken, 
alsmede de argumenten om in elk van de vier studies een multiniveau design toe 
te passen. Omdat patiënten genest zijn onder de huisarts en of huisartspraktijken, 
zijn multiniveau modellen zeer geschikt om de onderzoeksvragen te 




Ooit heb ik geroepen, nooit te gaan promoveren. En hoe is het dan toch zover 
gekomen? Dat is te danken aan heel veel mensen die op verschillende momenten 
een bijdrage leverden. Dit proefschrift is mogelijk geworden door de inzet 
van een aantal personen die direct of indirect  betrokken zijn geweest bij de 
totstandkoming ervan. Deze mensen wil ik hier graag bedanken voor hun hulp.
Allereerst wil ik mijn eerste promotor, Prof. dr. B. Meyboom-de Jong bedanken. 
Beste Betty, ik wil je bedanken voor de geboden mogelijkheden en het vertrouwen 
dat je mij gedurende de promotietijd hebt gegund. Ik waardeer je bijna onuitputte-
lijke werklust, maar in het bijzonder je aandacht voor en nieuws gierigheid naar de 
persoon achter de promovendus maken jou tot een bijzonder mens.
Mijn tweede promotor, Prof. dr. T.A.B. Snijders wil ik als tweede bedanken. Beste 
Tom, je bent niet alleen een echte wetenschapper, je scherpe oog voor de kern van 
de zaak is onnavolgbaar. Ik wil je dan ook bedanken voor de belangrijke bijdrage 
die je aan dit proefschrift hebt geleverd en het in mij gestelde vertrouwen. Heel 
bijzonder is dat onze paden ook kruisen bij het paardrijden en de tango.
Als derde wil ik Prof. dr. F.M. Haaijer-Ruskamp bedanken. Beste Floor, historisch 
ben jij degene waar het allemaal mee is begonnen. Ik ben je zeer dankbaar dat 
ik kon werken met echte data en de volgens jou simpele, maar methodologische 
complexe vragen heb mogen beantwoorden. Deze vragen hebben mij de 
gelegenheid geboden mijn methodologische vaardigheden te ontwikkelen. 
Daarnaast zal ik de interessante en goede gesprekken met Geerd niet vergeten. 
Bedankt Geerd, jij hebt ervoor gezorgd dat ik in de discussies met Floor stand 
hield.
Ook dr. J. Broer wil ik graag apart bedanken. Beste Jan, je kritische opmerkingen 
tijdens de besprekingen en de aangename manier waarop ik met je kon samen-
werken, zou ik graag ook na het proefschrift verder willen voortzetten. Samen met 
Wim Niessen hebben jullie een belangrijke bijdrage geleverd bij het onderzoek in 
de provincie Groningen naar het gebruik van benzodiazepines.
De leden van de leescommissie Prof. dr. S.A. Reijneveld, Prof. dr. P. Groenwegen 
en Prof. dr. F. Schellevis dank ik voor het beoordelen van dit manuscript. 
Dit proefschrift heeft zijn belangrijkste wortels bij huisartsgeneeskunde. De 
gegevens van duizenden patiënten werden door de huisartsen elke dag opnieuw 
ingevoerd en/of bijgewerkt in het huisartsinformatiesysteem. Daarna verbeterd 
en soms weer aangepast als Rikkert Smit met zijn team nog steeds fouten vonden. 
Beste Rikkert, heel erg bedankt voor de leuke tijd.
Ik wil de volgende medewerkers en huisartsen van het Huisarts-instituut 
bedanken: mw. R. Bange, mw. E.M. ter Braak, mw. E. Robben, L.J.G. Veehof, 
G.Th. van der Werf, J.F. Heres, J. Talsma, mw. B. Meyboom-de Jong, I.K. Schut, 
L. Hak voort, mw. A.H.M. Boekema, mw. A. Hiddema-van der Wal, C.P.M. Hofman, 
H.H. Meppelder, H.J.J.B.M. Noordman, J.H. Schipper, mw. J. Dijkema, mw. G. Donker, 
R. van der Eijk, R.F.C. Huijgen, mw. B.J. Roze, J.A. Smith en mw. I. Brink.
De vele bijeenkomsten met jullie onder leiding van Betty, zijn van onschatbare 
waarde voor mij geweest. Hier kon ik leren dat ‘levende’ bestanden, een term van 
Ger van der Werf, een andere aanpak vragen, dan wat geleerd wordt tijdens de 
studie. Ger, je hebt gelijk, want de meeste methodologen hebben geen idee wat 
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de problemen zijn bij ‘levende’ bestanden. Met Leo Veehof werd het eerste echte 
RNG-proefschrift geschreven. De samenwerking met Geert Sulter en Sebastiaan 
Vroegop levert nog steeds vruchten af. Beste Sebastiaan, ik hoop nog met je 
samen te werken tot de verdediging van jouw proefschrift. Ali Hiddema heeft niet 
alleen een bijdrage als huisarts geleverd. Ook haar bijdrage als huisarts die zelf 
programmeerde, is heel erg belangrijk geweest. Ook Willem Jan van der Veen wil 
ik bedanken voor de hulp bij het verkrijgen van data uit het RNG. 
Dr. L. Schure, Beste Lidwien, bedankt voor jouw stimulerende woorden bij elke 
ontmoeting. En ook de samenwerking met Karel Schuit zal ik niet vergeten. En 
vooral Ineke, bedankt voor de prettige tijd die ik samen met jou mocht door-
brengen, ik zal je mooie lach, zoals Leo dat noemt, niet snel vergeten. Aan Gerard 
Kamps hou ik nog goede herinneringen met betrekking tot het samenwerken. 
Helaas ben je er niet meer, maar ik verdenk je ervan, dat je stiekem meekijkt.
Personen die indirect hebben bijgedragen aan dit proefschrift zijn de de patiënten 
van het RNG en alle patiënten van Menzis. Dankzij de hulp en adviezen van 
Eddy Bruins, was het mogelijk de zeer grote bestanden van RZG, later Menzis, 
te kunnen bewerken. Heel erg bedankt Eddy. Wij (Sebastiaan en ik) hopen in 
de toekomst nog van je diensten gebruik te maken. Ik geniet vooral als ik kan 
luisteren naar je rustige, mooie stem, wanneer je iets uitlegt.
Alle medewerkers van de zesde en de vijfde etage van de Brug (UMCG), wil 
ik bedanken voor de prettige samenwerking en jullie belangstelling voor de 
vorderingen van mijn proefschrift. Met het gevaar dat ik een paar mensen vergeet, 
zal ik een aantal personen noemen. 
Prof. dr. R. Sanderman. Beste Robbert, met jou zijn de eerste stappen gezet 
voor mijn methodologische ervaringen met betrekking tot ‘structured equation 
modeling’ (SEM), samen bij Hans Ormel. Bedankt voor deze leuke tijd. 
Prof. dr. A.V. Ranchor. Beste Adelita, zo nu en dan is er een samenwerking en ik 
leer elke keer weer van je vragen. 
Dr. E. van Sonderen. Beste Eric, de vele heftige discussies hebben nog steeds hun 
waarde, want dan werd het allemaal weer duidelijk. Wie ooit het proefschrift van 
Luciene van Eijk heeft gelezen, kan daar iets van deze discussies terug zien. 
Mw. dr. J. Fleer. Beste Joke nu dit proefschrift af is, en Raoul Nap ook zijn proef-
schift gaat verdedigen, zal het artikel ook afkomen. 
Mw. T. van Ittersum en G. van Brekel. Beste Truus, dankzij jouw ondersteuning 
kan ik nu gemakkelijk literatuur zoeken en verwerken in de systemen die zich 
maar steeds verder uitbreiden. Hierbij wil ik ook Guus bedanken, want hij was 
vanuit het CMB de grote goeroe op dit gebied. Ik verwacht dat met de ontwik-
kelingen van de informatietechnologie, jullie werkgebied zich zeker tot apart vak 
zal ontwikkelen. 
Ook Tineke van Wees en Renate Kroese wil ik bedanken voor de altijd weer 
helpende hand en steun. En uiteraard vergeet ik niet de lach van Gerda Klooster-
man en leuke gesprekken van Lida Op ’t Ende, vooral jullie bereidheid mij steeds 
weer aan te horen en te helpen. Beste Ria (Molanus), hoewel je niet meer bij onze 
afdeling ben, wil ik je ook bedanken voor de leuke tijd die ik hier mocht hebben.
Dr. L.M. Middel en dr. J van Dijk. Beste Berry en Jitse, van jullie heb ik veel geleerd 
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tijdens jullie promotietijd, namelijk dat het na vele worstelingen uiteindelijk toch 
af kwam. 
Prof. dr. J.W.Groothoff, Beste Johan, ik heb het voorrecht bij jou in de vakgroep 
te zitten. Dat is voor mij een groot genoegen. Dankzij jouw inspanningen ben en 
blijf ik financieel gezond. Dank voor alle steun en bescherming die ik heb mogen 
ontvangen tijdens de promotieperiode. Je was op elk tijdstip (’s avonds en ’s week-
ends) bereid mij te ondersteunen bij allerlei zaken. Ik hoop dat onze weekend 
ontmoetingen ook na de promotie door mogen gaan.
Dr. A. Boomsma. Beste Anne, bedankt dat ik deelgenoot mocht zijn van jou 
‘hoogst’ inspirerende discussies en leesgroepen. Ik kan altijd bij jou terecht met 
mijn Lisrel (SEM) problemen. Heel erg bedankt.
Samenwerking met diverse afdelingen van het Universitair Medisch Centrum 
Groningen (UMCG):
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Denig, Alexandra Doeglas en Ardy Kuperus en Peter Mol, Carel Schaars, Willeke 
Kasje, Nynke Veninga en Jasperin Doormaal resulteerde in een aantal artikelen. 
Van de afdeling Orthopedie wil ik Prof. J.R. ten Horn, Prof. S. Bulstra, dr. M. Stevens, 
dr.I. Scheek, Lex Boerboom,  dr. B. van Dalen en dr. C. Gerritsma-Bleeker bedanken 
voor de samenwerking. Beste Martin en Inge, ik hoop dat de mooie samen werking 
die we hebben, zo door kan gaan. Beste Lex, succes met jouw promotie onderzoek. 
Beste Bella en Carina, af en toe hebben we contact en het blijft leuk. 
Afdeling Revalidatie:
In het bijzonder OKER, met niet te vergeten dr. P.U Dijkstra en dr. A. Lettinga. 
Dr. Michiel Reneman, dr. Sandra Brouwer, Prof J. dr. Geertzen, Prof. dr. K. Postema, 
Prof. dr. H.J. ten Duis, Prof. dr.W.H.Eisma, Prof. dr. Ludwig Göeken, dr. C van der 
Sluis, dr. R. Dekker, dr. Bianca Nijhuis, dr. Leontien Sturms, dr. Marleen Schön-
herr, dr. Jan-Willem Meijer, dr. Rients Huitema, dr. ir. At L.Hof en Rita Schiphorst 
Preuper. Bedankt voor de zeer prettige samenwerking.
En dr. Cees van de Schans voor de sessies, die nu voortgezet worden door Paul 
Hod selmans en Mirjam van Ittersum: dank voor de vele discussies.
Afdeling Neurologie: Prof dr. J.H.A.S de Keyser, dr. G.J.R. Luijkx, dr. P.C.A.J. Vroomen, 
dr. M. Uyttenboogaart en Zwany Metting, Prof. N. Leendert, dr. A.Portman en 
dr. G. Sulter.
Voor de toekomst ligt samenwerking in het verschiet met dr. J. Cohen, Ally van 
der Hell en Mirjam van Lohuizen m.b.t. multilevel design. De samenwerking 
met dr. T. Kropmans en dr. H. Raghoebar-Krieger was ook heel bijzonder. Beste 
Thomas en Helga, zonder veel woorden, bedankt.
Ook met de afdeling Farmacie is er een plezierige indirecte samenwerking met 
Prof. K. Brouwer en Prof. L. de Jong-van den Berg en een heel plezierige directe 
samenwerking met Katja Taxis, Michiel Duyvendak en Asmar Al Hadithy. Beste 
Michiel en Asmar, hoewel we voornamelijk telefonisch en per email com municeren, 
komt er een proefschrift.
Indirecte bijdragen aan dit proefschrift komen van de patiënten van het RNG en 
alle patiënten van Menzis. Ook hen wil ik hierbij bedanken.
Ook de leden van de afdeling epidemiologie, in het bijzonder dr. V. Fidler, 
dr. J. Vonk en dr. M. Boezems, Jan Schouten en Hans Burgerhof. Hoewel niet 
verbonden aan de afdeling epidemiologie wil ik Klaas Groenier hierbij speciaal 
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noemen. Beste Jan, jammer dat we elkaar zo weinig zien, maar het is altijd leuk 
om voor of tussen de mentorgroepen van gedachten te wisselen. Bedankt voor de 
adviezen en hulp, vooral bij mijn software-problemen.
Beste Klaas, de discussies voor, tijdens en na de sesies van het statistiekpracticum 
blijven interessant.
Een project dat niet uit te wissen sporen heeft nagelaten is het project van Frank 
de Man, samen met  Prof. dr. Ben Binnendijk, Prof. dr. Henk Jan ten Duis, Martha 
Dekker, Reina Ofrein en Bert Dercksen, Maarten de Wit, en nog vele anderen. 
Frank en Bert, heel erg bedankt dat jullie steeds vroegen hoe het vordert met mijn 
promotie.
I would like to thank some researchers from the Kosice Institute of Society and 
Health (KISH), dr. Iveta Nagyová, dr. Andrea Gecková and dr. Mária Šléšková for 
the collaboration. Dear Iveta, you were the pioneer who made it possible for all the 
KISH researchers to defend their dissertation in Groningen. I learned a lot during 
our pleasant and stimulating meetings. Dear Andrea, we enjoyed your wedding 
party, it was really exciting. And finally Mária, I admire your quiet approach, 
modesty and drive.
Iemand die er niet meer is, is Magreet ter Schegget. Niet alleen het paardrijden 
had onze liefde, ook leuk samenwerken met jou, kon ik heel goed. Wat je hebt 
achtergelaten is HJ, Maerian de Jong, kleine Magreet en de mooie herinneringen.
Anne Starreveld, bedankt voor het vertalen, zelfs toen je op Antartica met vakantie 
was, ging je door met de vertaling. Bedankt Anne. We hebben veel uit gewisseld 
per mail en het was heel leuk en leerzaam. Naast het vertalen, waren er ook je 
kritische vragen en opmerkingen, ik zal ze missen. 
En dan de familie en vele vrienden die voornamelijk in het westen wonen. Bedankt 
dat ik zo nu en dan een kijkje kan nemen van wat er zich daar allemaal afspeelt. 
Isa, bedankt dat ik soms bij je kon logeren. Rietje van Oort, ik ken geen enkel 
persoon met een dergelijke groot sociaal hart. Ik leer elke keer weer van je. En 
niet te vergeten dé Petra, waar ik zo vaak heb mogen logeren als ik weer naar een 
congres ging, bedankt voor de bijzondere leuke tijd in Amsterdam en omstreken.
Lieve Erna, Bigi goedoe, ik wil je bedanken voor de ruimte die je mijn twee zussen 
en mij hebt gegeven voor persoonlijke ontwikkeling. Ik heb je bewonderd in de 
apotheek waar je werkte. Dat je dat allemaal wist wat je met allerlei stoffen pillen, 
drankjes en zalven kon maken, zodat iemand weer beter werd, had mijn grote 
bewondering.
Edith, lieve zus, ik ben blij dat ik bij jou altijd welkom ben en ik vind het leuk dat 
Melvin, één van mijn paranimfen kan zijn. 
De lange gesprekken met Renée en Myrna hebben ook hun sporen in dit proef-
schrift nagelaten. Probeer ze maar te vinden, want ik vertel het jullie niet, omdat 
we anders nog langere gesprekken krijgen.
Lieve Marianne, je bent degene met wie ik al heel lang discussie voer over het nut 
van de wetenschap. Bedankt dat je mijn paranimf wil zijn, ook voor je redactionele 
adviezen en het meedenken bij de stellingen. 
Vanzelfsprekend wil ik Hilde noemen, die eigenlijk niet bedankt wil worden, maar 
dat wel verdiend heeft. Het studeren zal nooit ophouden, niet voor jou maar, 
ook niet voor mij. Met jou kon ik altijd over methodologie praten en discussieren 
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en je was de gangmaker als het weer eens vastliep. Wat altijd door zal blijven 
gaan, zijn onze discussies, of we nu in Thailand zijn, op de Filippijnen, in Chili, 





1 Al Hadithy AF, Wilffert B, Stewart RE, Looman NM, Bruggeman R, Brouwers JR, et al. 
Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African-
Caribbean inpatients: differences in association with dopamine and serotonin receptors. Am J 
Med Genet B Neuropsychiatr Genet 2008 Sep 5;147B(6):890-7.
2 Arrindell W, Akkerman A, van der Ende J, Schreurs P, Brugman A, Stewart R, et al. Normative 
studies with the Scale for Interpersonal Behaviour (SIB): III. Psychiatric inpatients. 
Personality and Individual Differences 2005 Mar;38(4):941-52.
3 Arrindell W, Boomsma A, Ettema H, Stewart R. Nog meer steun voor het multidimensionale 
karakter van de SCL-90-R. De Psycholoog 2004;39:368-71.
4 Arrindell WA, Ende Jvd, Sanderman R, Oosterhof L, Stewart R, Lingsma MM. Normative 
studies with the Scale for Interpersonal Behaviour (SIB): i. Nonpsychiatric social skills 
trainees. Personality and Individual Differences 1999 Sep;27(3):417-31.
5 Arrindell WA, Boomsma A, Ettema H, Stewart R. Verdere steun voor het multi-dimensionale 
karakter van de SCL-90-R. De Psycholoog 2004;39(4):195-201.
6 Beemsterboer W, Stewart R, Groothoff J, Nijhuis F. The influence of sick leave frequency 
determinants on homogeneous groups in two socio-economically comparable, but socio-
culturally different regions in the Netherlands. Central European Journal of Public Health 
2008;16(4):151-60.
7 Boerboom AL, Huizinga MR, Kaan WA, Stewart RE, Hof AL, Bulstra SK, et al. Validation of a 
method to measure the proprioception of the knee. Gait & Posture 2008 Nov;28(4):610-4.
8 Boonstra AM, Van Laar I, Stewart R, Posthumus JB, Schiphorst-Preuper HR. Patient’s 
treatment goals in pain. European Journal of Pain 2006;10(Supplement 1):S249.
9 Boonstra AM, Schiphorst Preuper HR, Reneman MF, Posthumus JB, Stewart RE. Reliability and 
validity of the visual analogue scale for disability in patients with chronic musculoskeletal 
pain. International Journal of Rehabilitation Research 2008 Jun;31(2):165-9.
10 Boonstra AM, Reneman MF, Posthumus JB, Stewart RE, Schiphorst Preuper HR. Reliability 
of the Life Satisfaction Questionnaire to assess patients with chronic musculoskeletal pain.
International Journal of Rehabilitation Research 2008 Jun;31(2):181-3.
11 Brouwer S, Dijkstra PU, Stewart RE, Goeken LN, Groothoff JW, Geertzen JH. Comparing 
self-report, clinical examination and functional testing in the assessment of work-related 
limitations in patients with chronic low back pain. Disabil Rehabil 2005 Sep 2;27(17):999-
1005.
12 Dijkstra PU, Geertzen JHB, Stewart R, van der Schans CP. Phantom Pain and Risk Factors: A 
Multivariate Analysis. Journal of Pain and Symptom Management 2002 Dec;24(6):578-85.
13 Gecková A, van Dijk J, Stewart R, Groothoff JW, Post D. Influence of social support on health 
among gender and socio-economic groups of adolescents. Eur J Public Health 2003;13(1): 
44-50.
14 Geertzen JHB, Dijkstra PU, Stewart RE, Groothoff JW, Duis HJT, Eisma WH. Variation in 
measurements of range of motion: A study in reflex sympathetic dystrophy patients. Clinical 
Rehabilitation 1998;12(3):254-64.
15 Geertzen JHB, Dukstra PU, Stewart RE, Groothoff JW, Ten Duis HJ, Eisma WH. Variation in 
measurements of grip strength. A study in reflex sympathetic dystrophy patients. Acta 
Orthop Scand Suppl 1998;279:4-11.
16 Haaijer-Ruskamp FM, Evenwel RT, Dingemans CA, Stewart R. [Placement in a nursing home 
does not automatically lead to increased use of drugs]. Ned Tijdschr Geneeskd 1992 Nov 
21;136(47):2331-5.
17 Haaijer-Ruskamp FM, Stewart R, Wesseling H. Does indirect consultation lead to 
overprescribing in general practice? Soc Sci Med 1987;25(1):43-6.
123
18 Kamps GB, Stewart R.E., van der Werf GT, Schuling J, Meyboom-de Jong B. Adherence to the 
guidelines of a regional formulary. Fam Pract 2000;17(3):254-60.
19 Kasje W, Denig P, Stewart R, de Graeff P, Haaijer-Ruskamp F. An educational programme for 
peer review groups to improve treatment of chronic heart failure and diabetes mellitus type 2 
in general practice. Journal of Evaluation in Clinical Practice 2006;12(6):613-21.
20 Kasje WN, Denig P, Stewart RE, de Graeff PA, Haaijer-Ruskamp FM. Physician, organisational 
and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in 
heart failure treatment: a multilevel study. Eur J Clin Pharmacol 2005 Apr;61(2):145-51.
21 Kropmans T, Dijkstra P, Stegenga B, Stewart R, de Bont L. Smallest detectable difference 
of maximal mouth opening in patients with painfully restricted temporomandibular joint 
function. Eur J Oral Sci 2000 Feb;108(1):9-13.
22 Kropmans TJ, Dijkstra PU, Stegenga B, Stewart R, de Bont LG. Smallest detectable difference 
in outcome variables related to painful restriction of the temporomandibular joint. J Dent Res 
1999 Mar;78(3):784-9.
23 Kropmans TJB, Dijkstra PU, Stegenga B, Stewart R, de Bont LGM. Repeated assessment of 
temporomandibular joint pain: reasoned decision-making with use of unidimensional and 
multidimensional pain scales. Clin J Pain 2002 Mar;18(2):107-15.
24 Middel B, Kuipers-Upmeijer H, Bouma J, Staal M, Oenema D, Postma T, et al. Effect of 
intrathecal baclofen delivered by an implanted programmable pump on health related quality 
of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 1997 Aug;63(2):204-9.
25 Middel B, Stewart R, Bouma J, van Sonderen E, van den Heuvel WJ. How to validate clinically 
important change in health-related functional status. Is the magnitude of the effect size 
consistently related to magnitude of change as indicated by a global question rating? J Eval 
Clin Pract 2001 Nov;7(4):399-410.
26 Middel B, Goudriaan H, de Greef M, Stewart R, van Sonderen E, Bouma J, et al. Recall bias 
did not affect perceived magnitude of change in health-related functional status. Journal of 
clinical Epidemiology 2006 May;59(5):503-11.
27 Middel B, de Greef M, de Jongste MJL, Crijns HJGM, Stewart R, van den Heuvel WJA. Why don’t 
we ask patients with coronary heart disease directly how much they have changed after 
treatment? Journal of Cardiopulmonary Rehabilitation 2002 Jan;22(1):47-52.
28 Nagyova I, Stewart R, Macejova Z, van Dijk J, van den Heuvel W. The impact of pain on 
psychological well-being in rheumatoid arthritis: the mediating effects of self-esteem and 
adjustment to disease. Patient Education and Counseling 2005 Jul;58(1):55-62.
29 Nagyova I, Krol B, Szilasiova A, Stewart R, van Dijk J, van den Heuvel W. General Health 
Questionnaire-28: Psychometric evaluation of the Slovak version. Studia Psychologica 
2000;42(4):351-60.
30 Niessen W, Broer J, Stewart R, Haaijer-Ruskamp FM. Modification of the use and prescription 
of benzodiazepines in the region of East-Groningen. In: Schippers GM, Broekman TG, editors. 
Alcohol, drugs, and tobacco research 2001-2002, register of research in the Netherlands and 
flanders on the use, the users, and the effects of alcohol, drugs and tobacco in 2001-2002.
Meppel: Krips BV; 2003. p. 236-7.
31 Niessen WJM, Stewart RE, Broer J, Haaijer-Ruskamp FM. Vermindering van gebruik van 
benzodiazepinen door een brief van de eigen huisarts aan chronische gebruikers [Reduction 
in the consumption of benzodiazepines due to a letter to chronic users from their own general 
practitioner]. Ned Tijdschr Geneeskd 2005;149(7):356-61.
32 Ormel J, Sanderman R, Stewart R. Personality as modifier of the life event distress 
relationship: A longitudinal structural equation model. Personality and Individual Differences 
1988;9(6):973-82.
124
33 Ormel J, Stewart R, Sanderman R. Personality as modifier of the life change - distress 
relationship: A longitudinal modelling approach. Social Psychiatry and Psychiatric 
Epidemiology 1989 Jul;24(4):187-95.
34 Posthumus MD, Limburg PC, Westra J, Cats HA, Stewart RE, van Leeuwen MA, et al. Serum 
levels of matrix metalloproteinase-3 in relation to the development of radiological damage in 
patients with early rheumatoid arthritis. Rheumatology 1999 Nov 1;38(11):1081-7.
35 Pulles T, Biesiot W, Stewart R. Geluid en gezondheid, een interdisciplinair onderzoek naar de 
gezondheidseffecten van lawaai in de woonomgeving. Geluid en Omgeving 1989;12(2):68-72.
36 Raghoebar-Krieger HMJ, Sleijfer D, Bender W, Stewart RE, Popping R. The reliability of 
logbook data of medical students: An estimation of interobserver agreement, sensitivity and 
specificity. MED EDUC 2001;Medical-Education. 2001; 35:7-631.
37 Raghoebar-Krieger HMJ, Bender W, Kreeftenberg HG, Stewart R.E., Sleijfer DT. Medical 
students’ experiences of diseases in internal medicine in university and community 
hospitals. Medical Teacher 2002;24(4):402-7.
38 Sanderman R, Stewart R. The assessment of psychological distress: Psychometric properties 
of the General Health Questionnaire (GHQ). Int J Health Sciences 1990;1(3):195-202.
39 Scaf-Klomp W, van Sonderen FL, Stewart R, van Dijck JA, van den Heuvel WJ. Compliance after 
17 years of breast cancer screening. J Med Screen 1995;2(4):195-9.
40 Schaars C, Denig P, Kasje W, Stewart R, Wolffenbuttel B, Haaijer-Ruskamp F. Physician, 
Organizational, and Patient Factors Associated With Suboptimal Blood Pressure Management 
in Type 2 Diabetic Patients in Primary Care. Diabetes Care 2004 Jan 1;27(1):123-8.
41 Schuit KW, Otter R, Stewart R, Sleijfer DT, Meijler WJ, Meyboom-de Jong B. The effects of 
a postgraduate course on opioid-prescribing patterns of general practitioners. Journal of 
Cancer and Education 2000;Journal-of-Cancer-Education. 2000; 15:4-217.
42 Schure L, van den Heuvel E, Stewart R, Sanderman R, de Witte L, Meyboom-de Jong B. Beyond 
stroke: Description and evaluation of an effective intervention to support family caregivers of 
stroke patients. Patient Education and Counseling 2006 Jul;62(1):46-55.
43 Sleskova M, Salonna F, Geckova A, Nagyova I, Stewart R, van Dijk J, et al. Does parental 
unemployment affect adolescents’ health? Journal of Adolescent Health 2006 May;38(5): 
527-35.
44 Stewart R.E., Vroegop S, Kamps GB, Werf G.Th.van der, Meyboom-de Jong B. Factor 
influencing adherence to guidelines in general practice. International Journal of Technology 
Assessment in Health Care 2003 Jan 8;19(3):546-54.
45 Stewart R.E., Broer J, van der Werf GT, Meyboom-de Jong B. De werkbelasting van huisartsen 
in achterstandswijken in de stad Groningen. Tijdschr Gezondheidswet 2005;83(2):75-82.
46 Stewart R, Niessen W, Broer J, Snijders T, Haaijer-Ruskamp F, Meyboom-de Jong B. General 
Practitioners reduced benzodiazepine prescriptions in an intervention study: a multilevel 
application. Journal of clinical Epidemiology 2007 Oct;60(10):1076-84.
47 Sturms LM, van der Sluis CK, Stewart RE, Groothoff JW, Ten Duis HJ, Eisma WH. A prospective 
study on paediatric traffic injuries: health-related quality of life and post-traumatic stress. 
Clinical Rehabilitation 2005;19(3):312-22.
48 Sulter G, Elting JW, Stewart R, Den Arend A, De Keyser J. Continuous pulse oximetry in acute 
hemiparetic stroke. J NEUROL SCI 2000;Journal-of-the-Neurological-Sciences. 2000 OCT 01; 
179:1-2.
49 The B, Diercks RL, Stewart RE, van Ooijen PM, van Horn JR. Digital correction of magnification 
in pelvic x rays for preoperative planning of hip joint replacements: theoretical development 
and clinical results of a new protocol. Med Phys 2005 Aug;32(8):2580-9.
125
50 Uyttenboogaart M, Stewart R, Vroomen P, De Keyser J, Luijckx G. Optimizing Cutoff Scores for 
the Barthel Index and the Modified Rankin Scale for Defining Outcome in Acute Stroke Trials. 
Stroke 2005 Sep 1;36(9):1984-7.
51 Uyttenboogaart M, Luijckx GJ, Vroomen P, Stewart R, De Keyser J. Measuring disability in 
stroke: relationship between the modified Rankin scale and the Barthel index. Journal of 
Neurology 2007 Aug 4;254(8):1113-7.
52 Uyttenboogaart M, Vroomen PCAJ, Stewart RE, De Keyser J, Luijckx GJ. Safety of routine IV 
thrombolysis between 3 and 4.5 h after ischemic stroke. Journal of the Neurological Sciences 
2007 Mar 15;254(1-2):28-32.
53 Uyttenboogaart M, Koch MW, Stewart RE, Vroomen PC, Luijckx GJ, De Keyser J. Moderate 
hyperglycaemia is associated with favourable outcome in acute lacunar stroke. Brain 2007 
Jun 1;130(6):1626-30.
54 van Dalen IV, Groothoff J, Stewart R, Spreeuwenberg P, Groenewegen PP, van Horn J. Motives 
for seeking a second opinion in orthopsedic surgery. Journal of Health Services Research and 
Policy 2001;6(4):195-201.
55 van den Heuvel ETP, Witte LP, Stewart RE, Schure LM, Sanderman R, Meyboom-de Jong B. 
Long-term effects of a group support program and an individual support program for informal 
caregivers of stroke patients: which caregivers benefit the most? Patient Education and 
Counseling 2002 Aug;47(4):291-9.
56 van Wilgen CP, Dijkstra PU, Stewart RE, Ranchor AV, Roodenburg JLN. Measuring Somatic 
Symptoms With the CES-D to Assess Depression in Cancer Patients After Treatment: 
Comparison Among Patients With Oral/Oropharyngeal, Gynecological, Colorectal, and Breast 
Cancer. Psychosomatics 2006 Dec 1;47(6):465-70.
57 Veehof LJ, Stewart RE, Meyboom-de Jong B, Haaijer-Ruskamp FM. Adverse drug reactions and 
polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 1999 Sep;55(7):533-6.
58 Veehof LJ, Stewart R, Haaijer-Ruskamp FM, Meyboom-de Jong B. Chronische polyfarmacie bij 
eenderde van de ouderen in de huisartspraktijk. [Chronic polypharmacy in one-third of the 
elderly in family practice]. Ned Tijdschr Geneeskd 1999 Jan 9;143(2):93-7.
59 Veehof LJG, Stewart RE, Haaijer-Ruskamp FM, Meyboom-de Jong B. The development of 





Roy Edmund Stewart werd geboren op 23 mei 1949 te Paramaribo, Suriname. Na 
de lagere school en middelbare school, behaalde hij in 1968 zijn diploma aan de 
Surinaamse Kweekschool om later in Nederland te Zwolle af te studeren aan de 
Christelijke Pedagogische Academie in 1970.
Hij begon de studie psychologie aan de Rijksuniversiteit Groningen en behaalde in 
1987 zijn doctoraalexamen met als afstudeerrichting methodologie.
Tijdens zijn studie heeft hij diverse assistenschappen met betrekking tot 
methodologie vervuld bij het Rekencentrum, het Centrum voor Energie en 
Milieukunde, en bij de Faculteit der Medische Wetenschappen, afdeling 
Sociale Geneeskunde en Medische Psychologie. Van 1993 tot 1999 heeft hij 
methodologische ondersteuning geboden aan het medicatie- en morbiditeits 
registratienetwerk Groningen (RNG) van de Disciplinegroep huisartsgeneeskunde, 
vooral op het gebied van onderzoek naar medicatie, voorschrijfgedrag en 
polyfarmacie.
Hij heeft verschillende bestuurlijke functies vervuld bij maatschappelijke 
organisaties, o.a bij het Cultureel Centrum voor Latijns-Amerikanen en is lid 
geweest van de Minderhedenraad, een adviesorgaan van de gemeente Groningen. 
Vanaf 1999 werkt hij als medewerker bij de afdeling Gezondheidswetenschappen 
van het Universitaire Medisch Centrum Groningen (UMCG). Zijn taak is in eerste 
instantie methodologische ondersteuning bij promotie- en andere onderzoeken. 
Daarnaast is hij actief in het wetenschappelijk onderwijs van medische studenten 
als mentor en geeft hij cursussen met betrekking tot methodologie.
129
Graduate School for Health Research 
SHARE
130
This thesis is published within the Graduate School for Health Research SHARE (embedded in 
the University Medical Center Groningen / University of Groningen). 
More information regarding the institute and its research can be obtained from our internetsite: 
www.rug.nl/share.
Recent dissertations:
Buist I (2008) The GronoRun study; incidence, risk factors, and prevention of injuries in novice 
and recreational runners
Supervisors: prof dr RL Diercks, prof dr W van Mechelen
Co-supervisor: dr KAPM Lemmink
Škodová Z (2008) Coronary heart disease from a psychosocial perspective: socioeconomic and 
ethnic inequalities among Slovak patients
Supervisor: prof dr SA Reijneveld
Co-supervisors: dr JP van Dijk, dr I Nagyová, dr LJ Middel, dr M Studencan
Havlíková E (2008) Fatigue, mood disorders and sleep problems in patients with Parkinson’s 
disease
Supervisor: prof dr JW Groothoff
Co-supervisors: dr JP van Dijk, dr J Rosenberger, dr Z Gdovinová, dr LJ Middel
Bos EH (2008) Evaluation of a preventive intervention among hospital workers to reduce physical 
load
Supervisor: prof dr JW Groothoff
Co-supervisor: dr B Krol
Dijk GC van (2008) Care of people who are Powerless in Daily Living (PDL care); a theoretical 
approach
Supervisor: prof dr R Sanderman
Co-supervisor: dr A Dijkstra
Hulst, M van (2008) Health economics of blood transfusion safety
Supervisors: prof dr MJ Postma, prof dr CTh Smit Sibinga
Wagenmakers R (2008) Physical activity after total hip arthroplasty
Supervisors: prof dr S Bulstra, prof dr JW Groothoff
Co-supervisors: dr M Stevens, dr W Zijlstra
Aukes LC (2008) Personal reflection in medical education
Supervisors: prof dr JPJ Slaets, prof dr RP Zwiers
Co-supervisor: dr J Cohen-Schotanus
Barbareschi G (2008) Socioeconomic status and the course of quality of life in coronary heart 
disease and cancer; from description toward an explanation
Supervisor: prof dr R Sanderman
131
Zuurmond RG (2008) The bridging nail in periprosthetic fractures of the hip; incidence, 
biomechanics, histology and clinical outcomes
Supervisor: prof dr SK Bulstra
Co-supervisors: dr AD Verburg, dr P Pilot
Wynia K (2008) The Multiple Sclerosis Impact Profile (MSIP), an ICF-based outcome measure for 
disability and disability perception in MS: development and psychometric testing
Supervisors: prof dr SA Reijneveld, prof dr JHA De Keyser 
Co-supervisor: dr LJ Middel
Van Leeuwen RR (2008) Towards nursing competencies in spiritual care
Supervisors: prof dr D Post, prof dr H Jochemsen 
Co-supervisor: dr LJ Tiesinga
Vogels AGC (2008) The identification by Dutch preventive child health care of children with 
psychosocial problems : do short questionnaires help?
Supervisors: prof dr SA Reijneveld, prof dr SP Verloove-Vanhorick
Hinnen SCH (2008) Distress and spousal support in women with breast cancer
Supervisors: prof dr R Sanderman, prof dr AV Ranchor, prof dr M Hagedoorn
Nijhuis BGJ (2007) Team collaboration in Dutch paediatric rehabilitation
Supervisors: prof dr K Postema, prof dr H Nakken, prof dr JW Groothoff
Co-supervisors: dr HA Reinders-Messelink, dr ACE de Blécourt
Kort NP (2007) Unicompartmental knee arthroplasty
Supervisor: prof dr SK Bulstra
Co-supervisors: dr JJAM van Raay, dr AD Verburg
Weert E van (2007) Cancer rehabilitation – effects and mechanisms
Supervisors: prof dr K Postema, prof dr R Sanderman
Co-supervisors: dr CP van der Schans, dr JEHM Hoekstra-Weebers, dr R Otter
132
